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CHAPTER I 
INTRODUCTION 
Alpha adrenergic receptors have been reported to limit coronary 
blood flow under conditions of augmented oxygen demands when 
production of vasodilator metabolites might be expected to overwhelm 
the influence of alpha mediated vasoconstriction. Even when blood 
flow is reduced, alpha receptors have been shown to limit flow to the 
ischemic region. The blood supply to the heart is closely tied to 
myocardial metabolism. When the balance is upset under conditions of 
ischemia such as occur following a coronary artery occlusion, oxygen 
demand outstrips the oxygen supply and an infarction may result. 
Early investigations into prevention of myocardial infarction focused 
on reducing the oxygen demand by blocking myocardial beta-1 receptors 
which mediate increases in myocardial oxygen consumption when 
stimulated. Studies indicated that elevated levels of sympathetic 
input in the presence of beta-blockade might alter the amount of blood 
flow to the ischemic myocardium by limiting the flow into the region 
via alpha-mediated vasoconstriction. 
The first study in this dissertation proposed to examine the 
effect of sympathetic nerve stimulation in the presence of beta-
blockade on infarct size. In this preparation, the infarct size was 
assessed with tri-phenyltetrazolium chloride and normalized to the 
area at risk. 
The second study was done to determine what effect sympathetic 
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nerve stimulation had in the presence of beta-blockade on regional 
myocardial blood flow following coronary artery occlusion. The 
hypothesis was that alpha-mediated vasoconstriction limited blood flow 
to the ischemic zone by reducing the collateral blood flow to the 
region or by restricting flow in the ischemic zone. 
While alpha receptor vasoconstriction can be demonstrated under 
conditions of beta-blockade and elevated sympathetic input to the 
heart, the hypothesis that alpha receptors exhibit a tonic restraint 
on coronary flow, while accepted by some investigators, has been 
refuted as untenable by others. There were several hypotheses 
examined in the third study. The first was to demonstrate whether 
there was significant alpha-mediated tone under resting conditions 
following circumflex coronary occlusion, second, whether this tone 
limits flow to the ischemic zone and third, whether regional 
denervation of the ischemic zone provides any beneficial effects by 
removing the tonic alpha restraint. The technique used for regional 
denervation was developed in this laboratory and included cutting of 
the ventrolateral cardiac nerve where it courses over the pulmonary 
veins, and painting a thin strip of phenol around the perimeter of the 
circumflex artery perfusion zone. Topical application of phenol has 
been shown to penetrate approximately 0.25 cm into the epicardium 
causing coagulation necrosis and destruction of sympathetic nerves 
which run in the upper 0.5 mm of the epicardium. 
The last study was done to determine whether alpha mediated 
vasoconstriction in the circumflex bed could be elicited by specific 
cardiac thoracic nerves, and whether the vasoconstriction was predomi-
nantly alpha-1 or alpha-2 mediated. Recent evidence suggests that 
alpha-2 receptors although originally believed to be presynaptic in 
origin are also located on post-synaptic effector organs. 
It is hoped that the work presented in this dissertation will 
provide additional information regarding the influence of sympathetic 
nerves on coronary blood flow under pathophysiologic conditions of 
coronary artery occlusion and myocardial ischemia as well as on blood 
flow during physiologic conditions. 
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CHAPTER II 
GENERAL LITERATURE REVIEW 
Under normal physiologic conditions, the autonomic nervous 
system is the major external influence on coronary vascular resist-
ance. The research presented in this dissertation is concerned 
primarily with determining the extent of control of coronary blood 
flow exerted by the sympathetic branch of the autonomic nervous 
system, specifically in the pathophysiologic setting of myocardial 
ischemia. 
A. SYMPATHETIC INNERVATION OF THE HEART 
The sympathetic supply to the heart is via the first through the 
fourth thoracic spinal sections (138). The cell bodies of the 
preganglionic fibers are located in the intermediolateral cell column. 
The axons leave the spinal nerve and synapse in the paravertebral 
ganglion via the white rami communicantes. Unmyelinated post-gangli-
onic fibers leave via the gray rami communicantes to end on effector 
cells within the heart. A detailed description of the innervation of 
the heart was provided by Woollard in 1926 (136). Forty five days 
after removal of the stellate ganglia, Woollard used methylene blue 
staining to study the innervation of the heart. The nerves supplying 
the heart course along the coronary arteries, forming spirals around 
the vessels. The coronary circulation was described as receiving the 
richest innervation of all arterial beds (137). Woollard concluded 
4 
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from his studies that the large coronary arteries are innervated by 
both the parasympathetic and sympathetic systems, and that the smaller 
arteries are innervated primarily by vagal fibers. Penetration of the 
myocardium by these nerves gave rise to a plexus of fibers underlying 
the epicardium as well as the endocardium. More recently, confirma-
tion of Woollard's studies has been provided by investigations 
utilizing histo-fluorescence. The coronary arteries have been found 
to be densely innervated by adrenergic terminals (32), which are 
located primarily in the adventitia of the vessel (33). 
Subsequent studies have described the specific cardiac nerves to 
the heart. Nonidez gave detailed anatomical descriptions of the 
cardiac nerves and their distribution to the heart (100). He estab-
lished that many preganglionic fibers synapse in the middle cervical 
ganglion, and that a number of preganglionic fibers synapse above the 
level of the aortic arch. In addition, Nonidez determined that 
parasympathetic fibers supply the structures above the coronary 
sulcus. In his description of the cardiac sympathetic nerves, he 
described the superior cardiac sympathetic nerve which carries 
sympathetic post-ganglionic fibers. This nerve carried fibers which 
end as pressoreceptors on the arch of the aorta. Nonidez did not 
consider this nerve to be a true cardiac sympathetic nerve, as it did 
not distribute below the aortic arch. The major left cardiac nerve 
was the middle cardiosympathetic nerve which reaches the left ven-
tricular base and joins nerve branches of the coronary arteries to 
form a nerve plexus on the posterolateral surface of the left ven-
tricle. 
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The nomenclature devised by Mizeres in his studies is still used 
today (92). The three major left side cardiac nerves were the 
innominate (ICN) cardiac nerve, the ventromedial cervical cardiac 
nerve (VMCCN) and the ventrolateral cervical cardiac nerve (VLCCN). 
These latter two nerves are analogous to the superior cardiosympa-
thetic nerve and the middle cardiosympathetic nerves of Nonidez, 
respectively. Mizeres' studies came to some slightly different 
conclusions from those of Nonidez. Mizeres, in describing the course 
of the ICN, concluded that the ICN was not a cardiac nerve since it 
did not reach the left ventricular wall. Furthermore, the VMCCN was 
found to be composed of both branches of the autonomic nervous system, 
having both vagal and sympathetic fibers. Although Nonidez did not 
consider the superior cardiosympathetic nerve (VMCCN) a true cardiac 
nerve, as did Mizeres, both investigators were in accord that the 
VMCCN sent branches to the aorta. The VLCCN was described by Mizeres 
as the largest of the nerves. It also had many interconnections with 
the vagus, and carried sympathetic postganglionic fibers as well as a 
few afferent fibers. Mizeres postulated that there may be ganglia in 
the ventral limb of the ansa subclavia. 
In a later study in 1958, Mizeres determined that stimulation of 
the left cardiac nerves had more of an influence on the force of 
contraction of the heart, rather than any noticeable effects on 
cardio-acceleration (93). Randall expanded these original observa-
tions of Mizeres in a number of studies investigating the functional 
importance of cardiac sympathetic nerves (106,107). These studies 
will be described in more detail later. 
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B. ADRENERGIC INFLUENCES ON CORONARY BLOOD FLOW 
One of the earliest recorded mentions of coronary vasomotor 
activity was described by Newell-Martin in 1880, when he noted a vaso-
motor response of the coronary arteries (99). Newell-Martin had 
undertaken the study to determine what happens to coronary pressure 
throughout the cardiac cycle. The debate at that time involved 
whether flow occurred solely during diastole due to obstruction of the 
Sinus of Valsalva by the aortic leaflets during systole. During the 
course of this study, he noted that in one of the pressure tracings, 
the coronary artery pressure was greater than carotid artery pressure 
(76 mm Hg, and 64 mm Hg, respectively). Rather incidently, Newell-
Martin remarked that often, it was difficult to cannulate a coronary 
branch, since it appeared to be considerably smaller upon insertion of 
the cannula than it had at first appeared. After a few minutes, it 
would dilate to twice the size it was when constricted. This visual 
observation on coronary vasomotor tone might at the time have seemed 
merely anecdotal. However, several years later, Porter provided the 
first evidence that coronary arteries respond to external stimuli 
(105). By stimulating the cervical vagus, Porter was able to decrease 
the flow through the cut end of a coronary artery from 13 to 8 drops 
per 15 seconds. The rate of flow was found to return to control 
levels following cessation of the stimulation period. Thus, it was 
demonstrated by Porter that coronary arteries can constrict in 
response to neural stimulation, and also that the cervical parasympa-
thetic trunk contained sympathetic fibers. 
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From the beginning of the century, numerous investigations ad-
dressed the topic of adrenergic influences on coronary blood flow. 
Wiggers contended that vasodilation was the main response of coro-
naries, although he observed that when the heart was not beating, 
coronary blood flow decreased in response to adrenalin (134). Studies 
undertaken by Barbour suggested that 'vasospasm' may be due to release 
of adrenalin and the consequent vasoconstriction of the arteries (6). 
Brodie and Cullis determined that the coronary vessels were supplied 
with both vasoconstrictor and vasodilator fibers (15). They deter-
mined that although the primary effect was constriction which could be 
elicited by a low dose of adrenalin, a large dose of adrenalin 
overwhelmed the constrictor effect causing a vasodilation. This 
apparently satisfactory explanation for the paradoxical actions of 
adrenalin was not enough to prevent a plethora of investigations 
concerning adrenergic influences on coronary blood flow. 
A cursory examination of the literature on this subject reveals 
that there are a number of studies with conflicting results. Coronary 
arteries have been reported to constrict (6,7,121,125) dilate (26,-
135), constrict and dilate (2,3,10,12,50,56,73,95), or do nothing 
(31), in response to adrenergic stimuli. In some instances an initial 
constriction preceding a dramatic vasodilation may have been recorded 
by an investigator but was not remarked upon (135). 
A plausible explanation for these differences can be attributed 
to the variety of preparations used. Studies have been done on 
isolated hearts (57,67), isolated vessels (2,7,9,26,73,95), nonworking 
hearts (55), arrested hearts (52), anesthetized animals (58,121,128), 
9 
and conscious animal preparations (83,104). Furthermore, even in the 
vessel strip preparation, opposing responses can be obtained depending 
on the size of the vessel examined (2,95,139). 
The ground work for clarification of the results from these 
studies was laid by Cannon and Rosenblueth in a series of experiments 
done in the early 1930's (20). Cannon was among the first investiga-
tors to describe the effects of 'sympathin' as separate from 'adre-
nin'. He postulated that sympathin was the chemical mediator of 
sympathetic nerve stimulation and that when released it combined with 
a substance in the effector organ to produce either sympathin E or 
sympathin I. Depending on which organ was stimulated the response 
might vary. Thus sympathin released from the heart was excitatory, 
but that released from the coronary arteries was inhibitory due to the 
variable concentration of the sympathin I or E substances in each 
tissue. 
It was Ahlquist however, who demonstrated that the same chemical 
mediator could exert different effects depending on where it was 
released (1). Ahlquist determined that there were two types of 
adrenergic receptors which mediated the effects of sympathin which he 
believed to be identical to adrenin. These receptors could not be 
categorized as purely inhibitory or excitatory as Cannon had believed. 
To prove his hypothesis, Ahlquist selected a series of sympathomimetic 
amines for which the order of potency on the following functions was 
determined: vasoconstriction, excitation of the uterus and ureters, 
contraction of the nictitating membrane, dilation of the pupil, and 
inhibition of the gut. The order of potency was, from most active to 
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least active: !-epinephrine> dl-epinephrine> arterenol >methyl 
arterenol >methyl epinephrine > N- isopropyl arterenol. However, the 
order of potency for the same amines was different, (N-isopropyl 
arterenol > 1-epinephrine > methyl epinephrine > dl-epinephrine > 
methyl arterenol > arterenol, from most to least active), on the 
following functions: vasodilation, inhibition of the gut, and myocar-
dial stimulation. One type of receptor was associated with most of 
the excitatory functions and at le~st one inhibitory function of the 
intestine (the alpha receptor), and the other receptor which he 
arbitrarily designated the beta receptor was associated with most of 
the inhibitory functions and one important excitatory function 
(myocardium). Thus, N-isopropyl arterenol was more potent on actions 
associated with beta receptors, whereas arterenol was more potent on 
those actions determined to be mediated by alpha receptors. 
Identification of the chemical mediator released by sympathetic 
nerves was accomplished by von Euler, who localized norepinephrine to 
nerve terminals and the sediment of axons in the mid 1950's (132). By 
the mid 1950's, the action of sympathetic nerves was known to be via 
release of norepinephrine which stimulated both alpha and beta 
receptors, thus eliciting different end organ responses depending on 
the concentration of receptor present. 
In 1967, Lands determined that beta receptors could be divided 
into two subtypes, beta-1 and beta-2 (74,75). His basis for this 
subdivision came from experiments he had performed on the actions of 
several sympathomimetic amines including isoproterenol, epinephrine 
and norepinephrine on different physiological functions. The effects 
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of these different agents were assessed on fatty acid mobilization 
from rat adipose tissue, cardiac stimulation, bronchodilation, and 
vasodilation. A similarity was found for the relative potencies of 
each of the drugs on lipolysis/cardiac stimulation and on broncho-
dilation/vasodilation. There was a low correlation between the action 
of norepinephrine, for instance on cardiac stimulation and broncho-
dilation, but the correlation between its potency on lipolysis and 
cardiac stimulation was high. Lands designated the receptors located 
on the heart and adipose tissue, and small intestine as beta-1, and 
those found on the uterus, diaphragm, bronchioles and vasculature as 
beta-2. Following the development of specific beta-agonists and 
antagonists in the 1960's, the location and function of beta-1 and 
beta-2 receptors in the cardiovascular system was clarified by 
different investigations. 
Klocke found that isoproterenol in a potassium arrested heart 
caused a drop in perfusion pressure of a constant flow system which 
was blocked by nethalide (beta-blocker) (71). Several investigations 
determined that coronary beta receptors were of the beta-2 type 
(14,52,55,86). Gross and Feigl published a study in which they con-
cluded that the coronary vascular receptor is of the beta-2 type. In 
the potassium arrested heart they found that practolol (a beta-1 
antagonist) blocked the dilation evoked by isoproterenol only at very 
high concentrations (lo-3M), whereas propranolol blocked the dilation 
at lo-7 M. Salbutamol, although a selective beta-2 agonist, produced 
a dilation only one eighth as potent as that induced by the non-
selec tive beta-agonist isoproterenol (52). Their findings concurred 
with an earlier study by Broadley, in which salbutamol was also used 
to evoke direct vasodilation (14). 
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However, in a different study, Hamilton and Feigl determined 
that beta-2 receptors on the arteries are not of functional importance 
(SS). In the beating non-working heart, they blocked beta-1 receptors 
with practolol, and alpha receptors with dibozane, then stimulated the 
left stellate ganglion at 10 Hz. They found that the vasodilation 
which could be attributed to beta-2 receptors under these conditions 
was very slight. Stimulation of beta-2 receptors by isoproterenol in 
the presence of 
beta-1 blockade did evoke a significant vasodilation. Thus, they 
concluded that although beta-2 receptors can cause significant 
vasodilation in the coronary bed when stimulated by exogenous cate-
cholamines, they are not of physiologic importance since neural 
stimulation has more of an effect on alpha and beta-1 myocardial 
receptors. Domenech and MacLellan found similarly that beta-2 
activation caused a large dilation in the subepicardium and effected a 
redistribution of blood flow to the subepicardium from the subendo-
cardium (34). This preparation involved beta-1 blockade with practo-
lol, and stimulation of beta-2 receptors with salbutamol, and isopro-
terenol, hence the confounding influence of alpha receptor stimulation 
by neurally released catecholamines was circumvented in this study. 
Beta-1 receptors have also been proposed to cause direct as well 
as indirect vasodilation of coronary vessels. Vatner et al. demon-
strated in the conscious animal, that in the presence of beta-1 
blockade, isoproterenol (beta-l,beta-2 agonist) and pirbuterol (a 
13 
beta-2 agonist) no longer caused vasodilation due to beta-1 receptors 
(129), which seemed to confirm the results from an earlier study (8). 
In the study by Baron et al., canine coronary and skeletal muscle 
vessel strips were blocked by phenoxybenzamine (alpha blocker), and 
isoproterenol caused a vasodilation which was blocked by propranolol 
as well as by practolol a beta-1 blocker. However, isoproterenol 
adminstration following beta-1 blockade with practolol did not block 
the vasodilation of skeletal muscle arterioles, which have predom-
inantly beta-2 receptors (8). 
The concept of metabolic control of coronary blood flow was 
introduced more than 70 years ago when Brodie and Cullis observed that 
an increase in cardiac activity led to an increase in cardiac meta-
bolism and the release of carbonic acid. They tested the effect of 
this metabolic substrate by putting it directly on coronary arteries 
and observed that it caused dilation (15). 
Shipley and Gregg noted that left stellate ganglion stimulation 
caused parallel increases in coronary blood flow and cardiac work 
(116). This came about because an increase in work led to an increase 
in metabolism and vigor of contraction. They proposed two explana-
tions for their findings. First they postulated that there was a 
local production and release of metabolites and second, that stimula-
tion of the stellate ganglia produced a local, relative anoxia caused 
by a disproportionate increase in the rate of oxygen utilization and 
existing coronary blood flow. Subsequent studies (38,41,49) confirmed 
these observations that there was a link between myocardial oxygen 
consumption and coronary blood flow. Eckstein used a preparation in 
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which he could control cardiac output, and in which the coronary 
arteries were perfused at a constant pressure (38). A nerve branch 
from the left stellate ganglion was stimulated at 50 Hz. In this 
study, during stimulation of the cardiac nerve, cardiac work increased 
by 13%, whereas myocardial oxygen consumption increased 100% from 
control and coronary blood flow increased 37% from control. His 
interpretation of these results was that since the increase in 
myocardial oxygen consumption was much greater than the increase in 
cardiac work, when cardiac sympathetic nerves were stimulated, they 
release an adrenin-like substance which "renders the heart anoxic and 
inefficient". Feinberg and Katz concurred with Shipley and Gregg that 
catecholamines augment coronary blood flow and cardiac work (41). 
However, in their study, they found a decrease in the A-V 02 differ-
ence and an increase in coronary sinus 02 content. This apparent 
vasodilation, in addition to metabolic vasodilation contradicted 
evidence gathered by other investigators from that time. Intracor-
onary injection of epinephrine and norepinephrine elicited a reduction 
in coronary sinus blood oxygen tension concomitant with an increase in 
blood flow in the fibrillating heart in a study by Berne (10). His 
explanation for this was that myocardial oxygen consumption increased 
more than coronary blood flow. 
The limitation in the blood flow increase during adrenergic 
stimulation was also noted in a study by Hashimoto (57). In an 
isolated Langendorff heart which was cross-perfused from a donor 
animal, he found that epinephrine and norepinephrine increase myocar-
dial oxygen consumption more than isoproterenol. However, isoproter-
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enol caused greater changes in blood flow that either epinephrine or 
norepinephrine. Utilizing two early adrenergic blockers, he separated 
the alpha and beta actions of these drugs. Administration of the beta 
blocker dichloroisoproterenol (DCI) with the subsequent stimulation by 
norepinephrine and epinephrine, elicited decreases in coronary blood 
flow although there were no longer increases in myocardial oxygen 
consumption. The decrease in blood flow was reversed by alpha 
blockade with dibenzylene. With isoproterenol there was a propor-
tionate increase in blood flow and MV02, but with epinephrine and 
norepinephrine, MV02 increased more than coronary blood flow. 
Dibenzylene prior to administration of norepinephrine and epinephrine, 
eliminated the mismatch in flow and oxygen consumption previously seen 
with both catecholamines. 
Although there is a link between myocardial oxygen consumption 
and coronary blood flow, blood flow did not increase as much as 
expected during sympathetic stimulation in the above studies, since 
the reduction in coronary sinus oxygen tension indicates an increased 
extraction of oxygen due possibly to alpha receptor limitation of 
flow. This might explain the conclusions of Eckstein that the heart 
became inefficient during sympathetic stimulation since the matching 
between cardiac work and increase in blood flow was not so close 
during sympathetic stimulation as it was at rest (38). In retrospect, 
it seems obvious that alpha receptor stimulation contributed to the 
mismatch in coronary blood flow and oxygen consumption. In Eckstein's 
study, coronary sinus oxygen content decreased from 8.5 to 3.5 vol%, 
during an increase in blood flow, indicating a limitation in flow 
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during metabolic vasodilation. The differences in the preparation 
used by Feinberg and Katz can explain their contradictory findings 
that oxygen consumption decreased while blood flow increased (41). In 
their study, the drugs were given intravenously, the hearts were not 
neurally decentralized, nor were blood pressure or heart rate con-
trolled. The effects of baroreceptor reflexes on the heart superim-
posed on systemic injection of sympathomimetic agents caused a wide 
variation in the control response to the drugs. They reported that 
epinephrine elicited a pressor response in 4 out of 10 of the dogs, 
and of the remaining 6, 5 had blood pressures which returned toward 
control. Moreover, heart rate was elevated in six of the animals, and 
depressed in four of the animals. Berne, on the other hand, admini-
stered norepinephrine intracoronary, to a fibrillating heart, thus 
avoiding the confusing contribution of baroreceptors reflexes, and 
metabolic increases in blood flow (10). 
The increased work of the contractile elements leads to a net 
production of cellular metabolites. The identity of the elusive 
metabolite produced by the heart was proposed by Berne in 1964 to be 
adenosine (11). Adenosine fulfills many criteria for metabolically-
mediated vasodilation, it is present in the normal heart, it readily 
crosses the cell membrane, and is rapidly metabolized in the blood and 
surrounding tissues (13). When Lands designated the receptor medi-
ating cardiac stimulation as beta-1 in 1967, the link between neural 
stimulation and coronary blood flow was made. Since that study, the 
identification and localization of beta receptors discussed above led 
to the general consensus that beta-1 mediated increases in myocardial 
metabolism were the primary neural influence on coronary blood flow, 
and that beta-2 receptors, although located on the coronary vascula-
ture, play a distant second in eliciting vasodilation. 
c. NEURAL INFLUENCES DURING MYOCARDIAL ISCHEMIA 
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The coronary circulation is subject to a number of influences 
both extrinsic and intrinsic. The primary determinant of coronary 
blood flow is the metabolism of the heart. In addition, the autonomic 
nervous system modulates coronary blood flow. Under circumstances in 
which sympathetic nervous system (SNS) activity is elevated such as in 
exercise, beta-1 mediated metabolic vasodilation augments coronary 
blood flow with the favorable consequence of increased delivery of 
oxygen to the myocardium. However, myocardial ischemia illustrates a 
case in which the increase in SNS activity can become deleterious. 
Following a coronary artery occlusion there is an increase in the 
level of plasma catecholamines (66,109,110). In addition, there is an 
increase in sympathetic nervous system activity (85,124). The 
resulting stimulation of both alpha and beta receptors leads to an 
oxygen supply-demand imbalance since oxygen delivery is limited due to 
the combination of arterial obstruction and vasoconstriction. 
Simultaneously, the need for oxygen is increased in the non-ischemic 
myocardium due to the stimulation of beta-1 receptors. Consequently, 
standard treatment involved administration of beta-receptor blockers 
such as propranolol or timolol. These pharmacologic agents were 
thought to provide protection due to blockade of beta-1 mediated 
increases in oxygen consumption (87,133). Functional studies sup-
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ported these conclusions. Although stimulation of beta receptors 
augments myocardial contractility under normal conditions, under 
conditions of ischemia, function has been shown to deteriorate. 
Davidson et al. demonstrated in the contracting Langendorff rat heart, 
that isoproterenol increased left ventricular pressure (LVP) from 103 
to 166 mm Hg, and LVdP/dt from 1840 to 6000 mm Hg/sec under control 
conditions. Following the reduction in flow to the heart from 9.5 to 
2.4 ml/min, LVP was only 25 mm Hg, and LVdP/dt 683, mm Hg/sec. 
Infusion of isoproterenol further reduced LVP to 23 mm Hg, and LVdP/dt 
to 601 mm Hg/sec. Although the change from control ischemic condi-
tions was not significant it can be seen that the usual inotropic 
actions of isoproterenol are inconsequential, if not detrimental to 
the ischemic myocardium (29). These findings were extended to the 
conscious animal preparation by Vatner et al. (130). Vatner found 
that the amount of paradoxical motion (123) in the ischemic zone, was 
reduced by the injection of propranolol. They also described a 
redistribution of blood flow to the ischemic zone. Gallagher et al. 
reported that during coronary artery occlusion, heart rate increased 
113% from resting levels during isoproterenol injection. At the same 
time the percent change in wall thickening (%b WT) and segmental 
shortening, decreased from resting levels, whereas during control, %b 
WT had increased to 40% during isoproterenol from 34% at rest. During 
a mild stenosis, at rest %b WT was 28% but during isoproterenol, it 
decreased to -.3%, indicating paradoxical motion had developed (43). 
Matsuzaki et al. demonstrated that administration of atenolol improved 
regional left ventricular function in a severely ischemic region 
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during exercise compared to exercise without atenolol. Regional 
myocardial blood flow during exercise and coronary artery occlusion in 
the ischemic region was also improved due to an increase in the 
endo/epi ratio (89). 
Most of the early studies which investigated the effects of beta 
blockade on infarct size reduction used propranolol. Pretreatment 
with 5 mg/kg of propranolol injected intraarterially caused a reduc-
tion in the amount of necrotic posterior papillary muscle in a study 
by Rasmussen et al. The necrotic area was reduced from 76 ± 5% in the 
control animals to 43 ± 5% in the animals pretreated with propranolol 
ten minutes before occlusion. Delayed treatment with propranolol, at 
three hours after occlusion, also reduced the total amount of necrotic 
tissue to 62 ± 4% (108). 
There are some disagreements in the literature as to the 
beneficial effects of beta blockade on infarct size. Burmeister used 
three different blocking agents atenolol, nadolol and propranolol. 
The drugs were given 5 minutes prior to coronary artery occlusion. 
The left anterior descending artery was occluded for 1 hour and then 
allowed to reperfuse. At 24 hours the hearts were excised, sliced and 
put in nitroblue tetrazolium. The infarct size as a percent of the 
left ventricle was assessed, and Burmeister found that all three drugs 
reduced infarct size compared to control (19). Reduction in infarct 
size was demonstrated in other laboratories with various beta adrener-
gic blockers (63,117,131). However, there were also studies which 
contradicted these positive results. Lange showed that pindolol and 
metoprolol did not reduce infarct size, although both beta blockers 
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were given after occlusion (76). Peter also did not show a protective 
effect of propranolol (103). In a recent study by Geary et al., 
propranolol did not reduce the infarct size in baboons. Geary 
attributed his negative findings to the fact that baboons do not have 
the extensive preformed collateral system of dogs (44). However, 
other studies have investigated the effects of beta-blockade on blood 
flow and have found that although beta blockers may reduce infarct 
size, the mechanism does not appear to be blood flow mediated (72,76,-
103). It is generally believed that the beneficial effects are 
probably due to a reduction in myocardial oxygen consumption. (87,-
133). Most of the early studies did not assess infarct size as 
accurately as the methods available in recent studies. In humans, the 
only way of assessing the severity of infarction was by determinations 
of serial CPK levels, and S-T segment elevation, methods which are 
notoriously prone to error. In addition, in experimental studies, the 
variations in the type of anesthetic used, duration of occlusion, time 
of treatment, background level of catecholamines and possible involve-
ment of cardiac reflexes in all probability add to the disparity in 
results. Many of these studies have been applied to the human 
condition in which the elevation of sympathetic input is natural 
during exercise, or anger. The first study of this dissertation 
proposed to address the effect of elevated levels of sympathetic input 
in the presence of beta-blockade on infarct size. 
D. ALPHA RECEPTOR INFLUENCES ON CORONARY BLOOD FLOW 
Numerous studies throughout the 1950's and 1960's indicated that 
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alpha receptors indeed had a vasoconstrictor influence. Berne 
described an initial decrease in blood flow during administration of 
norepinephrine followed by an increase in blood flow of longer 
duration, at the time ascribing the increase in blood flow to an 
increase in myocardial metabolism (10). Although he considered 
catecholamines to be primarily vasoconstrictors, the net effect was 
vasodilation (12). It was generally believed that although the 
primary action of neural norepinephrine was to cause vasoconstriction, 
this was almost immediately overwhelmed by stimulation of beta 
receptors. 
Feigl provided indirect evidence of alpha receptor mediated 
vasoconstriction. In chloralose anesthetized dogs pretreated with 
propranolol, blood flow measured with an electromagnetic flow probe, 
decreased 18% from control levels during stimulation of the left 
stellate ganglion. This vasoconstriction was blocked by phenoxybenz-
amine (39). 
In 1967, Pitt et al. demonstrated that in conscious dogs, alpha 
and beta receptors have a role in modulation of coronary blood flow. 
In beta-blocked animals (with propranolol), intravenous injections of 
catecholamines caused vasoconstriction which could be eliminated by 
blockade of alpha receptors with dibenzylene. Beta-receptor mediated 
vasodilation could be elicited in the presence of alpha receptor 
blockade and occurred prior to any alterations in metabolic or 
hemodynamic indices (104). 
Zuberbuhler and Bohr also demonstrated a role for alpha recep-
tors in control of coronary blood flow. They found that isolated 
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strips of large coronary arteries underwent an initial contraction 
followed by relaxation in response to norepinephrine and epinephrine 
which suggested that large vessels might have equal populations of 
alpha and beta receptors. In contrast, the strips taken from smaller 
coronary vessels almost always relaxed when exposed to catecholamines, 
and the relaxation was reversed by the beta blocker nethalide. This 
was interpreted as demonstration of an exclusively beta receptor 
population in the smaller resistance vessels (139). Other investiga-
tions have demonstrated a differential population of adrenergic 
receptors (2,95). 
Malindzak using a whole animal preparation and cardiac sympa-
thetic nerve stimulation in addition to injections of catecholamines, 
showed that large vessels have more of a tendency to contract in 
response to catecholamines, as will smaller vessels although the 
constrictor response of smaller 'resistive' vessels is generally 
masked by the compensatory metabolic responses of the myocardium to 
sympathetic stimulation (84). 
Additional evidence in support of alpha vasoconstriction came 
from a study by McRaven et al. They found that injections of norepi-
nephrine or isoproterenol caused a drop in perfusion pressure in the 
circumflex artery which was perfused at a constant flow. The drop in 
pressure was reversed following blockade of beta receptors with 
practolol (a beta-1 blocker). Nerve stimulation (lOV, 4msec, variable 
frequency) after practolol administration resulted in vasoconstriction 
which was reversed by administering phentolamine. They concluded that 
alpha receptors could directly constrict coronary arteries when 
stimulated by neurally released catecholamines, but that this effect 
is minimal and that vasodilator effects both direct and indirect 
played a more important role, with vascular receptors having a more 
important influence than myocardial receptors (91). 
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Vatner et al. demonstrated the ability of alpha receptors to 
cause a potent vasoconstriction (128). Ultrasonic dimension gauges 
were implanted on the circumflex artery to measure the change in 
coronary diameter. Following administration of methoxamine (an alpha 
agonist, 50 g/kg/min) there was a transient increase in coronary 
diameter followed by a decrease in diameter (9 ± 2%) even though 
arterial pressure was elevated by 65 ± 5%. The calculated resistance 
for large arteries and total resistance used to estimate small artery 
resistance, increased by 108 ± 29 and 92 ± 14% respectively, indica-
ting that alpha vasoconstriction was transmural and involved not only 
the large epicardial arteries but also the smaller resistance vessels. 
In another study by Macho and Vatner, prazosin was found to 
reduce mean arterial pressure by 15 ± 4% in conscious dogs and to 
decrease coronary vascular resistance significantly. Although 
prazosin caused significant reductions in various inotropic indices 
(LV dP/dt, left ventricular end-diastolic diameter etc.) it did not 
increase coronary blood flow significantly. Hence they concluded that 
prazosin decreased resistance significantly mainly by reductions in 
afterload and preload thereby reducing oxygen consumption, but did not 
exert its effects on resistance by increasing blood flow (83). Vatner 
had shown previously that stimulation of alpha receptors with methox-
amine could produce powerful vasoconstriction in the presence of 
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increased perfusion pressure, however in that earlier preparation, the 
animals' reflexes were intact, and no ganglionic blockade was admin-
istered (128). 
None of these studies declared that alpha receptors had a major 
influence on blood flow under resting conditions. While demonstrating 
that alpha-receptors cause constriction, these studies did not 
actually provide evidence from a physiological standpoint of the 
importance of alpha receptors. In the aforementioned examples, alpha-
receptor influences were demonstrated only in beta blocked prepara-
tions, or vessel strips in which vasomotor tone was independent of 
metabolic influences. 
It wasn't until the mid-1970's that there was evidence that 
alpha receptors may modulate coronary blood flow even with concomitant 
activation of beta receptors. In a study by Feigl, blood oxygen 
tension in the coronary sinus was measured, along with circumflex 
artery blood flow (40). During stimulation of the left stellate 
ganglion for 90 seconds the heart rate, blood pressure and coronary 
blood flow increased from control, while coronary sinus oxygen tension 
(CS02) decreased from 19 mm Hg to 15 mm Hg. Following administration 
of propranolol, stimulation of the left stellate no longer produced 
the marked increases in inotropic and chronotropic indices, but 
coronary sinus oxygen tension was further reduced from 17 to 11 mm Hg. 
This indicated that alpha receptors were 'unmasked' since increases in 
metabolism were blunted by propranolol, and the decrease in CS02 
tension was interpreted as evidence of alpha receptor vasoconstric-
tion. Following alpha blockade with dibozane, CSOz and coronary 
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vascular resistance no longer changed in response to left stellate 
stimulation. This study provided insight into the involvement of 
alpha receptors in modulating blood flow. By measuring changes in 
cso2 , instead of only looking at changes in blood flow, it was 
determined that even with metabolic increases in flow, alpha-receptors 
limited flow enough to cause an increased oxygen extraction and 
decreased coronary sinus oxygen tension. Although these changes had 
been noted in previous studies (10,38), Feigl demonstrated conclu-
sively that alpha-receptors are responsible for the seemingly paradox-
ical changes in flow and oxygen tension. 
Mohrman and Feigl demonstrated in the closed-chest chloralose 
anesthetized dog that alpha receptors restrict the beta-1 mediated 
increase in blood flow by 30% (94). Sympathetic activation was 
elicited by either intracoronary injections of norepinephrine or 
carotid sinus hypotension. Measurements of 02 extraction and coronary 
venous 02 content were used as determinants of the ability of the 
heart to extract oxygen. When alpha blockade with dibozane was 
initiated, less oxygen was extracted and the coronary venous 02 
content increased, indicating that there had previously been a 
limitation of blood flow by alpha receptor stimulation. 
Other investigations have shown that alpha receptors can limit 
blood flow increases following physiologic augmentation of sympathetic 
activity during exercise (60,98). Murray and Vatner found in dogs 
that were exercised freely, that alpha receptors limited the increase 
in coronary blood flow during exercise. Heyndrickx, under similar 
conditions, found that alpha receptors can upset the 02 consumption/02 
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supply ratio. During control conditions, exercise decreased the ratio 
from 1.43 ± 0.05 at rest to 1.27 ± 0.03 during exercise. Following 
alpha blockade, the ratio went from 1.31 ± 0.05 at rest to 1.33 ± 0.02 
during exercise. They concluded from this that oxygen delivery is 
better matched to myocardial oxygen consumption during alpha blockade 
by blunting the effects of alpha vasoconstriction on oxygen delivery. 
Contrary to the findings of Heyndrickx, in which the match 
between oxygen supply and demand diverged during sympathetic stimula-
tion, Buchweitz and Weiss stimulated the ansa subclavia and found that 
endocardial and epicardial oxygen extraction and blood flow increased 
proportionately (16). Buchweitz and Weiss found in open chest 
anesthetized dogs, that stimulation of the ansa subclavia did not 
alter the 02 supply/02 consumption ratio. They concluded from their 
study that any coronary vasoconstriction which might occur with high 
levels of sympathetic input to the heart does not reduce the ability 
of coronary blood flow to meet the increased metabolic demand for 02 
and that these needs were adequately met by the vasodilation produced 
by the increased metabolic state of the heart. In their study, the 
hearts were electrically fibrillated, excised, and quickly frozen 
during control and stimulation of the stellate. In addition, pento-
barbital anesthesia was employed, which may have blunted adrenergic 
sensitivity to nerve stimulation. 
Recently, alpha-receptors have been found to contribute to the 
regulation of blood flow during flow limited conditions such as 
stenosis or occlusion. Buffington and Feigl examined the contribution 
of alpha receptors to ischemia during partial occlusion of the 
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circumflex artery (18). Blood flow into the left coronary artery was 
measured, and following a 70% area reduction, intracoronary norepi-
nephrine resulted in increased oxygen extraction, decreased coronary 
sinus oxygen content, and increased coronary vascular resistance. 
Following alpha blockade with phenoxybenzamine, the increase in 
myocardial oxygen consumption was prevented. They concluded that 
while alpha receptors may limit the increase in blood flow during 
coronary stenosis, it was not severe enough to cause net lactate 
production by the myocardium. These results concur with those of 
Gewirtz et al. who found that during a severe stenosis, alpha recep-
tors may compete with but probably do not overcome metabolic vasodila-
tion (46). 
In the presence of a coronary occlusion, 'coronary steal' has 
been described as the effect of shunting of blood from an one area of 
the myocardium to another area of reduced vascular resistance via 
collateral vessels. When a substance is given which causes vasodila-
tion of one region of the myocardium, while another region remains 
collateral dependent and maximally vasodilated, the vasodilation in 
the non-collateral dependent region causes an increase in blood flow 
velocity, and a decrease in perfusion pressure at the origin of 
collateral vessels. This results in an effective shunting of blood to 
the non-collateral dependent regions (101). 
Chiariello et al. described a 'reverse coronary steal' due to 
alpha receptor activation in the normal zone. In that study the left 
anterior descending artery (LAD) was ligated and methoxamine was given 
17-30 minutes after occluding the artery. The stimulation of alpha 
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receptors in the normal zone caused a reduction in flow to the normal 
zone from 90.6 ± 4.3 to 77.7 ± 3.2 ml/min/100 gm and increased the 
collateral flow to the ischemic zone from 21.4 ± 3.5 to 41.0 ± 4.2 
ml/min/100 gm (21). Giudicelli et al. reported similar findings. In 
their study, branches of the LAD were ligated in a chloralose anesthe-
tized dog. During stimulation of the left stellate ganglion (LSGS), 
regional flow increased to the normal area by 35% but not to the 
ischemic area. When atenolol was given, LSGS decreased flow to the 
normal zone by 24% but increased flow to the ischemic region by 64%. 
These effects were abolished by the administration of phenoxybenzamine 
(47). Buck et al. demonstrated that the unmasking of alpha receptors 
by beta-2 blockade with propranolol and pindolol caused a redistribu-
tion of blood flow to the subepicardium distal to a severe stenosis 
due to the predominance of alpha receptors in the larger more epicar-
dially located blood vessels (17). 
The role of alpha receptors appears to be elusive under certain 
circumstances. Gorman and Sparks reported a progressive vasoconstric-
tion distal to a partial occlusion (48). In this preparation, hearts 
were paced at 180 beats per minute. Myocardial blood flow was 
determined at 30 and 180 minutes after occlusion. Vasodilator reserve 
was demonstrated with adenosine and norepinephrine. Since norepineph-
rine increased flow in the ischemic region, the vasoconstriction which 
evolved with time probably was not due to norepinephrine. It is 
interesting that in this preparation, the injection of phentolamine or 
phenoxybenzamine increased flow in the ischemic zone, but propranolol 
in addition to phenoxybenzamine decreased flow. Thus, norepinephrine 
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increased flow via beta-adrenergic stimulation but was not responsible 
for the vasoconstriction. The authors could not satisfactorily 
explain the phenomenon as due to alpha receptor vasoconstriction, but 
postulated that it may have been due to the decreased release of 
vasodilator metabolites, the increased release of an unknown vasocon-
strictor substance, or increased cell-swelling due to the ischemia. 
A recent study by Grover and Weiss confirms the results of 
Gorman and Sparks, regarding the ability of the ischemic bed to 
vasodilate. They showed that with a 50% reduction of IAD flow, the 
oxygen supply/demand ratio of the occluded region was reduced compared 
to control. However, the reduced oxygen supply/demand ratio did not 
change when heart rate was increased up to 50% above the resting 
level. Thus, the authors concluded that a flow reserve must exist 
(53). 
It is possible that blood flow to the ischemic region is further 
compromised by alpha-mediated vasoconstriction in the ischemic zone. 
A recent report from our laboratory indicated that following coronary 
artery occlusion, simultaneous blockade of both alpha and beta 
receptors during sympathetic stimulation of the heart limited myocar-
dial damage to a significantly greater extent than blockade of 
beta-receptors alone (42). 
Investigations concerning alpha-mediated vasoconstriction are 
not limited to experimental studies but have been researched in the 
clinical setting too. Variant angina has been well-documented, and is 
believed by some to be alpha mediated. Levene reported in 1976, that 
a 41 year old women with angina demonstrated vasospasm during coronary 
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arteriography which coincided with episodes of angina. Relief of 
symptoms by administration of i.v. phentolamine, and phenoxybenzamine 
improved her exercise tolerance (81). The usual treatment for angina 
does not seem to work for variant angina. Kirshenbaum reported that 
while calcium channel blockers appear to alleviate the symptoms, 
nitrates help only in large doses, and propranolol is ineffective 
therapy, and may even aggravate the condition (70). These findings 
were substantiated by Maze et al., who concluded further that although 
alpha-blockers are effective in the treatment of vasospasm, in 
practice they are given only if nitrates and calcium channel blockers 
are ineffective (90). Other studies have added information on the 
role of alpha receptors during coronary artery disease (68,69,96,97). 
Kern et al. determined that beta-blockade with propranolol can 
potentiate vasospasm in some patients with CAD, possibly by unopposed 
alpha-tone (68). In another study, 18 patients with coronary artery 
disease underwent the cold pressor test, with paced heart rates of 95 
beats per minute. During the cold pressor test, coronary vascular 
resistance (calculated as mean arterial pressure over blood flow 
measured with thermodilution) increased by 15%. Five minutes after 
100 mg of the alpha-1 blocker trimazosin, the cold pressor test 
increased coronary vascular resistance by only 6% (69). The ability 
to increase coronary vascular resistance with the cold pressor test is 
not limited to patients with coronary artery disease, as normal 
patients who do not develop spasm, will have increases in coronary 
vascular resistance in the presence of beta-blockade (68). This 
confirms an earlier report by Mudge (97), in which it was reported 
that patients with coronary artery disease have limited vasodilatory 
mechanisms, and inappropriate increases in coronary vascular resist-
ance during cold pressor testing. 
E. ALPHA-2 RECEPTOR MEDIATED CORONARY VASOCONSTRICTION 
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Over the past ten years, the possible involvement of alpha-2 
receptors in coronary blood flow has been examined. Studies by Starke 
and Langer proposed that alpha receptors can inhibit the release of 
norepinephrine by a negative feedback mechanism (77,78,118). Langer 
originally proposed that alpha receptors be separated into prejunc-
tional and postjunctional receptors calling the former alpha-2 
receptors and the latter alpha-1 receptors (77). Eventually it was 
determined that pharmacological differentiation of the receptors would 
be more appropriate, since alpha-2 receptor activity could be demon-
strated on the effector organ also (78). A physiologic basis for 
prejunctional modulation of norepinephrine release was provided by 
Lokhandwala (82). Since those studies were done, alpha-2 receptors 
have been reported to contribute to coronary artery vasoconstriction 
(64). It has also been proposed that post-junctional alpha-2 recep-
tors as well as pre-junctional alpha receptors influence coronary 
blood flow (24,30,58,59,61,62,119). 
Heusch and Deussen concluded that there was a continuous 
unmasking of sympathetic vasoconstriction with increasing severity of 
stenosis, which is mediated by post-junctional alpha-2 receptors (58). 
Holtz et al. also reported that norepinephrine induced vasoconstric-
tion was attenuated predominantly by alpha-2 blockade not by alpha-1 
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blockade (62). This effect was examined during cardiac sympathetic 
nerve stimulation (10 Hz) by Saeed et !ti.... (113). They found that 
during stimulation, coronary sinus oxygen saturation was decreased, 
and responded similarly under beta-blockade with nadolol. With alpha-
2 blockade the decrease in CS02 was attenuated, but not with alpha-1 
blockade. It was not explained why the results were similar during 
beta-blockade, when all evidence points toward a greater role for 
alpha-receptors when unmasked by beta-blockade. It appears from 
recent investigations, that it is more likely that both alpha-1 and 
alpha-2 receptors mediate coronary vasoconstriction. Decker and 
Schwartz reported that the post-junctional receptors in the guinea pig 
heart are of the alpha-1 and alpha-2 type (30). Stevens and Moulds 
reported similar findings in isolated human blood vessels (119). 
Reusch and Deussen further categorized the alpha-receptors, 
alpha -1 being located on large arteries, and alpha-2 on smaller 
arteries (59). This was based on the response to nerve stimulation of 
changes in internal diameter of a large vessel, and late diastolic 
resistance which reflects the contribution of smaller arteries. 
Stimulation of the left stellate ganglion (LSS) in these studies was 
for 90 seconds with measurements made at 1 minute. It was interesting 
that in this study, LSS in the presence of propranolol caused a 
significant elevation of arterial pressure which was blocked by 
prazosin, but not by rauwolscine. This latter finding, although not 
discussed in detail, is in accord with a study by Randall in which LSS 
in the presence of beta-blockade increased mean arterial pressure 
(106). The increase which is not beta-mediated appears to be alpha-1 
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receptor mediated (58,118). However, the dearth of investigations on 
myocardial alpha receptors does not allow a clear explanation for 
these findings. 
The role of alpha receptors has been thoroughly demonstrated 
over a wide range of physiologic states, from their importance in 
modulation of resting blood flow in the conscious animal, to their 
involvement in limitation of blood flow during exercise, and finally 
their role in limitation of blood flow under pathophysiologic circum-
stances such as partial or severe stenosis. The second study of this 
dissertation proposes to determine whether alpha receptors decrease 
flow to the ischemic bed following complete coronary artery occlusion 
in the presence of beta-blockade. 
F. EFFECTS OF CARDIAC DENERVATION ON CORONARY BLOOD FLOW AND 
ISCHEMIC INJURY 
In the previous discussion, the concept of sympathetic modula-
tion of blood flow under a variety of conditions was reviewed. The 
question then arises as to what effect denervation would have on the 
heart and on coronary blood flow. A classical method for establishing 
the importance of a chemical mediator or hormone is to determine what 
physiologic events occur in its absence. Denervation of the heart was 
employed early to trace the pathways of nerves to the heart (136). 
However cardiac denervation was soon used not only to further experi-
mental knowledge of cardiac innervation. Leriche proposed that 
cardiac denervation provided protection against ischemia and infarc-
tion in the clinical setting (80). Contemporaries of his debated 
whether this would provide protection or simply eliminate a warning 
signal of angina and impending myocardial infarction. 
34 
Following Leriche's report on the beneficial effects of cardiac 
denervation in the treatment of intractable angina, other investiga-
tors devised their own methods of cardiac denervation (25,28), and the 
reports of the protective influences of cardiac denervation during 
cardiac disease began to accumulate. The method of denervation 
suggested a wide range of sympathectomy from simple removal of the 
stellate ganglia to removal of the superior, middle and caudal 
cervical ganglia, in addition to stellate ganglionectomy. The reports 
of the different clinical settings in which denervation was useful 
were as numerous as the different methods employed to denervate the 
heart. 
One widely used technique developed by Cooper et !!.l..... involved 
mediastinal neural ablation (25). However a later study by Peiss et 
al. determined that this technique was not totally effective in 
eliminating neural input to the heart (102). Peiss et al. found 
evidence for reinnervation after one year following excision and re-
implantation. Neither mediastinal neural ablation nor bilateral 
stellate ganglionectomy proved to be totally effective in eliminating 
the sympathetic nerves to the heart since some of the nerves travel 
via the vago-sympathetic trunk. Cox et al. in 1936 found that 
bilateral stellate ganglionectomy in dogs resulted in protection 
against sudden coronary occlusion (27). Moreover, denervation was 
proposed to protect against malignant arrhythmias (37,114) and against 
myocardial infarction due to coronary artery occlusion (65). The 
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manner in which cardiac denervation was purported to exert its 
beneficial influences on cardiac viability was not determined in these 
studies. Indeed, the effects of cardiac denervation on the function 
of the normal heart was not ascertained until a number of studies 
undertaken by Donald et al. (35). Donald and Shepard determined that 
the response to exercise in dogs which had undergone cardiac denerva-
tion was similar in terms of capacity for work. Although the ability 
to increase cardiac work during exercise was similar, the heart rate 
increased more slowly in the denervated animals. Furthermore, Guyton 
et al. proposed that in cardiac denervated animals the functional 
responses to various forms of stress were similar to responses of 
innervated animals due to the influence of circulating catecholamines 
and the supersensitivity to norepinephrine of denervated hearts (54). 
The beneficial influence of denervation has been challenged in a 
recent study by Lavallee et al. (79). Lavallee et al. showed that in 
conscious animals there is no protective influence of denervation on 
the development of a myocardial infarction in the conscious dog. The 
reason for the differences between this recent study and earlier ones 
was believed to be due to the use of conscious vs anesthetized 
animals. 
The mechanism of denervation protective influence on myocardial 
infarction has been proposed to be due to alterations in myocardial 
blood flow following a coronary artery occlusion. Barber et al. and 
DuPont et al. both showed a reduction in myocardial regional blood 
flow following denervation as compared to control (4,36). However 
DuPont et al. found that denervation caused an increase in blood flow 
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to border zones following coronary occlusion, although the flow to the 
core of the ischemic region was not increased (36). Both studies 
attributed the reduction in blood flow in the denervated regions to a 
reduction in myocardial metabolism, although neither study addressed 
the question of oxygen consumption and metabolism directly. Some 
years earlier, Gregg et al. had hypothesized that removal of cardiac 
nerves resulted in an overall reduction in myocardial metabolism (51). 
In recent years a number of investigators have employed denerva-
tion to determine whether there is a tonic restraint of coronary blood 
flow by a resting level of sympathetic input to the coronary arteries 
(22,61). 
Demonstration of alpha-receptor limitation of flow under resting 
conditions or a 'tonic restraint' of flow has been addressed by 
numerous investigators. Resting coronary blood flow was considered to 
be under local influence and of course sympathetic influences would 
only be noticeable when levels of sympathetic input were high. But 
consideration of resting sympathetic discharge of approximately 3 Hz, 
would appear to indicate that the coronary bed, under resting condi-
tions may have a small amount of sympathetic input. Katz and Jochim 
did show that removal of the stellate ganglia and vagi increased 
resting blood flow (67). About 35 years later, Schwartz and Stone 
also reported that left stellectomy not only increased the blood flow 
distribution to the endocardium, it also increased reactive hyperemia 
from 476 ± 71% to 622 ± 86% of control flow. Although propranolol 
could reduce the reactive hyperemic response, phentolamine following 
sympathectomy could not. However phentolamine prior to sympathectomy 
37 
did increase reactive hyperemia by 23% from the control response 
(115). 
Following regional sympathetic denervation with 6-Hydroxy dopa-
mine, Holtz et al. found that the blood flow measured with micro-
spheres, in the innervated region was 66 ± 14 ml/min/lOOgm compared to 
resting blood flow in the denervated region of 108 ± 16 ml/min/100 
gm. Administration of propranolol did not alter the blood flow 
distribution, however phentolamine abolished the regional differences 
by increasing the flow in the control region to levels equivalent to 
the sympathectomized region. They concluded that there is a substan-
tial level of alpha vasoconstrictor tone on coronary blood flow (61). 
Vatner et al. also proposed that alpha receptors exert a tonic 
control over coronary blood flow. Stimulation of the carotid sinus 
nerve in the conscious dog resulted in a decrease in aortic pressure 
of 28% and a decrease in coronary blood flow of 7%, resulting in a 
decreased resistance of 22% from control. Propranolol and dopamine 
did not prevent the dilation. Phenoxybenza.mine caused a reduction in 
resistance to levels comparable to those elicited during carotid nerve 
stimulation with beta-blockade. There was no change in the resistance 
during CSNS with phenoxybenzamine. Guanethidine (ganglionic blocker) 
also abolished the dilation, indicating that stimulation of the 
carotid sinus nerve resulted in removal of sympathetic tone. This 
withdrawal of alpha-tone resulted in a vasodilation which could be 
stopped by phenoxybenzamine or guanethidine (126). In a similar set 
of experiments, they found that alpha tone could be elicited by an 
efferent pathway involving the mechanical reflex of pulmonary stretch 
receptors. With an intracoronary injection of nicotine, the conse-
quent stimulation of chemoreceptors and increase in ventilation, 
induced a reflex dilation of coronary arteries via a withdrawal of 
sympathetics. The dilation was abolished by alpha receptor blockade 
or carotid sinus nerve section. This dilation occured in spite of 
reductions in metabolism (127). 
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An investigation by Chilian et al. does not support the idea of 
a resting level of alpha vasoconstriction of coronary arteries. In 
this study regional denervation was achieved by topical application of 
phenol. Resting blood flow in the sympathectomized region was not 
significantly different from blood flow in the normal zone or control 
region. Their results were not altered by beta-adrenergic blockade or 
combined alpha and beta blockade. The flows in the innervated region 
were 0.87 ± .08 and 0.85 ± 0.07 ml/min/gm (22). 
The effects of denervation have applications in tracing anatomic 
pathways to the heart, in the clinical setting of transplantation, and 
for treatment of angina. In addition, a number of studies in the past 
several years have investigated the possibility that ischemia itself 
causes a regional denervation; and that the ischemic muscle is 
'stunned' and unresponsive to nerve stimulation. 
Martins et al. studied the effects of coronary artery occlusion 
of cardiac function in both the ischemic and non-ischemic zones and 
the response to left stellate stimulation and exogenous noradrenalin. 
Dogs were anesthetized with alpha-chloralose, and either the 1AD or 
circumflex artery isolated. LSS during occlusion produced segmental 
expansion whereas noradrenaline produced segmental shortening in the 
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ischemic area. They explained this impaired response of the ischemic 
myocardium as due to the impaired response to sympathetic nerve 
stimulation. They did not offer a reason as to why impaired neuro-
transmission in the ischemic zone should cause an actual decline in 
regional ventricular function. It was, however not a significant 
reduction of expansion during LSS. LSS produced a change in length of 
O.l ± 0.3 mm, and exogenous noradrenaline of 0.5 ± 0.1 which was 
significantly different from the change in length during occlusion. 
No mechanism of denervation was advanced in this study (88). 
It is thought that sympathetic efferent nerves course in the 
upper 0.25 -0.50 mm of the epicardium, since topical application of 
phenol which destroys the upper 0.25 mm of epicardium, interrupts 
sympathetically mediated changes in ventricular contraction. Barber 
et al. (1982) demonstrated that not only does a transmural myocardial 
infarction interrupt sympathetic neurotransmission in the ischemic 
bed, it also impairs neurotransmission in the nonischemic regions (5). 
It has been demonstrated previously that sympathetic fibers run with 
coronary arteries and traverse the myocardium in a base to apex 
fashion (45). By injecting a rapidly hardening latex solution into a 
branch of the IAD, the authors were able to produce a transmural 
infarction by eliminating the contribution of collateral blood supply 
to the occluded region. The infarction was assessed using triphenyl-
tetrazolium chloride. To determine the responsiveness to sympathetic 
nerve stimulation, the effective refractory period (ERP) was measured 
during right (RSS) and left (LSS) stellate stimulation. Also, in 
chronically infarcted dogs, regional norepinephrine content was 
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measured in the ischemic and normal regions. In zones apical to the 
infarction, ERP did not change during RSS and left stellate stimula-
tion, while sites basal to the infarction remained responsive to both 
stellate stimulation and exogenous noradrenaline. The denervation was 
not homogenous however in the areas apical to the occluded region, as 
half of the sites remained responsive to stellate stimulation. The 
other sites which were not affected by stellate stimulation were 
responsive to noradrenaline. It should be noted that the possibility 
of chemical denervation in areas surrounding the infarcted region due 
to the release of alcohol during the hardening process may have 
affected the results. It was not well-defined in this study how 
distally located the sites for the effective refractory period 
measurements were. It appears as though the basal location was 
spatially well-removed, however, the apical sites were closer to the 
region of infarction. The consequences may be that the closer the 
location to the infarction, the greater the possibility that the 
region was actually denervated by the latex, and not due to interrup-
tion of sympathetic neurotransmission. 
A more recent study on the subject of ischemia induced denerva-
tion was done by Ciuffo et al. Myocardial segmental shortening was 
measured before and after an occlusion of twenty five minutes. Before 
the occlusion, the shortening was 12% and increased with LSS to 20% 
and with injected norepinephrine to 20% in the zone which was to 
become ischemic. After the period of ischemia and reperfusion, the 
shortening was only 4%. In response to LSS, shortening decreased even 
further to 2.4%, but did increase in response to noradrenaline (13%). 
The reduced responsiveness to neural stimulation persisted for two 
hours after reperfusion (23). 
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The loss of myocardial function following ischemia and reper-
fusion has been documented by other investigators. Heyndrickx 
observed that even when blood flow had returned to control values 
following ischemia, the function remained depressed for a longer time. 
However, in that study, he did not think it likely that the loss of 
function was due to impaired neurotransmission (60). The mechanism of 
the disruption of neurotransmission is not explained, and is particu-
larly intriguing since ischemia generally develops in the endocardium 
first and progresses toward the epicardium. Moreover, in the canine 
model the possibility of a transmural infarction is not as likely an 
occurrence as in other species due to the greater amount of collateral 
blood flow. The third study included in this dissertation was done to 
determine whether removal of tonic alpha-vasoconstrictor tone would 
increase the blood flow the ischemic zone. 
G. CARDIAC SYMPATHETIC NEURAL MODUI.ATION OF CORONARY BLOOD FLOW 
An early study on the functional importance of cardiac nerves to 
coronary blood flow and myocardial performance was reported by 
Szentivanyi (120). In that study, the author claimed to have been 
able to differentiate the fibers innervating the heart as being 
vasodilator and vasoconstrictor on the basis of their stimulation 
thresholds. Although these studies have not been duplicated, the idea 
that the large bundles of cardiac nerves could have differential 
influences on the heart was investigated extensively by Randall et al. 
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Using the technique of epicardial stripping or phenol application, the 
heart was selectively denervated, and the projections of cardiac 
nerves to the heart were delineated (106). To summarize his findings, 
the innominate caused an increased contractility in the right ven-
tricle and left ventricular apex. The ventromedial cardiac nerve 
increased right ventricular conus contractility, and the VLCCN 
increased contractility to the posterolateral left ventricle. He also 
found that the more distally the sympathetic trunk was stimulated, the 
more localized were the areas affected by nerve stimulation (107). 
Studies by Geis and Kaye determined that the right stellate ganglion 
(RSG) and the left stellate ganglion (LSG) innervate the anterior and 
posterior left ventricle. The RSG was found to send projections to 
the posterior base, and the LSG to project to the anterior left 
ventricle via branches from the VLCCN (45). These studies, although 
providing insight into the innervation of the heart, did not specif-
ically determine the effects of cardiac sympathetic nerve stimulation 
on blood flow the heart. Specific effects on the posterior left 
ventricle were not described in these studies. 
Rinkema et Jil.... eKamined the influences of left stellate stimula-
tion and right stellate stimulation on regional myocardial blood flow 
in the anesthetized dog. They found that flow to the circumflex 
region was increased more by LSS that flow to the anterior region. 
However, it was determined that the LSG innervated all portions of the 
left ventricular myocardium. Following administration of propranolol, 
Vasoconstriction during LSS was determined (111). These findings were 
in accord with results from Ross and Mulder, and Tato et al. 
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(112,122). Takenada et al. demonstrated that the anterior ansa 
subclavia and the VLCN cause vasoconstriction especially with practo-
lol or propranolol (121). 
Thus, although the left stellate ganglion can be concluded to 
affect regional left ventricular blood flow, separate cardiac nerve 
stimulation effects on blood flow have not been investigated previ-
ously. The exact location of sympathetic pathways to coronary vessels 
is not established. Changes in blood flow can be demonstrated with 
sympathetic stimulation, and vasoconstrictor effects during beta-
blockade can be used to isolate the effects of nerves going to 
coronary arteries from their effects on myocardial function. However, 
the exact pathways and nerves have not been described and isolated. 
Thus, the fourth study in this dissertation, examined which cardiac 
nerves modulate circumflex coronary blood flow, and whether the 
vasoconstriction elicited by these nerves is alpha-1 or alpha-2 
mediated. 
It is hoped that these studies will add to our present knowledge 
of the role of the cardiac sympathetic nerves on myocardial blood flow 
during ischemia. A clearer definition of sympathetic influences on 
the ischemic heart is important in light of the widespread clinical 
use of adrenergic blockers in the treatment of coronary artery disease 
and myocardial infarction. 
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CHAPTER III 
GENERAL METHODS 
A. SURGICAL PREPARATION 
Mongrel dogs of either sex were premedicated with either 
morphine sulfate (2.5 mg/kg, s.c.) or xylazine (2 mg/kg, s.c.) 
approximately 15-20 minutes before being given alpha-chloralose 
(50-100 mg/kg, i.v., Sigma Chem. Co. in solution with sodium borate, 
ratio of 1:1.23, chloralose: borate). Alpha-chloralose was chosen as 
the general anesthetic, since it does not adversely affect hemodynamic 
variables (2,11) and does not depress cardiovascular reflexes as does 
pentobarbital anesthesia (6,12,44). A polyethylene catheter (PE-260 
tubing) was placed in the right femoral artery and connected to a 
Statham P23dB pressure transducer for continuous monitoring of 
arterial blood pressure. The right femoral vein was catheterized with 
PE-260 tubing for fluid and drug administration. The trachea was 
cannulated with a glass Y-tube which was connected to a Harvard 
respirator. Each dog was ventilated with room air at a positive 
end-expiratory pressure of 5 cm of water. Both cervical vagi were 
isolated and severed. Succinylcholine (20 mg, i.v.) was administered 
as a muscle relaxant and the chest was opened in the 4th left inter-
costal space. The corneal reflex and response to pinching of the toe 
pad were checked every half hour when the effects of succinylcholine 
had worn off, and additional anesthetic was administered when needed. 
The heart was kept moist with sponge soaked in saline. In addition, a 
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layer of plastic wrap was kept over the open chest to minimize 
moisture and heat loss. In studies in which the heart was paced, a 
stainless steel bipolar electrode was sutured to the left atrial 
appendage, and the heart paced at 150 pulses/min from a Frederick Haer 
4i stimulator. Blood gases and pH were monitored throughout the 
experiment. pC02 and pH were maintained within normal limits (pC02 
30-40 mm Hg, pH 7.38-7.45), by adjusting the rate and/or volume of the 
Harvard respirator, with infusions of 8.4% sodium bicarbonate (1 
meq/ml) when necessary. p02 was monitored and kept within normal 
limits (80-100 mm Hg) by adjusting the volume of inspired air on the 
ventilator, with care taken that arterial pC02 levels were not 
altered. Core temperature, measured in the thoracic cavity by a YSI 
temperature probe, was kept between 37-39° C by means of a heating pad 
beneath the dog, and an infrared heating lamp above the dog when 
necessary. 
B. STIMUIATION PROTOCOL 
Both the right and left ansae subclaviae of the stellate ganglia 
were isolated. Both the anterior and posterior limbs of the ansae 
subclaviae, were stimulated (7-10 Hz, 5 msec, 5-7 V) using bipolar 
stainless steel electrodes. Characteristic changes in the lead II 
electrocardiogram consequent to stimulation confirmed that both limbs 
of the right and left stellate ganglia had been isolated. These 
changes included an increase in the heart rate and increased negativ-
ity of the T-wave as described by Yanowitz upon stimulation of the 
right stellate ganglion. Yanowitz also described the increased 
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positivity of the T·wave with left stellate ganglion stimulation (43). 
The alteration of the polarity and peaking of the T-wave are due to 
the altered repolarization pattern. Geesbreght and Randall reported a 
shortening of the P-R interval upon stimulation of the ansae subcla-
viae and a disappearance of the P-wave, with reappearance upon 
cessation of the stimulation. They attributed this movement of the 
P-wave into the QRS interval to a shifting location of the pacemaker 
(18). Figure 3-1 is a sample trace of the Lead II EKG during both 
right and left ansae subclaviae stimulation. 
Square wave pulses were delivered by either a Grass SD9 stimu-
lator or a Frederick Haer constant voltage output stimulator, and 
monitored on a calibrated differential oscilloscope. These stimula-
tion parameters have been used frequently in other studies involving 
stimulation of sympathetic nerves. Although these levels were higher 
than the frequency of tonic sympathetic discharge (1-3 Hz) described 
by Folkow, they were lower than what Folkow considered to be maximal 
physiologic levels (20 Hz) for stimulation of sympathetic nerves 
(16). In comparison to more recent studies, these levels were lower 
than those used in a recent study by Reusch and Deussen (20 Hz) (20), 
and they are of similar magnitude to those used in studies involving 
cardiac sympathetic nerve stimulation (10-20 Hz, 5 msec, 4-6 V, 
Randall et al. 1968)(30), (10 Hz, 5 msec, 3-5 V, (31) or stimulation 
of the first five thoracic ventral roots (10 Hz, 10 msec, 8V, Norris 
~ al.)(28). Hemodynamic responses were recorded on an 8 channel 
Beckman Recorder model 612 (Frequency response: 10 div@ 10 mm, DC to 
80 Hz; ± 1 db) at 25 mm/sec before, during and after the stimulation 
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FIGURE 3-1 
SAMPLE TRACING OF LEAD II EKG BEFORE, DURING AND AFTER 
STIMUI.ATION OF THE LEFT AND RIGHT STELLA.TE ANSAE SUBCI.AVIA 
The upper pair of tracings shows a recording of the Lead II EKG 
(2Smm/sec) during stimulation of the left stellate ansae subclavia 
(LSS, 8Hz, Smsec, 7V). The arrows indicate where ansae subclavia 
stimulation occurred. A represents the control EKG trace, ~ is the 
tracing during LSS, and f is the EKG following LSS. The time scale is 
in seconds. Note the marked increase in positivity of the T-wave 
during LSS, and the disappearance of the P-wave during LSS. The P-wave 
gradually reappeared from the QRS complex following stimulation. 
The middle pair of tracings shows the Lead II EKG during stimu-
lation of the right stellate ganglion. The arrow shows the beginning 
of the stimulation period. A.~,g, denote similar times as in Panel 
One. Right stellate stimulation was stopped immediately prior to the 
bottom trace. Note that prior to RSS, the T-wave was positive, and 
that during RSS and following RSS, the T-wave was inverted, and that 
the P-R interval remained constant. 
The bottom pair of tracings shows the Lead II EKG during stimu-
lation of the LSS following administration of timolol (0.2 mg/kg, 
i.v.). LSS was started at the arrow, and stopped immediately prior to 
the tracing of the bottom panel. Note that none of the changes which 
occurred in Panel One are present in this recording. 
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protocol. 
In each study, the ansae subclaviae of both the right and left 
stellate ganglia were tied with 2-0 silk and cut distal to the strands of 
silk. The cut distal ends were placed across the stainless steel 
bipolarelectrode for subsequent stimulations. Section of the right and 
left ansae subclaviae and the cervical vagi, effected neural decentrali-
zation of the heart. This was performed to prevent reflexes from arising 
following coronary artery occlusion, and to insure against afferent 
stimulation of the cardiac nerves. During the stimulations, the polarity 
of the bipolar electrode was kept the same with the negative electrode 
toward the heart thus avoiding the possibility of anodal nerve block. 
C. ISOI.ATION OF THE CIRCUMFLEX ARTERY 
The pericardium was incised and sutured to the walls of the chest 
to form a pericardial cradle. Approximately 5 mm of the circumflex 
artery was isolated distal to the first marginal branch in studies l, 2, 
and 3. In the first study, the circumflex was ligated for 6 hours. In 
studies 2 and 3, the circumflex artery was occluded for a maximum of 7-8 
minutes, after which the occlusion was released and the artery allowed to 
reperfuse for 35-40 minutes. This period of occlusion was chosen to 
minimize the development of ischemic damage and allows multiple assess-
ments of blood flow during the course of several different experimental 
manipulations. It has been dernonstrated that with periods of occlusion 
of up to ten minutes followed by a twenty minute period of reperfusion 
there is negligible ultrastructural damage (5), biochemical or metabolic 
alterations (32). In addition, Barber et al. have shown that a period of 
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occlusion of five minutes does not alter baseline blood flow when 
followed by a period of reperfusion of thirty minutes (4). Janes et al. 
reported that repeated periods of lAD occlusion of 5 minutes duration 
followed by a 10 minute reperfusion do not alter the responsiveness of 
the anterior wall to stellate ganglion stimulation as assessed by segment 
length and intramyocardial pressure (21). In study 4, approximately 5 mm 
of the circumflex artery was isolated as close as possible to its origin 
to allow perfusion of the majority of the circumflex bed. In the fourth 
study, the circumflex artery was occluded briefly while a catheter was 
inserted and tied in place. Normally the period of occlusion lasted no 
longer than 1-1.5 minutes before perfusion with blood from the carotid 
artery was begun. Dissection and isolation of the circumflex artery with 
2-0 silk may cause interruption of the nervous supply to the posterior 
wall. Dolezel et al. reported that implantation of a methacrylate ring 
around the left coronary artery resulted in a significant decrease in the 
adrenergic innervation as assessed by Falck's histochemical technique 
(13). They hypothesized that scarring of the area of implantation 
consequent to the surgery resulted in compression of the pericoronary 
nerves and the ultimate degeneration of the adrenergic nerves supplying 
the area distal to the implantation. However, Knight et al. reported 
that even with the extensive isolation of the circumflex artery necessary 
for implantation of ultrasonic flow probes on the circumflex artery, the 
increase in posterior wall thickening during stimulation of the ansae 
subclaviae in the group with the flow probe (71 ± 14%) was not signifi-
cantly different from the increase in posterior wall thickening of the 
control group (67 ± 9%). In addition posterior wall norepinephrine 
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levels in the flow probe group (629 ± 4 pg/mg) were not significantly 
different from the levels in the control group (589 ± 88 pg/mg) (24). 
Thus it may be that although isolation of a coronary artery partially 
interrupts adrenergic transmission to the region in question, norepi-
nephrine levels do not decline significantly following instrumentation. 
Whether isolation of the artery interrupts nerves controlling vasomotor 
activity has yet to be investigated. 
Lidocaine (40 mg,i.v.,bolus) was given prior to the initial 
coronary artery occlusion and during the course of the experiment as an 
additional bolus dose if there was an increased incidence of ventricular 
arrhythmias. 
D. ADRENERGIC BLOCKING AGENTS 
Table 3-1 provides a summary of the autonomic agonists and antago-
nists used throughout the studies. Timolol, a non-selective beta--
blocker, was chosen instead of propranolol for several reasons. As 
described by Scriabine et al. it is 5-10 times more potent than propran-
olol, and exerts fewer agonist properties (35). Timolol also has fewer 
central effects than propranolol (38). At concentrations required to 
block beta-receptors, timolol does not exhibit membrane stabilizing 
effects as does propranolol at an equipotent dose (29,36). Blockade by 
timolol (0.2 mg/kg, i.v.) was considered to be adequate when stimulation 
of the left ansae subclavia produced no changes in the Lead II electro-
cardiogram (See Figure 3-1) or heart rate. The blocking dose of timolol 
was based on its beta-1 properties, since as was mentioned in the 
literature review, the beta-2 receptors do not exert an important 
TABLE 3-1 
AUTONOMIC AGONISTS AND ANTAGONISTS USED 
SYMPATHETIC AGENT 
Adrenergic Blockers: 
Timolol 
Prazosin 
Rauwolscine 
Adrenergic Stimulants: 
Norepinephrine* 
Phenylephrine 
BHT-920 
PARASYMPATHETIC AGENT 
Parasympathetic Stimulant: 
Acetylcholine** 
Parasympathetic Blockade: 
Atropine 
SITE OF ACTION 
beta-1,beta-2 receptors 
alpha-1 receptors 
alpha-2 receptors 
alpha-1&2, beta-1 and 
beta-2 receptors 
alpha-1 receptors 
alpha-2 receptors 
nicotinic and mus-
carinic receptors 
muscarinic receptors 
*Left stellate stimulation (8Hz, 5msec, 5-7V) 
**Vagal stimulation (20Hz, 5msec, SV) 
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DOSE USED 
0.2 mg/kg,LD, 
0.08 mg/kg/-
hr ,MD 
0.5 mg/kg 
0.3 mg/kg 
5 g/kg 
0.1 mg/kg 
0.2 mg/kg 
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influence on cardiac function or coronary blood flow in the dog. 
Maintenance doses of timolol (0.08 mg/kg/hr, i.v.) were given to insure 
blockade of beta-receptors throughout the experiment. This dose of 
timolol has been used in other studies (19) and is approximately 1/10 of 
the usual dose of propranolol administeredin experimental studies (20,23, 
40). Alpha-1 blockade was achieved with prazosin hydrochloride (0.5 
mg/kg, i.v.); a dose which is sufficient to attenuate the average 45-50 
mm Hg rise in arterial pressure elicited by a 5 g/kg dose of phenyl-
ephrine (27,41). Prazosin has been demonstrated in a number of studies 
to exert non-significant effects on alpha-2 receptors (10,42). Phenyl-
ephrine was chosen to test the efficacy of alpha-1 blockade since it is 
considered to exert its agonist effects preferentially on post-junctional 
alpha-1 receptors. Rauwolscine (0.3 mg/kg, i.v.) is considered to be a 
reasonably pure alpha-2 blocking agent, since at this dose it does not 
block the effects of alpha-1 adrenergic agonists (26). This dose has been 
shown to block the increase in diastolic pressure effected by a O.lmg/kg 
dose of BHT-920 (37). BHT-920 is a selective alpha-2 stimulator which is 
pharmacologically similar to clonidine (25,39). Atropine (0.2 mg/kg, 
i.v.) was given in Study 4 to eliminate the influence of the parasympa-
thetic nerves upon stimulation of the thoracic cardiac nerves (31). 
Adequate blockade by atropine was tested with stimulation of the left 
thoracic vagus (20 Hz, 5 msec, 5V). 
E. REGIONAL BLOOD FLOW DETERMINATION 
In studies involving determinations of regional myocardial blood 
flow, radioactive labeled microspheres (14.5 ± 0.6 m) were used (3M Co, 
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New England Nuclear). This size sphere was chosen since it causes less 
axial streaming than larger sized spheres (7) and less arteriovenous 
shunting than smaller spheres (1,7). Fortuin et al. determined that with 
arterial injection of microspheres of this size, less than 1% appeared in 
the coronary sinus (17). The microspheres were suspended in a 10% 
dextran solution with 0.05% polyoxyethelene-20 sorbitan mono-oleate 
(Tween 80) to dispel, the inherent aggregation of microspheres (33). The 
vials containing the spheres were sonicated for at least 20 minutes prior 
to microsphere injection, and vigorously agitated in a vortex mixer 
immediately prior to use. Blood flow was calculated using the theoret-
ical organ technique. For 30 seconds before microsphere injection, a 
reference blood sample was withdrawn from the femoral artery at a rate of 
5-7 ml/min, and reference blood withdrawal continued for at least 90 
seconds following microsphere injection. This period of withdrawal 
insured that all of the spheres were trapped in the animal's blood 
vessels or in the syringe. Also, it has been shown that 98% of the 
spheres are collected within the first 60 seconds (15). The withdrawal 
rate of the pwnp was calibrated at the end of each experiment to deter-
mine the exact rate of withdrawal. Microspheres were injected into the 
left atriwn via a catheter over a period of 30-40 seconds and were 
flushed with 10 ml of warm saline. The electrocardiogram was monitored 
during the injection period, with care taken to stop injection during 
periods of arrhythmia. Careful handling of the left atrial catheter 
minimized the incidence of injection arrhythmias, as did slow injection 
of the microspheres. At the end of the experiment, each heart was 
electrically fibrillated, excised, and a segment of 5-French infant 
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feeding tubing was inserted into the circumflex artery distal to the site 
of occlusion. Microfil was injected into the circumflex catheter to 
delineate the perfusion area of the CX. Microfil, a liquid compound used 
to fill and opacify the vascular spaces of post-mortem tissues, was used 
in Studies 2 and 3 to define the perfusion area of the circumflex bed 
since it does not get filtered out of the vessels and become absorbed by 
neighboring vessels and tissue. Also, the stain does not dissipate when 
placed in 10% formalin for fixing, as Evans blue dye does. The hearts 
were fixed for 24-48 hours, after which samples of the myocardium were 
cut from both the stained and unstained regions, weighed, and placed in 
plastic tubes. Figure 3-2 illustrates how the ischemic area was deline-
ated, and the method by which the heart was sliced from apex to base. A 
sample slice shows how the endocardial and epicardial samples were cut 
from the left ventricle. The reference blood withdrawal samples were 
also put into plastic tubes, and the syringes containing the blood 
samples were rinsed with saline, and the rinse put into the respective 
labeled counting tubes. Heart and reference organ samples were counted 
by a TM Analytic gamma counter (model 1185) utilizing a three inch Na! 
crystal sensitive to gamma emissions. The data from the gamma counter 
were sent directly to an APPLE computer and stored on floppy disc, for 
later analysis. Blood flow values were obtained by the use of a computer 
program which calculated blood flow in ml/min/gm using the original data 
stored on disc from the gamma counter. Blood flows were calculated using 
standard equations with the appropriate corrections for background and 
interference coefficients. The equation used to calculate blood flow 
was: MBF- (Ct/TW) x (RBW/Cb), where MBF - myocardial blood flow in ml/min 
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FIGURE 3-2 
ILLUSTRATION OF THE METHODS USED TO OBTAIN MYOCARDIAL 
SAMPLES FOR REGIONAL BLOOD FLOW DETERMINATIONS 
Illustration of the manner in which samples were taken for calcu-
lation of regional myocardial blood flow. AO-aorta, I.A-left atrium, PA-
pulmonary artery, RV-right ventricle, LAD-left anterior descending 
coronary artery, CIRC-circumflex coronary artery, LV-left ventricle. A 
sample slice in the mid wall of the left ventricle is shown in the left 
hand figure. The right hand figure shows how samples were cut from the 
left ventricle. The stippled area is the area into which Microfil had 
been injected, and delineates the circumflex (ischemic) region. NZ-
normal zone, IZ-ischemic zone (collateral dependent zone). Sample 
numbers are used to define which region each sample was cut from. Sample 
numbers 1 and 3 are normal zone endocardium, sample numbers 2 and 4 are 
normal zone epicardium, sample numbers 5,7, and 9 are ischemic zone 
endocardium and so forth for each of the slices of left ventricle. 
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per gm, Ct - tissue radioactivity in counts/min, TW - tissue sample 
weight in grams, RBW - reference blood withdrawal rate in ml/min, and Cb 
- total radioactivity in reference blood sample. Buckberg et al. deter-
mined by statistical analysis that a minimum of 400 microspheres per 
sample was necessary to obtain a statistical error of <10% in calcula-
tions of blood flows. To obtain a larger number of microspheres per 
sample would have necessitated the injection of such a large quantity of 
microspheres, that hemodynamic variables might have been changed (7). In 
the present studies, approximately 4.5 million microspheres per blood 
flow determination were injected into the left atrium. Baer et al. re-
ported that left atrial injections of 15 m microspheres totaling 48 x 
106 did not affect hemodynamic variables or alter regional myocardial 
blood flow (3). It was calculated that in order to achieve the minimum 
number of microspheres per sample, tissue sizes of >500 mg or tissue 
samples with blood flows greater than 20 ml/min would have at least 400 
microspheres trapped in the micro-vasculature. 
Certain basic principles as outlined by Buckberg were adhered to 
with the injection of microspheres (8). We used the femoral artery as 
the blood withdrawal organ since this has been determined to provide a 
more reproducible collection of microspheres than other arterial lines 
such as the brachial artery. Second, the left atrium was used for the 
injection of microspheres to provide for adequate mixing of the spheres 
prior to entering the left ventricle or the left ventricular outflow 
tract. Third, the time for withdrawal was more than adequate to collect 
the majority of microspheres (>95~) circulating in the blood stream, as 
described by others (7,15). 
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F. USE OF THE MICROSPHERE METHOD FOR CALCULATION OF BLOOD FLOW DURING 
ISCHEMIA 
Utilization of the microsphere technique to determine ischemic 
blood flow is prone to error for several reasons. As explained above, 
samples containing at least 400 spheres will yield accurate blood flow 
measurements. However, in regions in which blood flow is compromised 
enough to cause ischemia, the number of microspheres lodged in the tissue 
might not have been sufficient. Retrospective analysis of ischemic 
tissues in which sample size was greater than 1 gram yielded average 
blood flow values for the entire heart which were not different from the 
blood flow values used in the actual analysis of data (see Appendix A). 
Second, injections of microspheres should be done under stable hemody-
namic conditions. The potential influence of arrhythmias was compensated 
for by injecting the microspheres over 30-40 seconds, since microspheres 
represent mean blood flow over consecutive heart beats. In blood flow 
determinations following coronary artery occlusion, microspheres were 
injected after five minutes of occlusion, during which time hemodynamic 
parameters were fairly stable, with the exception of some occasional 
arrhythmias, thus fulfilling the requirement of a steady state for 
accurate measurement of blood flow. Even shorter periods of occlusion 
(<30 sec) have been used to measure blood flow immediately following 
coronary occlusion (14), thus one can be reasonably certain that a steady 
state was achieved by five minutes after occlusion. Third, the use of 
microspheres during ischernia might lead to errors in calculation of blood 
flow as shown by Jugdutt et al. who have found that there is a real loss 
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of microspheres from cardiac tissue that has become ischemic (22). 
However the study done by Jugdutt used a period of ischemia of several 
weeks in chronically instrumented dogs, and 7-10 m microspheres were 
used. Another reason for the errors in blood flow determination cited by 
Jugdutt was that there was an 'apparent' loss of microspheres from 
ischemic tissue due to formation of edema. This should not have been as 
important in an animal model in which the periods of occlusion lasted for 
only 5 minutes, followed by reperfusion. Basuk et al. reported that 
periods of 10 minutes of occlusion followed by 20 minutes of reperfusion, 
caused little ultrastructural damage, and only slight edema formation 
(5). Capurro et al. found that there was microsphere loss due to a 
prolonged period of ischemia prior to fixing of the samples in formalin 
(9). In this study the hearts were excised within 20 minutes of the last 
period of occlusion. 
G. DATA ANALYSIS 
All data were expressed as mean ± SEM. All studies involved the 
use of some form of analysis of variance to test for differences between 
groups, with a form of modified T-test to isolate the differences. All 
statistical tests were run on SAS (Statistical Analysis System)(34). The 
particular tests used, and data analysis will be discussed under each 
specific project. 
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CHAPTER IV 
EFFECTS OF CARDIAC SYMPATHETIC NERVE STIMUIATION 
DURING ADRENERGIC BLOCKADE ON INFARCT SIZE IN ANESTHETIZED DOGS. 
A. INTRODUCTION 
Myocardial injury or infarction may occur as a result of either an 
interruption of coronary blood flow or a severe disruption in the balance 
between oxygen supply and demand. Augmentation of sympathetic nervous 
system activity following coronary occlusion is reflected by a rise in 
plasma catecholamine levels (33,34), and has been demonstrated directly 
by recordings of cardiac sympathetic nerve discharge (6,23). Activation 
of beta-1 receptors by cardiac sympathetic nerves or circulating 
catecholamines produces an increase in coronary blood flow primarily via 
an increase in myocardial oxygen consumption (MV02) and the resultant 
production of vasodilator metabolites (4). There is also evidence that 
catecholamines may effect coronary vasodilation directly by stimulation 
of beta-1 receptors (40) and beta-2 receptors (16) located on the 
coronary arteries. During myocardial ischemia, increases in MV02 might 
become crucial in determining the amount of flow available to the 
ischemic region. Increases in MV02 producing vasodilation in normal 
tissue, may result in a "steal" of blood from the vasodilated ischemic 
region (10). If the oxygen demands of the myocardial cells are increased 
by catecholamine stimulation in the presence of limited perfusion, a 
vicious cycle can result, in which the blood supply to the underperfused 
area is compromised further due to the increasing work demands of the 
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heart and vasodilation of normal areas. In addition, recent 
investigations have demonstrated the potentially important contribution 
of alpha receptors in limiting coronary flow at low levels of blood 
pressure (7) and in the presence of a coronary stenosis (8,13). Hence, 
alpha-mediated vasoconstriction may not necessarily be overridden by the 
large metabolic demands associated with catecholamine stimulation (29) 
and in fact, could be deleterious by further limiting blood flow to the 
ischemic region. Thus, activation of both beta and alpha receptors by 
neurally released or circulating catecholamines might exacerbate the 
amount of damage initially incurred in the ischemic area. 
Since a certain amount of cellular necrosis is inevitable following 
permanent coronary artery occlusion, there has been considerable interest 
in limiting the size of the infarct to prevent any further loss of 
functional myocardial tissue. It appears likely that factors which reduce 
neurally mediated increases in myocardial oxygen demands, such as 
beta-receptor blockade (27,42) can reverse the potentially damaging 
effects of catecholamines in the ischemic myocardium. Several 
investigations have shown that propranolol and timolol, both non-selec-
tive beta-blocking agents, can limit the size of myocardial infarcts 
(19,20,27,32,33,38). Moreover, propranolol has been reported to maintain 
perfusion of zones bordering on the infarct (32), but the extent of 
protection may be largely dependent on collateral flow since propranolol 
did not restrict infarct si~e in baboons, which have no preformed 
collaterals (12). Grong et al., reported that timolol did not increase 
blood flow to the ischemic area (15), however, Vik Mo et al., showed that 
timolol provided more protection against infarct development than 
, 
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propranolol (41). The mechanisms whereby beta-blocking agents decrease 
ischemic damage have not been established conclusively. 
Other investigations have implicated alpha receptors in the 
development of a myocardial infarct. Chiariello et al, showed that 
treatment with labetolol (a combined alpha and beta-adrenergic blocking 
agent) following coronary artery occlusion resulted in a smaller infarct 
size in rats as compared to those rats receiving a beta blocker alone 
(9). They attributed this to a decrease in afterload on the heart 
following blockade of peripheral vascular alpha receptors. The advan-
tageous hemodynamic effects of combined alpha and beta-blockade were also 
reported by Nelson et al., (31). 
The purpose of the present study was to assess the influence of 
elevated sympathetic input on the development of a myocardial infarct 
following circumflex artery ligation in hearts during conditions of 
controlled autonomic input. Specifically, we tested the hypotheses that 
1) the reported beneficial effects of beta-blockade on infarct size are 
contingent upon a basal level of sympathetic nerve activity prior to and 
during coronary artery occlusion; 2) a high level of sympathetic activity 
following beta blockade in the neurally decentralized heart will result 
in an greater infarct size; and 3) the contribution of alpha receptors to 
the development of a myocardial infarct will be accentuated by blockade 
of beta-receptors with augmented sympathetic stimulation to the heart. 
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B. METHODS 
1. General Preparation 
Forty-two mongrel dogs of either sex (14-30 kg) were premedicated 
with morphine sulphate (2.5 mg/kg; subcutaneously) twenty minutes prior 
to the intravenous administration of a solution containing alpha-
chloralose (100 mg/kg). A catheter was placed in the right femoral 
artery and connected to a Statham P23 dB pressure transducer for continu-
ous monitoring of arterial blood pressure. The right femoral vein was 
cannulated for fluid and drug administration. The trachea was cannulated 
with a glass Y-tube, which was connected to a Harvard respirator. Each 
dog was ventilated with room air at a positive end-expiratory pressure of 
5 centimeters of water. Both cervical vagi were isolated and severed. 
Through a thoracotomy in the fourth left intercostal space, both the 
right and left stellate ganglia were isolated and decentralized. In 
three groups of dogs, the anterior and posterior ansae subclavia from the 
left stellate ganglia were placed across a bipolar electrode for subse-
quent stimulation. In order to pace the heart a separate bipolar elec-
trode was attached to the left atrial appendage at a site remote from the 
level of circumflex artery occlusion. The circumflex coronary artery was 
isolated distal to the first marginal branch with 2-0 silk for subsequent 
occlusion. 
2. Protocol 
The dogs were divided into five groups. In Groups 1, 2, 4 and 5, 
the hearts were neurally decentralized as described above and electric-
ally paced at 150 beats per minute. In previous studies we had deter-
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mined this heart rate to be above the average heart rate of chloralose 
anesthetized dogs. It was not possible to pace the hearts in Group 3, 
since the heart rates increased to approximately 200 beats/minute 
following left stellate stimulation, and the rates decreased to about 150 
beats/minute over the course of two to three hours. The first group 
served as a control group (CTRL; n-5), receiving no beta-blocking agents 
or neural stimulation. In the second group (TIM; n-6), a blocking dose 
(0.2 mg/kg) of the non-selective beta-adrenergic blocker timolol, was 
administered intravenously as a bolus at least twenty minutes prior to 
circumflex artery occlusion. A maintenance dose of timolol (0.04 
mg/kg,IV bolus) was given every hour to insure adequate beta-blockade. 
This dose was found to be effective in blocking both inotropic and 
chronotropic actions of left stellate stimulation (8 Hz, 5 msec, 5-7 
volts). Group 3 (LSS; n-7) served as a control for the group of dogs 
receiving left stellate stimulation and timolol (Group 4). In this group 
the anterior and posterior ansae subclavia on the left side were 
stimulated electrically within five minutes of coronary artery occlusion 
and for the duration of the protocol (8 Hz, 5 msec, 5-7 volts) following 
parameters used by Barber et al.(3). No adrenergic blocking agents were 
administered in this group_ The fourth group (LSS-TIM; n-5) also 
received timolol prior to and during coronary occlusion. In addition, 
left stellate stimulation was begun immediately following CAO. Approxi-
mately twenty minutes before coronary artery occlusion, dogs in Group 5 
(LSS-TIM-PRAZ; n-6) received prazosin (O.Smg/kg, IV bolus), as well as 
timolol. The effectiveness of alpha receptor blockade was tested with 
phenylephrine (5 g/kg,IV bolus) (25). This dose of phenylephrine raised 
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the blood pressure an average of 64 mm Hg prior to blockade. If blood 
pressure did not increase more than 10 mm Hg following administration of 
phenylephrine, blockade by prazosin was considered to be adequate. Left 
stellate stimulation was also begun following CAO in this group. All 
dogs.received 40 mg of lidocaine prior to circumflex artery ligation to 
reduce the incidence of lethal arrhythmias early after coronary 
occlusion. In each dog, the occlusion was maintained for six hours. 
3. Determination of the Area at Risk 
The area at risk was determined in each dog in the following 
manner. After six hours of occlusion, the circumflex artery was 
cannulated immediately distal to the ligature using 5-French infant 
feeding tubing. A polyvinyl catheter was placed in the left atrium for 
injection of Evans blue dye (l.5% solution, lml/kg). The dye was 
injected rapidly into the left atrium and allowed to circulate until the 
anterior free wall was stained a deep blue. The circumflex artery distal 
to the point of occlusion was perfused simultaneously with 50 ml of warm 
0.9% NaCl using a modification of the methods described by Lange (23). 
Both the dye and saline were injected by hand. Immediately after 
injection of the dye the heart was electrically fibrillated and the left 
ventricle was vented with 18 gauge needles and excised. Venting was done 
to prevent the possible alteration of the area at risk due to acute 
ventricular dilation and the consequent increased wall tension. The 
right ventricular free wall, both atria, valvular tissue and aortic and 
pulmonary trunks were cut away leaving only left ventricle and septum 
intact. The left ventricle was sliced transversely from base to apex 
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into 6-8 slices, each slice approximately 1 cm in thickness, and both 
sides were photographed. The area at risk was defined as the unstained 
region of the myocardium (saline perfused), and total left ventricular 
area was calculated as the sum of the unstained area and the stained area 
following Evans blue injection. Colored pins were placed on either the 
basal or apical side for identification of which side was being viewed. 
4. Determination of Infarct Size 
Infarct size was assessed using triphenyl tetrazolium chloride 
solution (TTC) to stain for dehydrogenase enzymes (11,21,22). This 
method provides immediate quantitation of the infarct size and shows 
excellent correlation with the amount of necrosis determined 
histologically (11). The slices were rinsed in cold tap water and 
incubated for ten minutes in TIC maintained at 37 degrees centigrade. 
Each slice was again photographed to record infarct sizes. After film 
development the slices were projected onto a computer digitizing graphics 
tablet and the areas of the myocardium, area at risk, and infarct were 
measured by planimetry. The infarct size was normalized by estimating it 
as a percent of the area at risk. 
Of the 42 dogs, 19 dogs fibrillated within the first 15-20 minutes 
post-occlusion. 13 of these dogs died before the end of the 6 hour 
occlusion period. The six dogs which survived the occlusion period were 
included in the analysis of data. Of these dogs, two were in Group 2, 
three were in Group 3, and one was in Group 4. All dogs which fibril-
lated were electrically defibrillated and given an additional dose of 40 
mg lidocaine and 20 ml of an 8.~~ sodium bicarbonate solution. 
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5. Statistical Analysis 
Data were first analyzed using standard one way analysis of 
variance techniques. When the calculated F value was significant, differ-
ences between groups were determined using the Tukey test. Statistical 
significance was reached when the calculated value for p was less than 
0.05. All data are presented as mean± standard error of the mean (SEM). 
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C. RESULTS 
In Groups 1, 2, 4 and 5, (CTRL, TIM, LSS-TIM, and LSS-TIM-PRAZ, 
respectively) heart rate was kept constant throughout the experiment at 
150 beats per minute. The heart rate in Group 3 (LSS) increased from a 
control level of about 110 beats/min to 200 beats/min following left 
stellate stimulation. Since the heart rate reached such high levels and 
did not decrease to below 150 beats/min for several hours, these dogs 
could not be paced. Thus, the heart rates in Group 3 were higher than 
those in the other groups. 
The mean arterial pressure for all dogs remained constant through-
out the experiment except in dogs that fibrillated. The blood pressure 
in dogs that fibrillated dropped below 40 mm Hg for no more than ten 
minutes. If the dogs were not revived within that period of time, they 
were not included in the data analysis. However, all dogs which were 
successfully defibrillated were included in estimates of group mean 
arterial pressures. Mean arterial pressure was calculated as the average 
pressure over the six hour occlusion period. The mean arterial pressure 
(MAP) for the control group averaged 101.0 ± 5.5 mm Hg. For the timolol 
treated group, the averaged MAP was 99.5 ± 9.1 mm Hg. The group of dogs 
receiving left stellate stimulation had an averaged MAP of 109.2 ± 4.0 mm 
Hg. Group 4 MAP was 126.3 ± 9.5 and the MAP for Group 5 was 92.6 ± 5.1. 
The difference between groups was statistically significant (F value=2.-
87, p<.05) using analysis of variance. However, the Tukey test could not 
distinguish statistical significance between the specific groups at the 
.05 level. 
Figure 4-1 shows both the area at risk and the infarct size as a 
85 
FIGURE 4-1 
INFARCT SIZE AND AREA AT RISK AS A PERCENT OF 
LEFT VENTRICULAR AREA 
Percent of the left ventricle at risk or infarcted. On the left 
is the area at risk as a percent of left ventricular area. On the 
right is the infarct size as a percent of the left ventricular area. 
The data are expressed as mean values for each group ± SEM. *indicates 
Group 4 (LSS-TIM) was significantly different from Group 1 (CTRL) 
(p<0.05). tindicates Group 4 (LSS-TIH) was significantly different 
from Group 3 (LSS) (p<0.05). *indicates Group 4 (LSS-TIM) was signifi-
cantly different from Group 5 (LSS-TIM-PRAZ) (p<0.05). 
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percent of the left ventricular area. The mean values for the area at 
risk (left hand panel of Figure 1) of each group are: CTRL, 34.6 ±1.5; 
TIM, 35.0 ± 4.0; LSS, 28.6 ± 3.0; LSS-TIM, 32.5 ± 4.3; and, LSS-TIM-PRAZ, 
37.0 ± 4.3. No significant difference was found between groups for the 
area at risk as a percent of the left ventricular area. Thus, coronary 
artery occlusion at the same approximate anatomic level in each dog 
resulted in no significant differences in the size of the perfusion bed 
of the artery between groups. 
Mean values for infarct size as a percent of the left ventricular 
area are shown in the right hand panel of Figure 4-1 for each group are: 
CTRL, 8.4 ± 2.2; TIM, 11.8 ± 1.1; LSS, 9.1 ± 2.8; LSS-TIM, 19.1 ± 2.4; 
and, LSS-TIM-PRAZ, 8.8 ± 1.5. Significant differences were found between 
Group 4 (LSS-TIM) and CTRL, LSS, and LSS-TIM-PRAZ (p<0.05). There was no 
difference between LSS-TIM and TIM. The data for 
infarct size as a percent of the area at risk is shown in Figure 4-2. 
The mean value for CTRL was 23.5 ± 5.3; for TIM, 34.2 ± 1.4, for LSS, 
31.4 ± 7.8; LSS-TIM 59.3 ± 3.9; for LSS-TIM-PRAZ, 25.6 ± 5.3. 
Significant differences were found between LSS-TIM and all other groups 
(p<0.05). 
Analysis of the incidence of fibrillation, revealed that there were 
no significant differences in the numbers of dogs that fibrillated 
between the groups. Reevaluation of the data without the dogs that 
fibrillated did not change the significance between the groups. 
BB 
FIGURE 4-2 
INFARCT SIZE AS A PERCENT OF THE AREA AT RISK 
The percent of the area at risk infarcted. Infarct size from 
each of the groups is plotted as a percent of the area at risk. Data 
are expressed as mean ± SEM. *indicates Group 4 (LSS-TIM) was 
significantly different from all other groups (p<0.05). 
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D. DISCUSSION 
One of the major findings of the present study was that timolol 
treatment did not result in a smaller infarct size as a function of the 
left ventricle or as a function of the area at risk compared to control. 
This appears to be contrary to the results of previous studies in which 
beta blockade was reported to limit infarct size (19,20,27,32,33,38). The 
apparent discrepancy may be due to a basic difference in the experimental 
preparation. In those previous studies, the effect of beta-blockade was 
evaluated by comparing a group of animals that received the drug prior to 
coronary occlusion, to a group that received only the vehicle, both 
groups had intact cardiac innervation. Our rationale for using neural 
decentralization in the present study was that it would be an effective 
means of controlling cardiac autonomic input. In this way, we could 
eliminate the variability that occurs in extrinsic sympathetic activity, 
prevent the increase in reflex nerve activity secondary to coronary 
occlusion (26), and/or deliver a measurable and fixed level of selected 
sympathetic activation. 
The increased activation of adrenergic receptors which might 
exacerbate ischemic damage could be due to augmented sympathetic nerve 
activity, increased local release (35), local reflexes originating within 
the myocardium (2), or come from circulating catecholamines. However, 
the fact that there was no significant difference between the control 
group and the group receiving timolol demonstrates that circulating 
catecholamines did not influence significantly the course of infarction. 
If circulating or locally released catecholamines had been a significant 
determinant, then the size of the infarct in the group receiving timolol 
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would be expected to be larger via alpha receptor stimulation than the 
control set of animals. Furthermore, if there were a generalized release 
of catecholamines in response to coronary artery occlusion, much of this 
increase would be in the form of epinephrine, which has a greater 
affinity for vascular beta-2 receptors which were blocked by timolol 
(1). Coronary vascular beta-2 receptors are not considered to play an 
important role in the control of coronary blood flow (17). 
In addition the hearts were paced at 150 beats per minute to avoid 
the consequences that a variable heart rate would have on the development 
of ischemia. One of the beneficial effects of beta blockade is thought 
to be its ability to lower heart rate (42). By maintaining heart rate 
constant throughout the period of occlusion, the effects that a lower 
heart rate may have had on decreasing MV02 were eliminated. 
Another aspect of this study was that the infarct size as a 
function of the area at risk in the control group was smaller than those 
reported in other studies (30,36,37,43). There are several possible 
explanations for the observed differences. First, as explained above, in 
the present study all cardiac nerves were acutely sectioned, eliminating 
both direct and reflexly mediated nerve-stimulated catecholamine release 
and the concomitant increase in myocardial metabolism. Second, the 
specific anatomic location of the occlusion and the artery used in our 
study were different than those employed by others (30,36,37,43). Third, 
the occlusion in our study was maintained for six hours with no reper-
fusion. Finally, the various methods of measuring both infarct size and 
the area at risk of infarction, may contribute to the differences in 
results between separate studies. We chose to express the infarct size 
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as a percent of the area at risk as a means of normalizing the data. In 
this way we hoped to eliminate the variability in measurements between 
dogs that would occur if the left ventricle became the standard against 
which infarct size would be assessed. This method is supported by the 
results of our study. There was no significant difference found between 
TIM and LSS-TIM for the infarct size as a percent of the left ventricular 
area, whereas there was a difference between these two groups for the 
infarct size as a percent of the AAR. This can be accounted for by the 
inherently greater variability between left ventricular area as opposed 
to the circumflex artery perfusion bed. 
We found it surprising that the group of dogs receiving only LSS 
had a similar mean infarct size to the control group. This suggests that 
simultaneous activation of both alpha and beta receptors may act such 
that their opposing influences on coronary vascular smooth muscle offset 
one another. When opposing beta-mediated vasodilatory effects are 
removed, stimulation of alpha receptors proves deleterious to the 
ischemic heart. 
The results clearly demonstrate that efferent stimulation of the 
left ~ subclavia with concomitant beta-blockade produced larger 
infarcts than in the other groups. It is possible that the higher mean 
arterial pressure of this group of dogs had an adverse effect on the size 
of the infarct. An increase in arterial pressure represents an increase 
in afterload to the heart and thus, increased MV02. Recent evidence 
suggests, though, that acute increases in arterial pressure do not affect 
the outcome of coronary artery occlusion, being neither beneficial nor 
detrimental to infarct development (5). It is our supposition that alpha 
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receptors are responsible for the large size of the infarcts in Group 4 
(LSS-TIM). This is further supported by the results from Group 5 (LSS-
TIM-PRAZ) in which alpha-1 receptor blockade was effected by prazosin 
(25). It is possible that alpha receptors are more important in myocar-
dial ischemia with augmented levels of sympathetic input, since there was 
no significant difference between the control and timolol-treated 
groups. It might be argued that the levels of stimulation used were 
unphysiologic and might have overwhelmed the beta blockade. However, the 
level of blockade was adequate to prevent inotropic and chronotropic 
responses from occurring following left stellate stimulation. Thus, it 
is possible that the levels of cardiac sympathetic input normally present 
in the anesthetized dog were effectively blocked by beta-receptor 
blocking agents, and that these levels were not high enough to elicit 
significant alpha-mediated coronary vasoconstriction. However, with high 
levels of sympathetic input, and beta-1 adrenergic receptors blocked, 
alpha receptors may have a proportionally greater role in the 
development of a myocardial infarct. This may be the case in a conscious 
animal with elevated sympathetic tone during stressful situations or in 
exercising animals. Recently, Matsuzaki et al., have shown that 
myocardial function in a region of decreased flow is close to normal 
values at rest but deteriorates with exercise, and that atenolol (a 
selective beta-I-receptor blocker), although improving function in the 
ischemic area, does not restore it to control levels (28). 
As a result of the increase in infarct size following left stellate 
stimulation with beta blockade (Group 4), two conclusions may be drawn. 
Either alpha receptor activation increases the size of the infarct by 
94 
limiting coronary blood flow to the ischemic area, or there is a local-
ized non-beta receptor mediated increase in myocardial oxygen consump-
tion. Alpha receptor stimulation of platelet aggregation and the 
resultant formation of thrombi is an alternative explanation for an 
alpha-mediated increase in infarct size (17). Although alpha receptors 
might have limited blood flow to the normal area, via unopposed vasocon-
striction, no conclusions can be made regarding the actual mechanism of 
the increase in infarct size by alpha receptors in this study. Further 
investigations are needed to determine the involvement of alpha receptors 
in the development of ischemia, and its effects on the transmural and 
global distribution of blood flow. 
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CHAPTER V 
ADRENERGIC INFLUENCES ON CANINE MYOCARDIAL BLOOD FLOW 
FOLLOWING CORONARY OCCLUSION 
A. INTRODUCTION 
Competition of alpha-receptors with beta receptors in the regula-
tion of coronary blood flow has been investigated for the past ten 
years. The premise that alpha receptors restrict coronary blood flow 
despite augmented oxygen needs is well-documented. Alpha-receptor 
vasoconstriction has been demonstrated in conscious animals (21,24,35, 
43), anesthetized preparations (7,8,22,31), and isolated vessel strips 
(45). Alpha receptors have been postulated to exert not only a tonic 
influence on resting coronary blood flow (24,42,43) but also to limit the 
increase in blood flow consequent to exercise (23,33). Clinical evidence 
of intense vasospasm resulting in angina (28,34) and myocardial infarc-
tion (12,27) led other investigators to speculate on the contribution of 
alpha receptors to vasospasm. Alpha receptors have been implicated in 
the restriction of blood flow during administration of propranolol (26), 
and during the cold-pressor test, causing constriction severe enough to 
lead to angina (32). 
Whether alpha receptor stimulation modulates blood flow during 
ischemia has not been demonstrated conclusively. Even in the case of 
ischemia, when dilation due to ischemic metabolites would be expected to 
exert an overwhelming influence on blood flow, alpha receptors have been 
reported to limit blood flow (7). Other investigations have suggested 
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that during ischemia, beta receptor blockade affords protection to the 
myocardium by unmasking alpha receptors in the normal region which limit 
flow to the normal zone, enough to cause a 'reverse coronary steal' 
(11,19). However, Buck et al. concluded in their study that beta-recep-
tor blockade provided protection to the ischemic myocardium by lowering 
indices of oxygen demand, thus allowing the available blood supply to 
meet the oxygen demands of the myocardium (6). In a recent report from 
our laboratory, we found that combined blockade of alpha and beta 
receptors prior to coronary artery occlusion led to a decrease in the 
amount of myocardium which infarcted following coronary artery occlu-
sion. In dogs in which beta receptor blockade was administered, infarct 
sizes were larger in the presence of stellate stimulation as compared to 
control (16). Whether this was due to an effect on myocardial blood flow 
remains to be determined. We postulated that the process of myocardial 
infarction reported in that study was exacerbated by limitation of blood 
flow to the ischemic region via stimulation of alpha-1 receptors. The 
purpose of this investigation was to elucidate the role of alpha-1 
receptors on modulation of blood flow during coronary artery occlusion, 
with and without beta-blockade in the presence of elevated sympathetic 
input. In addition, we wished to determine whether prazosin would alter 
blood flow to the ischemic region regardless of whether it was given 
prior to or following coronary artery occlusion. 
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B. METHODS 
1. General Preparation 
Twenty three mongrel dogs of either sex were preanesthetized with 
morphine sulfate (2.5 mg/kg, s.c.) or xylazine (2 mg/kg, s.c.), 20 
minutes before administration of alpha-chloralose (50-100 mg/kg, i.v.). 
A catheter was inserted via the right femoral artery into the thoracic 
aorta and connected to a Statham P23 dB pressure transducer for continu-
ous monitoring of arterial blood pressure. A catheter was placed in the 
right femoral vein for intravenous administration of fluid and drugs. 
The left femoral artery was also cannulated for later blood withdrawal 
during the injection of microspheres. The trachea was cannulated with a 
Y-tube, the ends of which were connected to a Harvard respirator. The 
animals were ventilated with room air at a positive pressure of 5 cm of 
water. Both cervical vagi were isolated and cut. Succinylcholine was 
given as a muscle relaxant prior to opening the chest in the fourth left 
intercostal space. The dorsal and ventral limbs of both the right and 
left ansae subclaviae were isolated. Changes in the heart rate, P-R 
interval and T-wave configuration upon stimulation confirmed that both 
limbs had been isolated (17,44). The ansae were then cut distal to the 
stellate ganglia, and the cut distal ends of the left ansae subclavia 
were placed across a bipolar electrode. The pericardium was incised and 
sutured to the sides of the chest cavity to form a cradle. The 
circumflex artery was isolated distal to its first major branch, and a 
piece of 2-0 silk was placed under the artery. A catheter was inserted 
into the left atrial appendage for injection of microspheres. A loading 
dose of timolol (0.2 mg,kg, i.v.) was given prior to starting the actual 
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protocol, with maintenance doses of timolol administered throughout the 
duration of the experiment (0.08 mg/kg/hr, i.v.). Blockade of the 
beta-receptors was considered to be adequate when stimulation of the 
ansae subclavia no longer produced typical changes in either the 
electrocardiogram or heart rate. Blockade of alpha-1 receptors was 
accomplished by administration of prazosin HCL (0.5 mg/kg, i.v.). This 
dose of prazosin blocks the increase in blood pressure caused by a 5 
g/kg,i.v. dose of phenylephrine (average increase in blood pressure 45 
mm Hg) (29). The preparation was allowed to stabilize for at least 20 
minutes before beginning the experimental procedures. 
Blood gases were continuously monitored, and kept within normal 
limits (pH 7.38-7.45, pC02 25-35 mm Hg, p02 80-110 mm Hg) by adjusting 
the rate and depth of ventilation, with infusions of bicarbonate when 
necessary to keep pH normal. The core temperature, measured with a 
thermometer in the thoracic cavity was kept between 37-39° C, by means of 
a heating pad under the dog, and an infrared heating lamp above the dog. 
Plastic wrap was kept over the open chest to keep heat and moisture loss 
to a minimum. 
2. Regional Blood Flow Determinations 
In each group of animals, four blood flow determinations were made. 
Four of the following available species of 15 m microspheres (3-M) were 
used in random order: Ce-141, Cr-51, Nb-95, Sr-85 or Ru-103, and Sc-46. 
The microspheres were suspended in 50 ml vials of 0.5% dextran solution 
with 0.05% Tween 80. The vials were sonicated for 20 minutes prior to 
use, and agitated on a vortex mixer immediately before use. Reference 
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blood withdrawal from the left femoral artery was begun 30 seconds before 
injection of the microspheres. The microspheres were injected into the 
left atrium over a 30 second period and flushed with 10 ml of warm (37°C) 
saline. Reference blood withdrawal was continued for 90 seconds after 
completion of the microsphere injection. The total time for blood 
withdrawal averaged 2.5 minutes. Following the experimental procedures, 
the heart was excised, the circumflex artery ligated at the point of 
isolation, and a short piece of adult pediatric feeding tubing (8-French) 
inserted immediately distal to the ligature, and tied securely in place. 
Microfil was injected into the circumflex via the catheter until the 
epicardium of the posterior wall was visibly stained. The heart was then 
placed in formalin for 48 hours. After this, the heart was sliced into 
6-7 slices from apex to base. Samples of the myocardium were taken from 
the posterior wall (stained region), and from the anterior free wall (un-
stained region). Each sample was cut into endocardial and epicardial 
halves, weighed, and placed in labeled counting tubes. Blood withdrawal 
samples from each of the procedures, and the heart samples were counted 
in a TM Analytic Gamma Counter (model 1185), and the output from the 
gamma counter processed directly by an APPLE II computer. Flows were 
calculated using standard equations with corrections for background 
counts and interference coefficients. The equation for blood flow 
determination is: MBF - (Ct/TW) x (RllW/Cb) x 100, where MBF - myocardial 
blood flow in ml/min/100 gm; Ct - tissue radioactivity in counts/min, TW 
- tissue sample weight in grams, RllW - reference blood withdrawal rate in 
ml/min, and Cb - total radioactivity in reference blood sample. 
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3. Experimental Protocol 
Three groups of animals were studied. In each group four blood 
flow determinations were made. Figure 5-1 depicts in graph form the 
experimental protocols used in each group. 
a. Group l (Prazosin;Post-CAO) 
In Group 1 (n=5) the first flow determination was following 
beta-blockade with timolol (initial dose 0.2 mg/kg, i.v.); maintenance 
dose 0.08 mg/kg/hr, i.v.) and served as the control. The circumflex 
artery was then occluded for the remainder of the experiment. The second 
flow determination was made during circumflex artery occlusion, in the 
presence of timolol. Left stellate stimulation (LSS: 7-10 Hz, 5 msec, 7 
V) was begun and the third set of microspheres were injected during LSS 
with the circumflex occluded. After completion of the third microsphere 
injection, LSS was stopped. Prazosin (0.5 mg/kg i.v.) was administered 
prior to the last blood flow determination, LSS was begun, and the fourth 
set of microspheres was injected during LSS, under conditions of alpha-1 
blockade and coronary artery occlusion. The preparation was allowed to 
stabilize for at least 20 minutes between microsphere injections. This 
group will be denoted as the Prazosin;Post·CAO group since prazosin was 
administered after occlusion of the circumflex. 
In Group 1 (Prazosin;Post-CAO), the amount of prazosin delivered to 
the ischemic myocardium depended on the amount of collateral blood flow 
to the area, since prazosin was administered following coronary occlu-
sion. Thus, the efficacy of alpba-1 blockade was not necessarily 
homogeneous throughout the circumflex region. Hence, the next group of 
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FIGURE 5-1 
EXPERIMENTAL PROTOCOLS USED FOR GROUPS 1,2, AND 3 
Abbreviations denote the following: CAO: circumflex artery 
occlusion; LSS: stimulation of the left ansae subclavia (8 Hz); 
TIMOLOL: beta-blockade with timolol; PRAZOSIN: alpha blockade; RMBF: 
regional blood flow determination (microsphere injection). 
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animals was necessary to determine blood flow distribution during 
ischemia with prazosin given prior to occlusion to insure uniform 
blockade of the occluded region. 
b. Group Z (Prazosin;Pre-CAO) 
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In Group 2 (Prazosin;Pre-CAO, n-7), the occlusion periods lasted 
for a total of 7-8 minutes, and were followed by a thirty minute period 
of reperfusion. Microspheres were injected five minutes into the 
occlusion period, and the occlusion was released upon completion of the 
microsphere injection. The first flow determination was made following 
beta-blockade with timolol and served as the control. An atraumatic 
clamp was placed on the circumflex artery distal to the first marginal 
branch, and the second flow determination was made after 5 minutes of 
CAO. Upon completion of the injection, the occlusion was released and 
the heart allowed to reperfuse for 30-35 minutes. After this period, the 
CX was again clamped, stimulation of the left ansae subclaviae was begun 
and maintained throughout the third period of microsphere injection. At 
the end of the third microsphere injection, LSS was stopped, the arterial 
clamp was removed, and the artery allowed to reperfuse for 30-35 min-
utes. Prazosin (0.5 mg/kg, IV) was administered during the reperfusion 
period, and challenged with phenylephrine (5 g/kg, i.v.). At the end of 
the reperfusion period, the circumflex was again occluded, LSS was begun, 
and the fourth blood flow determination was made after 5 minutes of 
occlusion and LSS. Although total occlusion time was 7-8 minutes there 
is evidence that this period of occlusion does not cause ultrastructural 
damage (4) or alter baseline blood flow when followed by a 30 minute 
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period of reperfusion (2). This group will be called Prazosin;Pre-CAO 
since prazosin was given before occlusion of the circumflex artery. 
c. Group 1 (Ctrl-Prazosin) 
A third set of animals was included in this study to determine 
resting blood flow in the neurally decentralized preparation. In Group 
Three (n-7), the effects of prazosin on coronary blood flow during 
ischemia were tested without prior beta-blockade and with no sympathetic 
input. In this group of animals, the same model of circumflex occlusion 
was employed. The total duration of occlusion lasted from 7-8 minutes, 
with microsphere injections begun after five minutes of occlusion. Upon 
completion of the injection, the occlusion was released and the artery 
reperfused for thirty minutes. Four blood flow determinations were made 
in this group. The first microsphere injection served as a control, with 
no adrenergic blockers or sympathetic stimulation. The second injection 
was following a five minute period of coronary artery occlusion, again 
with no adrenergic blockers. The occlusion was released upon completion 
of the injection of microspheres, and allowed to reperfuse for thirty 
minutes. The third blood flow determination was made following a 
blocking dose of prazosin (0.5 mg/kg, i.v.). The last blood flow 
determination was made during coronary artery occlusion, in the presence 
of alpha-1 blockade. This group will be referred to as the Ctrl-Prazosin 
group to denote that prazosin was administered under control conditions, 
with no LSS or beta-blockade. 
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4. Data Analysis 
Statistical tests were run on the regional myocardial blood flow 
values, on blood flows normalized to control flow, on resistance values, 
and on the endo/epi ratios. Blood flows were normalized to percent of 
the control blood flow. Resistance was calculated as the quotient of 
mean arterial blood pressure / endocardial or epicardial blood flow at 
the time of injection. Only left ventricular samples were analyzed. 
Thus anterior wall and posterior wall blood flow refer exclusively to the 
left ventricular blood flow. In each heart all samples from similar 
regions (i.e. all anterior endocardial samples) were averaged together to 
obtain a single blood flow value for each intervention. The averaged 
value was used in the analysis of data. In order to determine whether 
prazosin would exert a different effect on blood flow depending on the 
severity of the blood flow reduction following occlusion, blood flows in 
the posterior wall were separated in the following manner. In each dog, 
posterior wall blood flows were divided into two groups for analysis, 
Group A included those samples in which blood flow was between 20-50% of 
control flow following coronary artery occlusion, and Group B included 
those samples in which blood flow fell to less than 20% of control flow 
following coronary artery occlusion. Repeated measures analysis of 
variance was used to test for differences between experimental protocols, 
and Tukey's multiple range test was employed to isolate for differences. 
Comparisons were made between all of the groups for both the endocardium 
and epicardium. Statistical significance was reached at a p value of 
<0.05. 
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C. RESULTS 
1. Group 1 (Prazosin;Post-CAO) 
The anterior and posterior wall blood flow values for Group 1 are 
listed in Table 5-1. In the anterior wall there were no significant 
differences in blood flow between any of the groups, in either the 
endocardium or epicardium. In Group A of the posterior wall, the three 
blood flow determinations were all significantly lower in the endocardium 
following coronary artery occlusion compared to control (p<0.0001). In 
the epicardium, the blood flow during coronary artery occlusion (46.66 ± 
4.98) was significantly lower than control (99.29 ± 11.67) (p<.0001). 
However, in the epicardium, flow increased during left stellate stimula-
tion (LSS) and during LSS following administration of prazosin, so that 
the last two determinations of blood flow following coronary artery 
occlusion (CAO-LSS, CAO-LSS-PRAZ) were not statistically different from 
control. In Group B of the posterior wall, flows following CAO in both 
the endocardium and epicardium were all significantly lower than control 
(p<0.0001). In neither Group A nor Group B, were there were any signifi-
cant differences between the interventions (CAO, CAO-LSS, CAO-LSS-PRAZ). 
When the flows were normali2ed to the control flow value (Table 5-
2), there were no significant differences between flows in the endocar-
dium or epicardium of the anterior wall. The blood flow was 
significantly depressed in the endocardium and epicardium during CAO, 
CAO-LSS and CAO-LSS-PRAZ of Posterior ~all Groups A and B compared to 
control (p<0.0001). 
There were no significant differences between groups in either the 
endocardial or epicardial calculated resistance in the anterior wall. 
MEAN 
SEM 
MEAN 
SEM 
MEAN 
SEM 
TABLE 5-1 
REGIONAL BLOOD FLOW VALUES (ML/MIN/100 GM) DURING 
PERMANENT CORONARY OCCLUSION 
GROUP 1 (PRAZ;POST-CAO) 
ANTERIOR LV 
ENDOCARDIUM EPICARDIUM 
CONTROL CAO CAO- CAO- CONTROL CAO CAO-
LSS LSS LSS 
PRAZ 
116.33 88.41 93.48 95 .65 103.40 89.36 99.98 
12.33 6. 72 7.83 16 .44 7.74 6.38 4.10 
POSTERIOR LV (A) 
ENDOCARDIUM EPICARDIUM 
CONTROL CAO CAO- CAO- CONTROL CAO CAO-
LSS LSS LSS 
PRAZ 
114. 82 38.681 37 .101 39. 611 99.29 46. 661 56.35 
16.01 6.26 14.18 16. 89 11.67 4.98 11.48 
POSTERIOR LV (B) 
ENDOCARDIUM EPICARDIUM 
CONTROL CAO CAO- CAO· CONTROL CAO CAO-
LSS LSS LSS 
PRAZ 
110.15 11. 851 22. 491 Z6. 25 1 93.71 40. 531 51. 601 
12.93 2.69 12.96 18.51 9.95 7.46 12.16 
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CAO-
LSS 
PRAZ 
91. 76 
14.26 
CAO-
LSS 
PRAZ 
57.95 
17.78 
CAO-
LSS 
PRAZ 
46. 98 1 
16.01 
(Data are represented as mean ± SEM. Control: blood flow during beta 
blockade; CAO: flow during circumflex occlusion; CAO-LSS: flow during 
circumflex occlusion in the presence of left ansae subclavia stimulation; 
CAO-LSS-PRAZ: CAO-LSS following i.v_ prazosin. 1indicates significant 
difference from control, p<0.0001; n=S) 
MEAN 
SEM 
MEAN 
SEM 
MEAN 
SEM 
TABLE 5-2 
NORMALIZED BLOOD FLOW VALUES (%) DURING 
PERMANENT CORONARY OCCLUSION 
GROUP 1 (PRAZ;POST-CAO) 
ANTERIOR LV 
ENDOCARDIUM EPICARDIUM 
CONTROL CAO CAO- CAO- CONTROL CAO CAO-
LSS LSS LSS 
PRAZ 
100.00 86.09 82.99 82 .20 100.00 93. 71 100.85 
0.00 8.39 9.69 7 .27 0.00 4.80 8.89 
POSTERIOR LV (A) 
ENDOCARDIUM EPICARDIUM 
CONTROL CAO CAO- CAO- CONTROL CAO CAO-
LSS LSS LSS 
FRAZ 
100.00 31.472 28.30 2 31. 202 100.00 48 .152 53.68 2 
0.00 1. 76 8.79 7.67 0.00 3.00 8.26 
POSTERIOR LV (B) 
ENDOCARDIUM EPICARDIUM 
CONTROL CAO CAO- CAO- CONTROL CAO CAO-
LSS LSS LSS 
FRAZ 
100.00 10. 532 16.66 1 19.37 2 100.00 45. 212 54. 052 
0.00 1.67 7.93 11.49 0.00 8.86 9.90 
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CAO-
LSS 
PRAZ 
88.88 
7.49 
CAO-
LSS 
PRAZ 
54.692 
12.33 
CAO-
LSS 
PRAZ 
47.39 2 
11. 28 
(Data represent the mean± SEM of percent of control flow. See Table 5-1 
for definition of group names. 2indicates significant difference from 
control, p<.0001, n=5) 
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Only the anterior wall resistances were calculated since the perfusion 
pressure of the posterior wall could not be assumed to be either aortic 
pressure, or uniform throughout the circumflex bed. 
Table 5-3 lists the endo/epi ratios for the Prazosin;Post-CAO and 
Prazosin;Pre-CAO groups. In Group 1 (Prazosin;Post-CAO), there were no 
significant differences between the endo/epi ratios in the anterior wall. 
In the posterior wall, the endo/epi ratio was significantly lowered 
during left stellate stimulation (0.68 ± 0.19 mm Hg 100 gm/ml/min) as 
compared to control (1.16 ± 0.13) (p<0.02). There no other significant 
differences between groups. 
The results from Group 1 indicate that combined alpha and beta 
blockade following permanent ligation of the circumflex artery does not 
increase flow to either the normal zone or the ischemic zone compared to 
the flow during left stellate stimulation without alpha blockade. 
2. Group 2 
Figure 5-2 depicts the regional myocardial blood flow (ml/min/100 
gm) for Group 2 (Prazosin;Pre-CAO). In the top left panel of the figure 
are the anterior wall endocardial blood flows. Administration of 
prazosin significantly increased blood flow to 134.08 ± 22.21, from 81.18 
± 5.76 during control (p<0.0001). The middle and right hand panels of 
the upper graph show the blood flows for Groups A and B of the posterior 
wall. Endocardial blood flows shown for both groups A and B were 
significantly lower than control during CAO, CAO-LSS and CAO-LSS-prazosin 
(p<0.0001). There were no differences between treatment groups. 
The bottom half of Figure 5-2 shows blood flow in the epicardium of 
ctrl 
x 1.13 
SEM 0.08 
ctrl 
x 1.14 
SEM 0.05 
TABLE 5-3 
ENDO/EPI RATIOS FOR PERMANENT AND REPETITIVE 
CORONARY ARTERY OCCLUSIONS 
GROUP 1 
ANTERIOR POSTERIOR(A) 
cao cao- cao- ctrl cao cao- cao- ctrl 
lss lss- lss lss-
praz praz 
1.15 0,94 1.05 1.16 0.78 0.683 0.79 1.18 
0.16 0.10 0.07 0.13 0.14 0.19 0.21 0.05 
GROUP 2 
ANTERIOR POSTERIOR(A) 
cao cao- cao- ctrl cao cao- cao- ctrl 
lss lss- lss lss-
praz praz 
1.30 1.26 1.13 1.20 0.92 0.96 1.44 1.21 
0.09 0.03 0.05 0.09 0.20 0.25 0.55 0.09 
(Data are listed as mean + SEM. Group 1 (n-5), Group 2 (n-7). 
POSTERIOR(B) 
cao cao- cao-
lss lss-
praz 
0.403 0.273 0.243 
0.12 0.07 0.05 
POSTERIOR(B) 
cao cao- cao-
lss lss-
praz 
0.444 0.464 0. 304 
0.07 0.03 0.04 
~p<0.02 compared to 
control, 4 p<0.0001 compared to control. See Table 5-1 for definition of 
Abbreviations.) 
,.... 
,.... 
.i:-
11s 
FIGURE 5-2 
REGIONAL MYOCARDIAL BLOOD FLOW VALUES (ML/MIN/100 GM) 
DURING REPETITIVE CORONARY ARTERY OCCLUSION 
GROUP 2 (PRAZOSIN;PRE-CAO) 
Mean ± SEM values for posterior and anterior wall blood flows in 
the left ventricular endocardium and epicardium of Group 2. Control: 
blood flow during control conditions, during beta-blockade; CAO: flow 
during occlusion of the circumflex; CAO-LSS: flow during occlusion of 
the circumflex artery and simultaneous left ansa subclavia stimulation; 
CAO-LSS-PRAZ: flow during conditions of CAO-LSS in the presence of 
alpha blockade. *indicates significant difference from control 
(p<0.0001, n=7). 
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the anterior left ventricle (left panel) and the posterior left ventricle 
(middle and right panels). Prazosin did not significantly alter the flow 
in the epicardium (as compared to control, CAO or CAO-LSS). Flows 
decreased significantly from control during each of the interventions in 
the posterior wall (p<0.0001). However, there were no significant 
differences between any of the interventions. 
Figure 5-3 shows blood flows normalized to the control blood flow 
value. The left hand panel of the top figure shows that blood flow 
following prazosin (167.03 ± 18.94) was significantly increased from the 
normalized control value (p<.0001). The middle panel and right panel of 
the upper figure, illustrate that blood flow was decreased significantly 
during all three interventions compared to control (p<0.0001). 
The lower panel of Figure 5-3 depicts epicardial blood flows in the 
anterior and posterior wall. Blood flow in the anterior wall increased 
significantly following prazosin (168.55 ± 16.48) as compared to control 
(100 ± 0) and left stellate stimulation (117.34 ± 8.91) (p<0.0001). 
Flows following CAO were all significantly lower than control in both 
groups of posterior wall blood flows (p<0.0001). 
Figure 5-4 shows calculated resistance values for the anterior 
wall. In the endocardium, resistance decreased significantly from 
control (1.36 ± 0.13) following prazosin administration (0.74 ± 0.13) 
(p<0.0001). Resistance subsequent to prazosin was also significantly 
lower than calculated resistance during left stellate stimulation without 
alpha-1 blockade (1.17 ± 0.11) (p<0.0001). In the epicardium, 
calculatedresistance was significantly lower following alpha-1 blockade 
(0.80 ± 0.11) compared to control (1.40 ± 0.17), CAO (1.29 ± 0.16) and 
FIGURE 5-3 
NORMALIZED REGIONAL MYOCARDIAL BLOOD FLOW VALUES (%) DURING 
REPETITIVE CORONARY ARTERY OCCLUSION 
GROUP 2 (PRAZOSIN:PRE-CAO) 
Mean± SEM values for blood flows normalized to control (n-7). 
The upper half of the graph represents the anterior and posterior left 
ventricular endocardial blood flows. *indicates a significant differ-
ence from control (p<0.0001). The lower half of the graph represents 
the anterior and posterior left ventricular epicardial blood flows. 
indicates a significant difference from control (p<0.0001). *'indicates 
a significant difference from CAO-LSS (p<.0001). See Figure 5-2 for 
abbreviations and legend. 
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FIGURE 5-4 
VASCULAR RESISTANCE IN THE ANTERIOR LEFT VENTRICULAR WALL 
DURING REPETITIVE CORONARY OCCLUSION 
GROUP 2 (PRAZOSIN:PRE-CAO) 
Mean ± SEM values for the calculated left ventricular 
resistances, in the anterior endocardium and the epicardium (n-7). * 
indicates significant difference frorn control (p<0.0001). "'kindicates 
significant difference from CAO (p<O_OOOl). ~indicates significant 
difference from CAO-LSS (p<0.0001). See Figure 5-2 for legend and 
abbreviations. 
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CAO-LSS (1.45 ± 0.13) (p<0.0001). 
There were no significant differences in the endo/epi ratios in 
either the anterior wall or posterior wall Group A. In Group B of the 
posterior wall, the endo/epi ratios were significantly lower than control 
in the three interventions following CAO (p<0.0001) (See Table 5-3). 
Thus, alpha-1 blockade with prazosin increased blood flow to the 
non-ischemic areas of the left ventricle, during left stellate stimula-
tion. However, blood flow to the ischemic myocardium was not altered 
significantly by prazosin administration, even when given prior to 
coronary artery occlusion. 
The third group of animals (n-7) did not show any significant 
changes in either blood flow or resistance in the posterior and anterior 
wall following administration of prazosin. Blood pressure did not change 
significantly following adminstration of prazosin. The absence of a drop 
in blood pressure following administration of prazosin in this group was 
most likely due to lower levels of background sympathetic activity in 
these dogs as opposed to the other groups. This group of dogs 
demonstrates that alpha-1 blockade without prior beta-blockade and in the 
absence of elevated sympathetic input does not increase flow or reduce 
resistance significantly from values prior to administration of prazosin. 
3. Blood Pressure 
Blood pressures during microsphere injection for Groups 1 and 2 are 
listed in Table 5-4. In Group 1 administration of prazosin dropped blood 
pressure significantly from Control, CAO, and CAO-LSS (p<0.05). In Group 
2 prazosin decreased blood pressure significantly from control and from 
TABLE 5-4 
BLOOD PRESSURES (MM HG) FOR PERMANENT (GROUPl) AND 
REPETITIVE (GROUP 2) CORONARY ARTERY OCCLUSIONS , 
CONTROL CAO 
108.32 ± 3.63 111.54 ± 4.70 
CONTROL CAO 
108.43 ± 5.52 101.50 ± 5.07 
GROUP 1 
CAO-LSS 
107.42 ± 6.86 
GROUP 2 
CAO-LSS 
106.14 ± 5.51 
CAO-LSS-PRAZ 
123 88.60 ± 5.43 
CAO-LSS-PRAZ 
87.17 ± 5.1313 
(Data are listed as mean+ SEM. Group 1 (n-5), Group 2 (n-7). 1p<0.05 
compared to control, 2p<0.05 compared to CAO, 3p<0.05 compared to CAO-LSS. See 
Table 5-1 for Abbrev.) 
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blood pressure during CAO-LSS (p<0.05). 
The results from this study suggest that, while alpha-1 receptors 
exert a modulating influence on regional myocardial blood flow in normal 
areas, their importance can only be demonstrated in the presence of beta-
blockade and elevated levels of sympathetic nerve stimulation. In 
addition, there does not appear to a significant influence of alpha-1 
receptors on blood flow in the ischemic zone following complete coronary 
artery occlusion. 
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D. DISCUSSION 
Previous investigations demonstrated that alpha receptors restrict 
increases in blood flow following coronary stenosis (7,8). Other 
investigations have demonstrated that under conditions in which beta-
mediated metabolic vasodilation might be expected to overwhelm alpha 
receptor-mediated vasoconstriction such as severe exercise, there is 
still limitation of blood flow via alpha receptors (23,33). 
Our goal was to examine whether sympathetic stimulation and alpha-1 
blockade with prazosin would redistribute blood flow to the posterior 
wall following circumflex artery occlusion. Chiariello et al. reported 
that alpha mediated vasoconstriction in the normal zone effected a 
reverse 'coronary steal' into the occluded bed (11). This finding was 
supported by Giudicelli et al., who found that stimulation of the left 
stellate in the presence of beta-blockade decreased blood flow to the 
non-ischemic region concomitant with an increase in flow to the ischemic 
region (19). Contrary to those reports, the major finding of this study 
was that prazosin did not increase blood flow to the posterior left 
ventricle following circumflex coronary artery occlusion. Although 
prazosin induced vasodilation in the normal zone in Group 2 (in which it 
was given prior to occlusion), evidently this was not sufficient to 
precipitate 'steal' of blood from the ischemic area. 
GROUP 1: 
In this group (Praz:Post-CAO), there was no effect of alpha 
blockade on blood flow to either the anterior or posterior wall. The 
lack of an increase in blood flow to the posterior wall of Group 1 may be 
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ascribed to the post-occlusion, systemic administration of prazosin, with 
a resultant non-uniform distribution to the collateral dependent 
posterior wall. It is also possible that alpha-1 receptors do not have 
an important influence on blood flow following a complete coronary artery 
occlusion. Previous studies utilized combined alpha-1 and alpha-2 
blockade to demonstrate alpha mediated vasoconstriction in their prepara-
tions. Although the role of alpha-2 receptors was not addressed in the 
present study, recent investigations have suggested that alpha-2 recep-
tors, both pre- and post-junctional may influence coronary blood flow 
(22,24). 
Insofar as flow could be delivered to the posterior wall only via 
collateral vessels, it is understandable that very little change in flow 
would be elicited in the ischemic bed as a result of anterior wall blood 
flow changes. Schaper reported that not only does it take several hours 
for nascent collateral vessels to open, the resistance of these collat-
erals is extremely high. Even when functional capacity has been reached 
after four weeks of occlusion, the resistance in collateral vessels is 
still 12-40 times higher than coronary vessels (40). In addition, the 
amount of left ventricle at risk of infarction following occlusion of the 
circumflex is larger (41) than the amount in previous studies (11,19) 
utilizing the LAD region. Schaper calculated that the relative number of 
collateral vessels supplying an ischemic region decreases with an 
increase in volume of the myocardium perfused (40). Thus, while other 
studies demonstrate reverse steal of blood into the ischemic region, it 
is unlikely that such a phenomena would exert a noticeable effect on 
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delivery of blood flow to, and salvage of the ischemic region in this 
study. 
It should not be overlooked that the posterior wall might have been 
unable to respond to nerve stimulation and adrenergic blockade, or that 
the nerves themselves might have been impaired following isolation of the 
vessel, and occlusion of the circumflex artery (15). Several laborato-
ries have described 'stunning' of the myocardium following coronary 
artery occlusion. Ciuffo et .ElJ... implanted ultrasonic dimension gauges in 
the midwall of the LAD region to assess myocardial function following 
periods of ischemia of up to two hours. They demonstrated that following 
a twenty-five minute period of occlusion and reperfusion, segmental 
shortening increased significantly in the post-ischemic zone in response 
to systemic injection of norepinephrine. However, the post-ischemic 
response to stimulation of the cardiac nerves was impaired, and the 
authors concluded that nerve conduction had been disrupted during the 
period of ischemia (13). One problem with Ciuffo's study was that the 
placement of the crystals in the midwall would not allow separation of 
function of the potentially ischemic endocardium from the epicardium. 
Another problem is that the LAD region does not respond as markedly to 
stimulation of the left cardiac nerves as does the circumflex region. 
Finally, regional blood flow assessed by microspheres did not show any 
difference in the response to nerve stimulation or systemic norepine-
phrine. A study by Barber et al. provided evidence for loss of catechol-
amines and nerve activity following the injection of latex into a branch 
of the LAD (3). In the study by Ciuffo et al., the period of occlusion 
was 25 minutes, and the study by Barber et al., the infarction was 
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transmural. Neither of these conditions is applicable for the present 
study since the period of occlusion was not long enough to cause 
transmural infarction, and in any case sympathetic fibers are thought to 
travel in the epicardiurn (18), which did not become severely ischemic in 
this study. 
The endo/epi ratios did not show any significant changes except in 
Group 1. During combined LSS and CAO, the endo/epi ratio dropped 
significantly from control in the posterior wall, due probably to a small 
amount of vasoconstriction in the endocardiurn superimposed on the 
existing level of decreased flow. What is interesting is that prazosin 
did not alter the endo/epi ratio in favor of increased flow to the 
epicardiurn. As Schaper remarked, increasing collateral flow to an 
ischemic region will result in decreased endo/epi ratios, with more flow 
going to the epicardiurn (40). This allows salvage of the epicardiurn at 
the expense of the endocardium. Reduction of tissue damage depends on 
limiting the wavefront of necrosis (37), and salvaging the epicardiurn at 
the expense of leaving a core of endocardiurn damaged. 
GROUP 2: 
In Group 2 (Praz:pre-CAO), prazosin did not increase blood flow to 
the occluded region, even when given before coronary artery occlusion. 
However, prazosin caused an increase in flow and a decrease in resistance 
to the anterior wall compared to control. If prazosin had acted merely 
by removing vasoconstriction imposed by LSS and beta-blockade, then it is 
interesting that it actually increased blood flow significantly from 
control levels. It is conceivable that the increase in flow mediated by 
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prazosin was ~ot via its adrenergic blocking actions, but via a non-
specific effect on the coronary vascular smooth muscle. Although an 
initial report by Constantine supported the idea that prazosin acted 
directly on smooth muscle to cause vasodilation (14), subsequent studies 
have shown that prazosin's actions are alpha-receptor mediated (9,20,43). 
The most probable explanation is that prazosin blocked coronary vascular 
alpha-I receptors and that the flow increase was due to removal of 
alpha-vasoconstriction. 
It is also possible in Group 2 (Praz:Pre-CAO) that prazosin's 
actions were due primarily to a release of vasoconstrictor tone imposed 
on anterior wall blood vessels by circulating catecholamines. The 
contribution of circulating catecholamines to increases in blood flow 
during mild exercise were examined in a recent investigation by Chilian 
et al., (10). Using conscious dogs, with regional denervation of the 
posterior wall, they found that alpha receptors limit augmentation of 
blood flow during exercise in the dog. This vasoconstriction appeared to 
be mediated primarily by circulating catecholamines, not by neurally 
released catecholamines. Their findings may explain why, contrary to our 
expectations, stimulation of the left stellate did not decrease flow 
significantly from control in either Group 1 or Group 2. Moreover, the 
left-side cardiac nerves do not innervate the anterior wall as uniformly 
as the posterior wall (36). Rinkema et al. demonstrated that in the 
presence of beta-blockade with propranolol, left stellate stimulation 
produced a 28% reduction in regional myocardial blood flow to the 
posterior LV, and only a 16% reduction in flow to the anterior wall (38). 
These results agree with an earlier study by Ross and Mulder. During LSS 
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in the study by Ross and Mulder, the resistance in the circumflex artery 
during beta blockade increased by 75% compared to a 19% increase in the 
LAD artery (39). 
Significant differences in resistance between Control, LSS, 
Prazosin and CAO·LSS, in the anterior wall were evident in Group 2 
(Praz;Pre-CAO) although flow had not changed significantly, due to a 
significant drop in blood pressure following the administration of 
prazosin. This result concurs with findings by Macho and Vatner in which 
prazosin did not increase flow significantly but may have evinced more of 
an effect hemodynamically (30). 
The resting level of resistance in the heart may account for 
differences in the endocardial and epicardial response to prazosin. 
Although the resistance was decreased in comparison to control and LSS, 
the endocardial resistance was not significantly lower than that during 
coronary artery occlusion. The obvious explanation is that the endocar-
dium was slightly more dilated than the epicardium, hence the response to 
additional vasodilation with prazosin was not as great. In the posterior 
wall, there were no differences between interventions. This may be due 
to the fact that blood flows were reduced so much following CAO, that 
slight differences were not demonstrable between the subsequent interven-
tions. 
SUMMARY OF GROUPS 1 AND 2 
The differences in results between Group 1 (Praz;Post-CAO) and 
Group 2 (Praz;Pre-CAO) regarding the anterior wall can be ascribed to 
differences in the experimental preparations. In Group 1, the period of 
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occlusion lasted for up to two hours, with no reperfusion. In addition, 
cardiac nerve stimulation was maintained for approximately 15 minute 
intervals, as opposed to five minutes in Group 2. The role of cardio-
cardiac reflexes in the response of the anterior wall to posterior wall 
occlusion should not be ignored, as reflex arcs through the middle 
cervical ganglion have been demonstrated in decentralized preparations 
(1). 
GROUP 3 
In the third group of dogs, alpha-1 blockade did not exhibit a 
noticeable effect on blood flow. Without prior beta blockade, alpha 
receptors were not unmasked and hence the effects of beta receptors were 
predominant (5). It was also shown that elevated levels of sympathetics 
were needed to stimulate the alpha receptors. It is possible that the 
existing levels of circulating catecholamines were not adequate to result 
in alpha-mediated vasoconstriction without prior beta blockade. 
In conclusion, contrary to what has been reported in the 
literature, we did not see an increase in blood flow to the ischemic 
region following alpha blockade with prazosin regardless of whether it 
was given before of after coronary occlusion. However, one disadvantage 
of using microspheres is that when blood flow is low, the resolution of 
the technique is limited. Flows of at least 20 ml/min/100 gm are 
necessary to deposit the required number of microspheres for reliable, 
reproduceable flow measurements. Thus, small changes in flow might have 
gone undetected because of the greater degree of variability and error in 
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measuring flow at such low levels. In addition, in comparison to control 
values of blood flow, the low flows would very large variations to have 
differences detected by analysis of variance and Tukey test statistical 
analysis. It is probable that alpha receptor blockade did not increase 
infarct size in the previous study by removing alpha mediated 
vasoconstriction in the ischemic zone. Although blockade of alpha 
receptors may alter the course of myocardial infarction, it is probably 
due to a mechanism that is not related to changes in myocardial blood 
flow. The possible involvement of alpha receptors in cardiac metabolism 
and function should be clarified in order to understand more clearly 
their involvement in the process of infarction. 
133 
E. REFERENCES 
1. Armour JA. Synaptic transmission in thoracic autonomic ganglia of 
the dog. Can J Physiol Pharmacol 61: 793-801, 1983. 
2. Barber MJ. Effect of time interval between repeated brief coronary 
artery occlusions on arrhythmia, electrical activity and myocardial 
blood flow. J Am Coll Cardiol 2(4): 699-705, 1983. 
3. Barber MJ, Mueller TM, Henry DP, Felten SY, Zipes DP. Transmural 
myocardial infarction in the dog produces sympathectomy in 
noninfarcted myocardium. Circulation 67 (4):787-796, 1983. 
4. Basuk WL, Reimer KA, Jennings RB. Repetitive episodes of myocardial 
ischemia: Effect on cell volume, electrolytes, and ultrastructure. 
Circulation 72(III): 65, 1985. 
5. Buchweitz E, Veiss HR. Effect of stimulation of ansa subclavia on 
regional myocardial 02 supply and 02 consumption. Am J Physiol 
244: H68-H72, 1983. 
6. Buck JD, Hardman HF, Warltier DC, Gross GJ. Changes in ischemic 
blood flow distribution and dynamic severity of a coronary stenosis 
induced by beta blockade in the canine heart. Circulation 
64(4): 708-715, 1981. 
7. Buffington CW, Feigl EO. Adrenergic coronary vasoconstriction in 
the presence of coronary stenosis in the dog. Gire Res 48: 
416-423, 1981. 
8. Buffington CW, Feigl EO. Effect of coronary artery pressure on 
transmural distribution of adrenergic coronary vasoconstriction in 
the dog. Gire Res 53: 613-621, 1983. 
9. Cavero I, Roach AG. The pharmacology of prazosin, a novel 
antihypertensive agent. Life Sciences 27: 1525-1540, 1980. 
10. Chilian WM,Harrison DG, Haws CW, Snyder VD, Marcus ML. Adrenergic 
coronary tone during submaximal exercise in the dog is produced by 
circulating catecholamines. Evidence for adrenergic denervation 
supersensitivity in the myocardium but not in coronary vessels. 
Circ Res 58: 68-82, 1986. 
11. Chiariello M, Ribeiro LGT, Davis MA, Maroko PR. "Reverse coronary 
steal" induced by coronary vasoconstriction following coronary 
artery occlusion in dogs. Circulation 56: 809-815, 1977. 
12. Ciraulo DA. Recurrent myocardial infarction and angina in a woman 
with normal coronary arteriograms. Am J Cardiol 35: 923-926, 1975. 
134 
13. Ciuffo AA, Ouyang P, Becker LC, Levin L, and Weisfeldt ML. 
Reduction of sympathetic inotropic response after ischemia in dogs. 
Contributor to stunned myocardium. J Clin Invest 75: 1504-1509, 
1985. 
14. Constantine, JV, Mcshane WK, Scriabine A, Hess, HJ. Analysis of the 
hypotensive action of prazosin In: Hypertension Mechanisms and 
Management. Eds. G. Onesti, KE Kim, and JH Moyer, New York: Grune 
and Stratton, 1973, pp. 429-443. 
15. Dolezel S, Gerova M, Hartmannova B, Dostal M, Janeckova H, Vasku J. 
Cardiac adrenergic innervation after instrumentation of the 
coronary artery in dog. Arn J Physiol 246: H459-H465, 1984. 
16. Flatley KA, Defily DV, Thomas JX, Jr. Effects of cardiac 
sympathetic nerve stimulation during adrenergic blockade on infarct 
size in anesthetized dogs. J Cardiovasc Pharm 7:673-679, 1985. 
17. Geesbreght JM, Randall WC. Area localization of shifting cardiac 
pacemakers during sympathetic stimulation. Am J Physiol 220 (5): 
1522-1527, 1971. 
18. Geis WP, Kaye MP. Distribution of sympathetic fibers in the left 
ventricular epicardial plexus of the dog. Circ Res 23: 165-170, 
1968. 
19. Giudicelli JF, Berdeaux A, Tato F, Garnier M. Left stellate 
stimulation: regional myocardial flows and ischemic injury in 
dogs. Am J Physiol 239: H359-H364, 1980. 
20. Graham RM, Oates HF, Stoker LM, Stoker GS. Alpha blocking action of 
the antihypertensive agent prazosin. J Pharm Exp Therap 210(3): 
747-752, 1977. 
21. Granata L, Olsson RA, Huvos A, Gregg DE. Coronary inflow and oxygen 
usage following cardiac sympathetic nerve stimulation in 
unanesthetized dogs. Gire Res 16: 114-120, 1965. 
22. Heusch G, Duessen A. The effects of cardiac sympathetic nerve 
stimulation on perfusion of stenotic coronary arteries in the 
dog. Circ Res 53: 8-15, 1983. 
23 Heyndrickx GR, Muylaert P, Panneir JL. Alpha-adrenergic control of 
02 delivery to myocardium during exercise in conscious dogs. Am J 
Physiol 242: H805-H809, 1982. 
24. Holtz J, Mayer E, and Bassenge E. Demonstration of alpha-adrenergic 
coronary control in different layers of canine myocardium by 
regional myocardial sympathectomy. Pfluegers Arch 372: 187-194, 
1977. 
135 
25. Katz LN, Jochim K. Observations on the innervation of the coronary 
vessels of the dog. Am J Physiol 126: 395-401, 1939. 
26. Kern MJ, Horowitz JD, Ganz P. Attenuation of coronary vascular 
resistance by selective alpha-1 adrenergic blockade in patients 
with coronary artery disease. J Am Coll Cardiol 5: 840-846, 1985. 
27. Khan AH, Haywood LJ. Myocardial infarction in nine patients with 
radiologically patent coronary arteries. N Engl J Med 291: 426, 
1974. 
28. Levene DL, Freeman MR. Alpha-adrenoceptor mediated coronary artery 
spasm. JAMA 236: 1018-1022, 1976. 
29. Macho P, Hintze T, Vatner SF. Effects of alpha-adrenergic receptor 
blockade on coronary circulation in conscious dogs. Am J Physiol 
243: H94-H98, 1982. 
30. Macho P, Vatner SF. Effects of prazosin on coronary and left 
ventricular dynamics in conscious dogs. Circulation 
65(6): 1186-1193, 1982. 
31. Mohrman DE, Feigl EO. Competition between sympathetic 
vasoconstriction and metabolic vasodilation in the canine coronary 
circulation. Circ Res 42: 79-86, 1978. 
32. Mudge GR, Grossman V, Mills RM, Jr., Lesch M, and Braunwald E. 
Reflex increase in coronary vascular resistance in patients with 
ischemic heart disease. N Engl J Med 295: 1333-1337, 1976. 
33. Murray PA, Vatner SF. Alpha-adrenoceptor attenuation of the 
coronary vascular response to severe exercise in the conscious 
dog. Circ Res 45: 654-660, 1979. 
34. Oliva PB, Potts DE, Pluss RG. Coronary arterial spasm in Prinzmetal 
angina: documentation by coronary arteriography. N Engl J Med 288: 
745, 1973. 
35. Pitt B, Elliot EC, Gregg DE. Adrenergic receptor activity in the 
coronary arteries of the unanesthetized dog. Circ Res 21, 75-84, 
1967. 
36. Randall VC, Armour JA, Geis WP, Lippincott DB. Regional cardiac 
distribution of the sympathetic nerves. Fed Proc 31(4): 1199-1208, 
1972. 
37. Reimer,l<A, Lowe JE, Rasmussen MM, Jennings RB. The wavefront 
phenomenon if ischemic cell death. I. Myocardial infarct size vs 
duration of coronary occlusion in dogs. Circulation 56(5): 786-794, 
1977. 
136 
38. Rinkema LE, Thomas JX, Jr., Randall WC. Regional coronary 
vasoconstriction in response to stimulation of stellate ganglia. Am 
J Physiol 243: H410-H415, 1982. 
39. Ross G, Mulder DG. Effects of right and left cardiosympathetic 
nerve stimulation on blood flow in the major coronary arteries of 
the anesthetized dog. Cardiovasc Res 3: 22-29, 1969. 
40. Schaper W. Residual perfusion of acutely ischemic heart muscle. In: 
The Pathophysiology of Myocardial Perfusion. Ed., W. Schaper. New 
York: Elsevier/North Holland Biomedical Press, 1979, pp. 345-378. 
41. Scheel KW, Ingram LA, Gordey RL. Relationship of coronary flow and 
perfusion territory in dogs. Am J Physiol 243: H738-H747, 1982. 
42. Schwartz PJ, and Stone HL. Tonic influence of the sympathetic 
nervous system on myocardial reactive hyperemia and on coronary 
blood flow distribution in dogs. Gire Res 41(1): 51-58, 1977. 
43. Vatner SF, Macho P. Regulation of large coronary vessels by 
adrenergic mechanisms in conscious dogs. Basic Res Cardiol 
76: 508-517, 1981. 
44. Yanowitz F, Preston JB, Abildskov JA. Functional distribution of 
right and left stellate innervation to the ventricles: Production 
of neurogenic electrocardiographic changes by unilateral alteration 
of sympathetic tone. Circ Res 18: 416-428, 1966. 
45. Zuberbuhler RC, and Bohr DF. Responses of coronary smooth muscle to 
catecholamines. Gire Res 16: 431-440, 1965. 
CHAPTER VI 
EFFECTS OF REGIONAL DENERVATION ON MYOCARDIAL 
BLOOD FLOW DURING CORONARY ARTERY OCCLUSION 
A. INTRODUCTION 
Although cardiac denervation had been utilized as an experimental 
tool to investigate the innervation of the heart (30), the suggestion 
that cardiac denervation could be used clinically to alleviate angina was 
initially suggested by Leriche (19). Subsequent investigations extended 
the number of clinical settings in which denervation was proposed to be 
beneficial to include protection against lethal arrhythmias (8,25) and 
myocardial infarction (17). The mechanism of these protective effects is 
not well-established. It was thought by some investigators that the 
protection may be due to alteration of regional myocardial blood flow 
during ischemia. DuPont et al. showed better perfusion of the border 
zones during coronary artery occlusion in animals with sympathectomized 
hearts compared to non-cardiac sympathectomized animals (7). However, 
Barber et al. found that blood flow to the ischemic zone did not change 
significantly following cardiac denervation (1). Both Barber et al., and 
DuPont et al. suggested that the beneficial effects may be due to a 
lowering of oxygen consumption (1,7). 
Previous investigations have demonstrated a role for alpha recep-
tors in the modulation of coronary blood flow under resting conditions 
and during exercise. Alpha receptors have also been implicated in the 
137 
138 
control of blood flow under conditions of ischemia severe enough to cause 
net lactate production (3). Holtz et al. demonstrated that the tonic 
level of sympathetic vasoconstriction mediated by alpha receptors was 
removed by regional denervation with 6-hydroxy dopamine (16). 
Our hypothesis was that removal of alpha receptor mediated vaso-
constriction in the ischemic zone, would enhance delivery of blood flow 
from the normal zone, via a 'reverse coronary steal'. Different tech-
niques for denervation have been used, ganglionectomy (5), autotrans-
plantation (29), chemical sympathectomy with 6-hydroxy dopamine (16), and 
intrapericardial denervation (23). Most of these studies utilized total 
cardiac denervation. The intrapericardial denervation technique, 
autotransplantation and mediastinal neural ablation interrupt parasympa-
thetic as well as sympathetic input. The disadvantages of these tech-
niques are the inability to localize denervation and use the normally 
innervated region as control. Recently the use of topical phenol has 
been used to facilitate the selective sympathetic denervation of the 
heart (2). This technique was originally utilized for mapping of 
sympathetic distribution of the left ventricle (12,22). We combined the 
technique of isolation and severing of the ventrolateral cardiac nerve, 
which innervates the posterior left ventricle with application of topical 
phenol to denervate the posterior wall. 
The second aim of this study was to determine whether sectioning of 
the VLCN as well as application of phenol in a ring circumscribing the 
posterior wall would eliminate sympathetic fibers which exert vasomotor 
control. 
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B. METHODS 
1. General Preparation 
Mongrel dogs of either sex were premedicated with morphine sulfate 
(2.5 mg/kg, s.c.) or xylazine (2 mg/kg, s.c.) approximately 15-20 minutes 
before being given alpha-chloralose (50-100 mg/kg, i.v.). A polyethylene 
catheter (PE-260 tubing) was placed in the right femoral artery and 
connected to a Statham P23dB pressure transducer for continuous monitor-
ing of arterial blood pressure. The right femoral vein was catheterized 
with PE-260 tubing for fluid and drug administration. The trachea was 
cannulated with a glass Y-tube which was connected to a Harvard respira-
tor. Each dog was ventilated with room air at a positive end-expiratory 
pressure of 5 cm of water. Both cervical vagi were isolated and sev-
ered. Succinylcholine (20 mg, i.v.) was administered as a muscle 
relaxant. The chest was opened in the 4th left intercostal space. Both 
the right and left ansae subclavia of the stellate ganglia were isolated 
and stimulated (7-10 Hz, 5 msec, 5-7 V) using bipolar stainless steel 
electrodes. Square wave pulses were delivered by a Frederick Haer 
stimulator and monitored on a calibrated oscilloscope. During stimula-
tion, changes in the heart rate, and Lead II electrocardiogram, specific-
ally the P-R interval and T-wave configuration confirmed that both the 
anterior and posterior limbs of the right and left ansae subclavia had 
been dissected out (11,31). Cutting of the right and left ansae subcla-
via, along with section of the cervical vagus, completed neural decen-
tralization of the heart to prevent any reflexes from arising following 
coronary artery occlusion, and to insure against afferent stimulation of 
the cardiac nerves. The pericardium was incised and sutured to the walls 
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of the chest to form a pericardia! cradle. No more than .5 cm of the 
circumflex artery (CX) was isolated distal to the first marginal branch. 
Blood gases and pH were monitored throughout the experiment and main-
tained within normal limits (pH 7.38-7.45, p02 80-120 mm Hg, pC02 30-40 
mm Hg, HC03 23-28 mm Hg) by adjusting the rate and/or volume of the 
Harvard respirator, with infusions of sodium bicarbonate (20 mEq/ml), 
when necessary, to maintain pH normal. Core temperature, measured in the 
thoracic cavity by a YSI probe, was kept between 37-39° C by means of a 
heating pad beneath the dog, and an infrared heating lamp above the dog 
when necessary. Succinylcholine (20 mg, i.v.) and additional anesthetic 
were administered as needed. The heart was kept moist with sponge soaked 
in saline, and plastic wrap was kept over the open chest to retain 
moisture and heat. 
Blockade by timolol (0.2 mg/kg, i.v.) was considered to be adequate 
when stimulation of the left ansae subclavia produced no changes in heart 
rate or the Lead II electrocardiogram. Maintenance doses of timolol 
(0.08 mg/kg/hr, i.v.) were given to insure blockade of beta-receptors 
throughout the experiment. Lidocaine was given if there was an increased 
incidence of arrhythmias. 
2. Regional Blood Flow Determination 
Four of the following species of radioactive labeled microspheres 
(15 m) were used in random order: Ce-141, Cr-51, Sr-85 or Ru-103, Sc-46, 
Nb-95. The spheres were suspended in a 5% dextran solution with 0.05% 
Tween 80. The vials containing the spheres were sonicated for at least 
20 minutes prior to microsphere injection, and agitated in a vortex mixer 
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immediately prior to use. For 30 seconds before microsphere injection, a 
reference blood sample was withdrawn from the femoral artery at a 
constant rate, and reference blood withdrawal continued for at least 90 
seconds following microsphere injection. The withdrawal rate of the pump 
was calibrated at the end of the experiment to determine the exact rate 
of withdrawal. Microspheres were injected into the left atrium via a 
catheter over a period of 30-40 seconds and were flushed with 10 ml of 
warm saline. At the end of the experiment, the hearts were excised and 
the circumflex artery injected distal to the site of occlusion with 
Microfil to delineate the perfusion area of the circumflex artery. The 
hearts were fixed in formalin for 24-48 hours, after which samples of the 
myocardium were cut from both the stained and unstained regions, weighed, 
and placed in labeled plastic tubes. The reference blood withdrawal 
samples were also put into labeled plastic tubes, the syringes containing 
the blood samples were rinsed with saline, and the rinse put into the 
respective labeled counting tubes. Heart and reference organ samples 
were counted by a TM Analytic gamma counter (model 1185) and data were 
processed by an APPLE computer. Flows were calculated using standard 
equations with corrections for interference coefficients and background 
counts. The equation used to calculate blood flows was: MBF- (Ct/TW) x 
(RBW/Cb) x 100, where MBF - myocardial blood flow in ml/min per 100 gm, 
Ct - tissue radioactivity in counts/min, TW - tissue sample weight in 
grams, RBW - reference blood withdrawal rate in ml/min, and Cb - total 
radioactivity in reference blood sample. 
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3. Regional Denervation 
Denervation of the posterior wall was accomplished by cutting the 
ventrolateral cardiac nerve where it courses over the pulmonary veins, 
and by stripping the adventitia of the pulmonary veins, cutting any small 
nerves located in the vicinity of the ventrolateral cardiac nerve, using 
a technique developed in this laboratory. Regional denervation was 
further insured by painting a thin ring of phenol around the perimeter of 
the posterior wall distal to the site of circumflex isolation and 
occlusion. Use of the blunt end of a cotton swab ensured that phenol did 
not spread into the anterior region. Phenol was also applied to the 
interventricular sulcus, along the fat of the atrioventricular groove, 
and in the region of the original dissection of the ventrolateral cardiac 
nerve. Phenol has been shown to penetrate approximately .25 mm into the 
epicardium thus destroying sympathetic fibers which travel superficially 
before penetrating the myocardium to innervate deeper layers (2,22). 
4. Experimental Protocol 
a. Group 1 (Ctrl-Lss-PhnLss-CaoPhnLss): 
The purpose of this group was to demonstrate that alpha-vasocon-
striction in the posterior wall following beta blockade would be elimi-
nated after regional denervation. Figure 6-1 illustrates the protocols 
used in this study. In Group l (n-7), the first flow measurement was 
made following beta-blockade with timolol, and served as control. 
Stimulation of the left ansae subclavia was begun (LSS:8 Hz, 5 msec, 5-7 
V), and the second injection of microspheres was made during the period 
of stimulation. Following completion of the microsphere injection, 
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FIGURE 6-1 
PROTOCOLS USED IN GROUPS 1 AND 2 
The abbreviations denote the following: Timolol: timolol was 
administered before beginning the sequence of microsphere injections; 
RMBF: regional myocardial blood flow determination; LSS: left ansae 
subclavia stimulation. Phenol: posterior wall denervation with topical 
phenol; CAO: circumflex artery occlusion. 
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FIGURE 6-1 
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stimulation was terminated, and the posterior wall was denervated. The 
third flow measurement was then made during a second period of left ansae 
subclavia stimulation (LSS-Phen). After the third injection period was 
completed, the stimulation was stopped, and the circumflex artery was 
ligated at the point of isolation, distal to the first marginal branch. 
After five minutes of coronary artery occlusion left stellate stimulation 
was again initiated, and the fourth flow determination was made (CAO-LSS-
Phen). 
b. Group 2 (CAO/CAO·LSS/CAO-Phn/CAO-LSS-Phn) 
In Group 2 (n-8), it was our aim to demonstrate that alpha-mediated 
vasoconstriction in the ischemic posterior wall would be eliminated 
following application of phenol. Four blood flow determinations were 
made in each dog. All animals received timolol (0.2 mg/kg) prior to 
starting the regional blood flow determinations. Regional denervation 
was done via the methods described above. The model for coronary artery 
occlusion was a 7-8 minute occlusion with injection of the microspheres 
after five minutes of CAO, followed by release of the occlusion and 
reperfusion for thirty minutes. The circumflex artery was occluded 
distal to the first marginal branch using an atraumatic clamp. Micro-
spheres were injected after five minutes of occlusion, and following 
completion of the injection, the occlusion was released, so that total 
occlusion time was between seven and eight minutes. 
The four experimental conditions were: 1) a control blood flow 
determination in which the circumflex artery was occluded for five 
minutes (CAO), 2) during coronary artery occlusion and simultaneous 
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stimulation of the left ansae subclavia (CAO-LSS) (LSS was begun immedi-
ately after the clamp was placed on the circumflex, and both the occlu-
sion and the stimulation were stopped at the end of the injection 
period), 3) During coronary artery occlusion following regional denerva-
tion with topical application of phenol (CAO-Phen), and 4) During 
coronary artery occlusion with stimulation of the left ansae subclavia 
following the topical application of phenol (CAO-LSS-Phen). 
5. Data Analysis 
Flows were expressed in ml/min/100 gm. Resistance was calculated 
as the quotient of mean arterial pressure and regional blood flow 
(MAP/MBF). In Group 1 the percent change in flow from control was 
calculated for each of the experimental protocols for both the endocar-
dium and the epicardium. In Group 2, blood flow during the first 
coronary artery occlusion served as the control blood flow determination. 
Percent changes in flow for the subsequent blood flow measurements in 
Group 2 were expressed as change from the first flow determination. 
Blood flows, resistance, percent change in blood flow, endo/epi ratios 
and blood pressures during each of the experimental conditions were 
analyzed separately. Analysis of variance for repeated measures was used 
to test for differences betveen interventions, and Tukey's test was 
employed to isolate the differences within groups. Statistical signifi-
cance was reached at a p value of <0.05. 
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C. RESULTS 
1. Group 1 
a. Hemodynamic Data: 
In the presence of beta blockade, blood pressure in Group 1 was 
significantly elevated during LSS (160.3 ± 14.4) compared to control 
(132.6 ± 9.06), LSS following phenol (LSS-Phen: 123.3 ± 10.2) and CAO-LSS 
following phenol (CAO-LSS-Phen: 115.4 ± 8.73) (p<.001). Heart rates 
during each of the blood flow measurements were not significantly 
different. 
b. Blood Flow Data: 
Table 6-1 lists the blood flow values for Group 1 (Ctrl/LSS/Phn-
LSS/CAO-Phn-LSS). Blood flow during LSS was significantly elevated from 
the other treatment groups in the anterior endocardium (p<.0001) and 
anterior epicardium (p<.001). In the posterior endocardium, blood flow 
during LSS was significantly higher than Control, LSS-Phen, and CAO-LSS-
Phen (p<.0001). Blood flow during LSS was significantly different from 
control and CAO-LSS in the posterior epicardium (p<.0001). Flow was not 
significantly different during LSS and during LSS following phenol 
application in the posterior epicardium. Blood flow fell significantly 
from Control and LSS following CAO in the posterior endocardium and 
epicardium (p<.0001). 
Percent changes in blood flow in Group l(Ctrl/LSS/Phn-LSS/CAO-Phn-
LSS) are shown in Figure 6-2. Jn the anterior wall, the changes in flow 
during LSS-Phen and CAO-LSS-Phen were significantly different from the 
change in flow during LSS in the endocardium (top left panel p<.0001), 
and in the epicardium (bottom left panel p<.002). In the posterior 
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TABLE 6-1 
Regional blood flow values for Group 1 (n-7) in (ml/min/100 gm). 
Data are listed as mean flow ± SEM. Flows are divided into anterior 
and posterior wall blood flows, and for each region endocardial and 
epicardial blood flows are listed. Blood flow values for each of the 
interventions are listed. Control: blood flow during control condi-
tions, with beta blockade; LSS: flow during left ansae subclavia 
stimulation; Phenol-LSS: flow during LSS following posterior wall 
denervation with topical phenol; CAO-Phenol-LSS: flow during LSS and 
circumflex artery occlusion, following posterior wall denervation. * 
indicates a significant difference from control, "trindicates signifi-
cant difference from LSS, *indicates significant difference from LSS-
Phen and 'indicates significant difference from CAO-LSS-Phen 
(p<.0001). 
TABLE 6-1 
REGIONAL MYOCARDIAL BLOOD FLOWS DURING PERMANENT 
CORONARY OCCLUSION BEFORE AND AFTER REGIONAL DENERVATION (GROUP 1) 
(ML/MIN 100 GM) 
ANTERIOR WALL 
ENDOCARDIUM 
CONTROL LSS PHENOL-LSS 
92.41 ± 7.33 118.18 ± 9.87**' 89.96 ± 8.81 
EPICARDIUH 
71. 25 ± 4. 88 92.09 ± 8.7B**t 71.33 ± 6.37 
POSTERIOR WALL 
ENDOCARDIUM 
CONTROL LSS PHENOL-LSS 
84.84 ± 6.38 118.35 ± 12.80**' 88.29 ± 8.10 
EPICARDIUM 
62.75 ± 4.49 86.0l ± 7.4o*' 69.57 ± 5.43 
CAO-PHENOL-LSS 
79.43 ± 8.47 
63.58 ± 5.31 
CAO-PHENOL-LSS 
14.88 ± 6. 18* 
20.45 ± 6.34* 
( sig. diff. from control, sig.diff. from LSS, sig.diff. from phenol-LSS, 
p<0.0001) 
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FIGURE 6-2 
PERCENT CHANGE IN BLOOD FLOV FROM CONTROL DURING 
PERMANENT OCCLUSION BEFORE AND AFTER REGIONAL DENERVATION 
Percent change in blood flow from control for group 1 (n=7). Data 
are shown as mean % ± SEM. The top panel illustrates endocardial 
flows for the anterior and posterior LV. The bottom of the graph are 
the epicardial flows for the anterior and posterior LV. *indicates 
significant difference from LSS (p<.0001), 1cindicates significant 
difference from LSS-Phen (p<.0001). See Table 6-1 for a description of 
the group labels. 
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endocardium (top right panel), the percent change in flow during LSS-
Phen was significantly different from LSS (p<.0001). In addition, the 
percent change in flow during CAO-LSS-Phen was significantly different 
from LSS and LSS-Phen (p<.0001). In the posterior epicardium, the 
percent change in flow during CAO-LSS-Phen was significantly lower than 
LSS and LSS-Phen (p<.0001). There were no differences between LSS, and 
LSS-Phen in the posterior epicardium. 
There were no significant differences in the endo/epi ratios of the 
anterior wall in Group 1 (Ctrl/LSS/Phn-LSS/CAO-Phn-LSS). The endo/epi 
ratio dropped significantly to 0.64 ± .10 in the posterior wall during 
combined CAO-LSS following phenol application compared to values of 1.39 
± .06, 1.42 ± .14 and 1.30 ± .08 during control, LSS and LSS following 
phenol, respectively (p<.001). There were no other differences between 
groups. There were no significant differences between groups in either 
the anterior or posterior wall resistances. 
In summary, in Group 1 (Ctrl/LSS/Phn-LSS/CAO-Phn-LSS), LSS in the 
presence of timolol increased blood pressure and blood flow to both the 
anterior and posterior wall even in the presence of beta blockade. These 
increases in blood pressure and blood flow to both the anterior and 
posterior left ventricle were eliminated by the regional denervation of 
the posterior wall. 
2. Group 2 
a. Hemodynamic Data: 
Blood pressure during CAO following phenol application (112.50 ± 
6.27) and during combined CAO-LSS following phenol application (112.76 ± 
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6.82) decreased significantly from CAO (132.88 ± 5.36) and CAO-LSS 
(129.00 ± 6.83) (p<.0002). There were no statistical differences between 
blood pressure during CAO and combined CAO-LSS or between blood pressure 
during either intervention following phenol application. 
b. Blood Flow Data: 
Blood flow values for Group 2 (CAO/CAO-LSS/CAO-Phn/CAO-LSS-Phn) are 
listed in Table 6-2. Rlood flow during CAO-Phen was significantly 
decreased from CAO and CAO-LSS (p<.02) in the anterior endocardium. 
There were no other significant differences between groups in the 
anterior epicardium or in the posterior endocardium and epicardium. 
Figure 6-3 depicts the data for Group 2 (CAO/CAO-LSS/CAO-Phn/CAO-
LSS-Phn). The data are represented as percent change from initial blood 
flow values during circumflex artery occlusion. In the anterior endocar-
dium (top left panel), the change in blood flow during CAO-Phen was 
significantly different from the change in blood flow during CAO-LSS and 
CAO-LSS-Phen (p<.002). CAO-LSS was also statistically different from the 
change in flow during combined CAO-LSS-Phen (p<.002). There were no 
significant differences between groups in the anterior epicardium (bottom 
left panel) or posterior endocardiUJ11 (top right panel). In the posterior 
epicardium (lower right panel), the percent change in blood flow during 
CAO-LSS-Phen was significantly different from the percent change in blood 
flow during CAO-Phen (p<.002). 
There were no significant differences in the endo/epi ratios for 
either the anterior or the posterior wall. There were no significant 
differences in calculated resistance for either the anterior or posterior 
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TABLE 6-2 
Regional blood flow values (in ml/min/100 gm left ventricle) for 
group 2 (n-7). Data are represented as mean± SEM. CAO: blood flow 
during circumflex artery occlusion; CAO-LSS: flow during CAO and left 
ansae subclavia stimulation; CAO-Phenol: flow during CAO following 
posterior wall denervation with topical phenol; CAO-LSS-Phenol: flow 
during CAO and LSS following regional denervation with phenol. * 
indicates significant difference from blood flow during coronary artery 
occlusion (CAO), tindicates significant difference from blood flow 
during CAO-LSS (p<.0.02). 
TABLE 6-2 
REGIONAL MYOCARDIAL BLOOD FLOWS DURING REPETITIVE CORONARY ARTERY 
OCCLUSION BEFORE AND AFTER REGIONAL DENERVATION 
CAO 
97.84 ± 10.48 
85.92 ± 10.14 
CAO 
8.97 ± 2.87 
17.55 ± 4.54 
CAO-LSS 
100.38 ± 9.81 
91.48 ± 8.69 
(GROUP 2) 
ANTERIOR WALL 
ENDOCARDIUM 
CAO-PHENOL 
81.29 ± 7.'Jo*' 
EPICARDIUM 
77 .38 ± 6 .54 
POSTERIOR WALL 
ENDOCARDIUM 
CAO-LSS CAO-PHENOL 
9.28 ± 1.86 6. 89 ± 1. 55 
EPICARDIUM 
17.45 ± 4.67 13.46 ± 2.68 
CAO-LSS-PHENOL 
91.72±8.87 
87 .17 ± 9 .11 
CAO-LSS-PHENOL 
7.63 ± 1.82 
16.20 ± 3.41 
( *sig. diff. from control, tsig. diff. from CAO-LSS, p<0.02) 
156 
FIGURE 6-3 
PERCENT CHANGE IN BLOOD FLOW FROM CONTROL CAO DURING REPETITIVE 
CORONARY OCCLUSION BEFORE AND AFTER DENERVATION 
GROUP 2 (CAO/CAO-LSS/CAO-PHEN/CAO-LSS-PHEN) 
Percent change in blood flow from flow measured during coronary 
artery occlusion alone. Data represent mean± SEM. (See Table 6-2 for 
expl'!kation of group names). *indicates significant difference from 
LSS, indicates significant difference from CAO-Phen (p<.002). 
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endocardium or epicardiurn.The results from this second group indicate 
that regional denervation of the posterior wall does not increase blood 
flow to the ischemic area. 
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D. DISCUSSION 
GROUP 1 (Ctrl/LSS/Phn-LSS/CAO-Phn-LSS) 
One of the aims of this study was to determine whether denervation 
of the posterior left ventricle would increase blood flow to that region 
by removing alpha vasoconstrictLon. An interesting aspect of this study 
was that blood flow to the anterior and posterior wall and systemic blood 
pressure in Group 1 were signLfLcantly elevated from control during LSS 
even after beta-adrenergic blockade with timolol. This contradicts the 
results of previous investigations in which sympathetic input during beta 
blockade resulted in a decrease in blood flow (24). Feigl observed that 
during LSS following beta-blockade with propranolol, blood flow decreased 
by 18% from control. This decrease in blood flow was blocked by admini-
stration of phenoxybenzarnLne (9). In a later study, Feigl demonstrated 
that during a 90 second stimulation of the left stellate ganglion, blood 
pressure and blood flow increased but coronary sinus oxygen tension 
decreased from 19 to 15 Dllll Hg. Following beta-receptor blockade with 
propranolol, these changes were blunted and coronary sinus oxygen tension 
fell from 17 to 11 mm Hg. The administration of dibozane blocked the 
sympathetically mediated increase in coronary vascular resistance and 
decrease in coronary sinus oKygen tension (10). Other studies have 
demonstrated a similar response of coronary vascular resistance during 
nervous stimulation following beta blockade (13). In addition, coronary 
artery vasoconstriction has been demonstrated during stimulation of alpha 
receptors with methoxamine (27). 
It should be emphasized that the duration of stimulation and the 
time course of blood flov measurements in the present study differs from 
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the studies cited above. In Feigl's studies, stimulation of the left 
stellate ganglion was of brief duration (90 seconds) (10), while in the 
present study the left ansae subclavia were stimulated for five minutes. 
Rinkema et al. injected microspheres immediately after beginning stellate 
stimulation (24). In addition, the stimulation of cardiac nerves is 
different from the systemic injection of exogenous adrenergic agonists. 
An investigation by Williams and Most reported that during brief stimu-
lation of alpha receptors via a bolus dose of phenylephrine, vasocon-
striction was elicited. However, with prolonged stimulation of alpha 
receptors, the constriction gradually disappeared, and flow returned to 
baseline levels (28). lt should be noted that the reduction in vessel 
diameter reported by Vatner was maintained over a sustained injection of 
methoxamine. In that preparation, the heart was not decentralized, nor 
had ganglionic blockade been administered (27). Hence the possibility 
exists that the vasoconstriction in Vatner's study was in part the result 
of withdrawal of sympathetic tone in the face of sustained elevated 
peripheral pressure. 
Thus, alpha-mediated vasoconstriction may be of a transient nature, 
whereas with longer periods of sympathetic stimulation, stimulation of 
alpha receptors no longer evokes vasoconstriction. There is evidence to 
suggest that alpha receptors on the myocardium can contribute to metabo-
lism (21). Therefore the role of alpha-receptors on myocardial metabo-
lism and the indirect effects on blood flow need to be established. 
The mechanism whereby blood pressure increased in Group 1 (Ctrl/LSS/Phn-
LSS/CAO-Phn-LSS) even thou~h myoeardial beta-receptors were blocked in 
unclear. It is possible in the present study that beta-blockade was 
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incomplete. However, changes in HR and the Lead II EKG were absent 
during suprarnaximal left stellate ansae subclavia stimulation. In 
addition, we found that increasing the dose of timolol did not eliminate 
the rise in arterial pressure during stimulation. Thus, the increase ion 
blood pressure was not mediated by beta receptors. Alpha-1 receptors 
have been localized to the myocardium (6,14), and Starke demonstrated 
that phenylephrine which is fairly selective for alpha-1 receptors, 
caused an increase in blood pressure which was not due to increased 
norepinephrine release (26). It is therefore possible that stimulation 
of alpha receptors led to the increase in blood pressure. 
We found in several animals, that the rise in arterial pressure was 
eliminated only when the application of phenol was extended from the 
point of the coronary sinus down the interventricular groove. Studies by 
Randall et al. which utili~ed the phenol denervation technique noted that 
nearly all of the inotropic responses of the anterior wall were elimi-
nated when a line of phenol vas extended along the A-V groove to the 
coronary sinus. However, they found that the rise in arterial pressure 
elicited by LSS remained present even when phenol had been extended along 
the base of the heart (22J. In the present study, it seems as though a 
few nerve fibers reach the anterior left ventricle via the interventric-
ular sulcus. The fact that flow was increased significantly in the 
anterior wall during LSS and dropped following application of phenol to 
the posterior wall suggests several possibilities. First, the presence 
of significant innervation of the anterior wall by the ventrolateral 
cardiac nerve or other nerves. Geis and Kaye found that fibers from the 
left stellate ganglion reach the anterior left ventricle after entering 
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the epicardial plexus along the A-V groove near the marginal artery. The 
origin of these fibers was believed to be in the ventrolateral cardiac 
nerve (12). Application of phenol decreased flow in Group 1 and dropped 
the flow in Group 2 from control and LSS. Thus phenol either interrupted 
the fibers to the anterior and posterior wall, or it dropped function in 
the posterior wall enough to affect the overall function of the heart and 
drop blood pressure. The second, more likely possibility is that since 
resistance did not change significantly it appears that the changes in 
flow were passive, and due merely to changes in blood pressure. Finally, 
it is also possible that LSS in some way can affect the capacitance of 
the proximal aorta and alter the afterload of the heart via non beta-
adrenergic mechanisms or by alpha mediated increases in myocardial 
contractility. 
In Group 1 (Ctrl/LSS/Phn-LSS/CAO-Phn-LSS) regional denervation 
dropped blood flow to both the endocardium and epicardium of the anterior 
and posterior wall. Thus while regional denervation has been reported to 
be beneficial to the heart during ischemia, it may not be due to release 
of sympathetic tone as Holtz has suggested (16). Rather, it is more 
likely to be due to a drop in overall myocardial metabolism as was 
originally suggested by Gregg et al.(15). The results of this study 
confirm previous findings of Chilian et al. (4) in which phenol did not 
increase blood flow to the denervated region with intact sympathetics. 
The discrepancy between the studies by Holtz et al. and Chilian et al. is 
not easily reconciled, since the differences in results may be due 
entirely to the mode of regional denervation employed in each study. It 
is reasonable to postulate that the changes in flow in the present study 
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may have been due to the changes in pressure since an autoregulatory 
response might not have been expected to occur within the time frame of 
the blood flow measurement. 
GROUP 2 (CAO/CAO-LSS/CAO-Phn/CAO-LSS-Phn) 
In Group 2, LSS did not increase flow to the anterior wall compared 
to control. However, in that group of animals, occlusion of the blood 
supply to the posterior wall was a confounding factor in interpreting 
alterations in blood flow to the anterior wall. Indeed, in another study 
from this laboratory (Chapter V), LSS did not change flow significantly 
from control although administration of prazosin did increase flow 
significantly from control but not from flow during left stellate 
stimulation. It is possible that in the present study following occlu-
sion in the posterior wall, function was impaired enough to limit the 
increase in blood pressure during LSS. It is unlikely that the nerves to 
the posterior wall were in some way impaired by the period of ischemia. 
Phenol application to the posterior wall dropped blood pressure even 
during stellate stimulation so that the nerves were in all probability 
functioning during the previous bouts of ischemia, particularly the 
nerves to the anterior wall which may have passed through the posterior 
wall. 
SUMMARY OF GROUPS 1 AND 2 
In conclusion, this study did not find evidence in support of 
sympathetically mediated vasoconstriction in an ischemic region which 
could be eliminated by regional denervation. We found no evidence to 
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suggest that denervation of the ischemic zone would enhance blood flow to 
that region by a 'reverse coronary steal' mechanism. However, this study 
did find that posterior left ventricular regional denervation did produce 
a drop in blood pressure in Group 2 (CAO/CAO-LSS/CAO-Phn/CAO-LSS-Phn), 
and a drop in blood flow to the anterior wall in Group 2 (CAO/CAO-
LSS/CAO-Phn/CAO-LSS-Phn) _ In Group l (Ctrl/LSS/Phn-LSS/CAO-Phn-LSS), the 
blood pressure and blood flow during left ansae subclavia stimulation in 
the presence of beta blockade increased. In this group, posterior wall 
denervation eliminated the response to sympathetic stimulation. However, 
since there was no change in resistance, the increase in blood flow was 
probably of a passive nature and reflected the rise in arterial pressure 
during LSS. The increase in blood pressure during LSS appears to non-
beta in origin, and might possibly be due to stimulation of myocardial 
alpha receptors. Furthermore, the drop in blood pressure following 
application of phenol indicates several possibilities. Either phenol 
interrupted nervous transmission to the entire left ventricle by denerva-
tion of the posterior wall, or posterior wall application of phenol 
caused an overall decrease in cardiac function and metabolism, thus 
dropping blood pressure and blood flow. 
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A. INTRODUCTION 
CHAPTER VII 
INFLUENCE OF THE CARDIAC NERVES ON 
BLOOD FLOW TO THE CIRCUMFLEX BED 
Since the early part of this century it has been well-documented 
that coronary arteries can constrict in response to adrenergic agents 
(31). Brodie and Cullis postulated the existence of both vasoconstrictor 
and vasodilator fibers to the coronary arteries (1). Studies undertaken 
by Randall et al. investigated the cardiac nerve distribution to the 
heart and its functional importance (22), thus extending earlier anatomic 
studies on the pathways of autonomic nerves to the heart (18,19). The 
studies by Randall et al. involved mapping the distribution of nerves to 
the left and right ventricles and atria. However, in those studies, and 
others from the same Laboratory, the investigations concentrated primar-
ily on the chronotropic and inotropic effects of sympathetic stimulation, 
and did not address the specific innervation of coronary arteries (7). 
In addition, due to technical limitations, innervation of the posterior 
wall was not as well defined as the anterior wall. Thus, it was not 
known whether each of the major cardiac sympathetic nerves exerted 
discrete control over specific coronary arteries as well as having 
localized influence on ventricular function. Other studies which have 
investigated cardiac syn.pathetic effects on blood flow have stimulated 
either the stellate ganglia (29) or thoracic roots (8) and not specific 
cardiac nerves, to investigate the regional distribution of blood flow in 
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response to nerve stimulation. 
Although under normal conditions, local control of blood flow 
predominates, it is also of interest to determine whether the cardiac 
accelerator nerves supplying local left ventricular regions also carry 
fibers to the coronary arteries, and which type of nerve fiber has 
greater influence on coronary blood flow during myocardial ischemia. By 
blocking beta receptors, it is possible to determine direct innervation 
of the circumflex artery due to vasoconstrictor effects. Thus one aim of 
this study was to determine the specific neural control of blood flow 
through the circumflex artery. 
The vasoconstrictor actions of nerve stimulation on coronary blood 
flow are well established in both experimental (5) and clinical situa-
tions (13). It is believed that the sympathetic nervous system exerts a 
tonic level of vasoconstriction (11,27) and that even under conditions of 
increased metabolic activity (19,20), alpha-receptors can limit increases 
in blood flow. Most previous studies did not differentiate between 
alpha-1 and alpha-2 receptors (5,30). However, results from some recent 
studies suggests that not only do pre-junctional alpha receptors modulate 
coronary vasoconstriction by exerting influences on norepinephrine 
release (10), but that post·junctional alpha-2 receptors also modulate 
coronary blood flow (4.12,2~). The second goal of this investigation was 
to determine whether alpha vasoconstriction reported in previous studies 
is mediated primarily by alpha-1 or alpha-2 receptors or whether both 
receptor subtypes exert equivalent influences on restricting coronary 
flow. 
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B. METHODS 
1. General Preparation 
Mongrel dogs of either sex were premedicated with morphine sulfate 
(2.5 mg/kg, s.c.) or xyla2ine (2 mg/kg, s.c.) approximately 15-20 minutes 
before being given alpha-chloralose (100 mg/kg, IV). A polyethylene 
catheter (PE-260 tubing) was placed in the right femoral artery and 
connected to a Statham P23dB pressure transducer for continuous moni-
toring of arterial blood pressure. The right femoral vein was cathe-
terized with PE-260 tubing for fluid and drug administration. The 
trachea was cannulated with a glass Y-tube which was connected to a 
Harvard respirator. Each dog was ventilated with room air at a positive 
end-expiratory pressure of 5 cm of water. Both cervical vagi were 
isolated and severed. The left carotid artery was cannulated with 
surgical grade Tygon tubing. This served as one limb of the extracor-
poreal shunt delivering blood to the circumflex artery, distal to the 
site of occlusion. SuccLnylcholine (20 mg, IV) was administered as a 
muscle relaxant. The chest vas opened in the fourth left intercostal 
space. Both the right and left ansae subclavia of the stellate ganglia 
were isolated and stimulated (7-10 Hz, 5 msec, 5-7 V) using bipolar 
stainless steel electrodes. The three major left side cardiac sympathe-
tic nerves were isolated, (Ventrolateral, ventromedial, innominate) in 
addition to the left anterior (.AAS) and posterior ansa subclavia (PAS). 
Square wave pulses (8 H~. 5 rnsec, 5-7 V) were delivered by a Frederick 
Haer Pulsar 4i constant voltage stimulator, and voltage and frequency of 
the delivered pulse were monitored throughout the experiment on a 
Tektronix T922R calibrated oscilloscope. Changes in the heart rate, and 
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Lead II electrocardiogram, specifically the P-R interval and T-wave 
configuration during stimulation of the left and right stellate ganglia 
confirmed that both the anterior and posterior limbs of the right and 
left ansae subclavia had been dissected out (6,33). The right and left 
ansae subclavia were cut distal to the stellate ganglia, and both 
cervical vagi were cut, thus completing neural decentralization of the 
heart and insuring against afferent stimulation of the cardiac nerves. 
The pericardium was incised and sutured to the walls of the chest to form 
a pericardial cradle. 
A catheter was placed in the left atrium for measurement of left 
atrial pressure. A Konigsberg high fidelity pressure transducer (P-22) 
was inserted into the left ventricular chamber via a stab wound in the 
apex, and tied securely in place with purse string sutures. The Konigs-
berg transducer was cross-calibrated with the systolic pressure of the 
thoracic aorta, and the diastolic pressure recorded from the left atrium. 
The left ventricular pressure signal was differentiated and recorded 
throughout the experiment. End diastole was determined as the start of 
the positive slope of the LV dP/dt signal (See Figure 7-1). All measure-
ments in this series of experiments were recorded on an 8-channel Gould 
recorder with a frequency response of 125 Hz ± 1 div; 10 div @ 10 mm. 
Calculation of resistance was determined as the quotient of the pressure 
gradient between the aorta and the left ventricle at end-diastole, and 
coronary blood flow at end diastole. 
The circumflex artery ~as Lsolated close to its origin, ligated 
with a piece of 2-0 silk. and a piece of adult feeding tubing (8-F) was 
inserted into the artery. and tied securely in place. The circumflex 
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FIGUltE 7-1 
REPRESENTATIVE TRACING OF MEASURED VARIABLES 
DURING CONTROL CONDITIONS PRIOR TO CARDIAC 
SYMPATHETIC NERVE STIMULATION 
A representative tracing of hemodynamic recordings during a 
control run. The heavy black line at the arrows, shows where the 
actual measurements were taken for calculation of blood flow and 
resistance. EKG: Lead II electrocardiogram; CX FLOW: circumflex blood 
flow; ART P: arterial pressure; .MEAN CX FLOW: mean circumflex blood 
flow; LV dP/dt: first derivative of left ventricular pressure; LAP: 
left atrial pressure, LVP: left -ventricular pressure. 
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artery was perfused with blood from the carotid artery which was cannula-
ted with surgical grade Tygon tubing. The blood from the carotid artery 
flowed through an In Vivo extracorporeal flow probe and was measured on a 
Carolina square wave electromagnetic analog flowmeter. A T-tube was 
connected to the extra-corporeal shunt and the side arm was used to 
facilitate flushing of the shunt system with heparinized saline, which 
was necessitated at frequent intervals to prevent the formation of clots. 
Prior to insertion of the shunt, the dog was heparinized with 200 units 
of heparin and the Tygon tubing was soaked in heparinized saline. The 
flowmeter was periodically calLbrated by running saline through the flow 
probe at known rates via a Harvard perfusion pump. The probe factor was 
adjusted accordingly. Flow was zeroed electrically and mechanically at 
the beginning of each set of nerve stimulations by clamping the tubing 
distal to extracorporeal flow probe. 
Blood gases and pH were monitored throughout the experiment and 
maintained within normal lLrnLts (pH 7.38-7.45, p02 80-120 mm Hg, pC02 
30-40 mm Hg, HC03 23-28 mm Hg) by adjusting the rate and/or volume of the 
Harvard respirator, with infusLons of sodium bicarbonate (20 meq/ml), 
when necessary, to maintain pH normal. Core temperature, measured in the 
thoracic cavity by a YSl probe, vas kept between 37-39 C0 by means of a 
heating pad beneath the dog, and an infrared heating lamp above the dog 
when necessary. Succinylcholine (10 mg, IV) and additional anesthetic 
were administered as needed. The heart was kept moist with sponge soaked 
in saline, and plastic wrap vas kept over the open chest to retain 
moisture and heat. LidocaLne was adrnLnLstered intravenously if the heart 
became arrhythmic, particularly durLng clamping of the circumflex artery 
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and insertion of the shunt. 
2. Adrenergic Receptor ~lockers 
The adrenergic blockers used in this study are listed in Table 7-
1. Blockade by timolol (0.2 mg/kg, IV) was considered to be adequate 
when stimulation of the left ansae subclavia produced no changes in the 
Lead II electrocardiogram. Maintenance doses of timolol (0.08 mg/kg/hr, 
IV) were given to insure blockade of B-receptors throughout the experi-
ment. Alpha-1 blockade was achieved with prazosin hydrochloride (0.5 
mg/kg, IV), a dose which was sufficient to attenuate the rise in arterial 
pressure elicited by a 5 g/kg dose of phenylephrine (17). Phenylephrine 
was chosen to test the efficacy of alpha-1 blockade since it was consid-
ered to exert its agonist effects preferentially on post-junctional or 
alpha-1 receptors. Rauwolscine (0.3 mg/kg, IV) was considered to be a 
reasonably pure alpha-2 blocking agent (14). Blockade by rauwolscine was 
challenged by 5-10 g/kg dose of ~HT-920. The adequacy of blockade was 
challenged in each dog. Atropine was administered prior to recordings of 
nerve stimulation, to prevent the stimulation of muscarinic receptors 
during stimulation of the cardiac sympathetic nerves. 
3. Experimental Protocol 
Figure 7-2 shows in diagram form the protocols used in this study. 
This study was comprised of four different protocols for investigation of 
the role of alpha receptors during cardiac sympathetic nerve stimulation. 
Stimulation of the cardiac nerYes was carried out under four separate 
experimental conditions, all of which were done in the presence of 
TABLE 7-1 
ADRENERGIC AND CHOLINERGIC AGONISTS AND 
ANTAGONISTS USED DURING CARDIAC 
SYMPATHETIC NERVE STIMULATION 
SYMPATHETIC AGENT SITE OF ACTION 
Timolol B-l,B-2 Blockade 
Prazosin alpha-1 blockade 
Rauwolscine alpha-2 blockade 
Phenylephrine alpha-1 stimulant 
BHT-920 alpba-2 stimulant 
PARASYMPATHETIC AGENT 
Atropine muscarinic blockade 
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DOSE USED 
0.2 mg/kg,LD, 
0.8mg/kg/h,MD 
0.5 mg/kg 
0.3 mg/kg 
5 g/kg 
5-10 g/kg 
0.2 mg/kg 
c 
A p 
T 
p 
R 
c 
A p 
T 
R 
p 
FIGURE 7-2 
PROTOCOLS US~D FOR GROUPS 1 AND 2 DURING 
CARDIAC NERVE STIMULATION 
GROUP 1 (N=7) 
VL VM l 
I 
A p VL VM I 
A p VL VM I 
A p 
GROUP 2 (N=7) 
I 
VL VM l 
I I I 
A p \JL VM I 
A p VL VM I 
A 
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I I 
VL VM I 
I I I 
p VL VM I 
Protocols for Groups 1 and 2. C: Control conditions of no adrenergic 
blockade; T: Stimulations done during £-blockade with timolol; P: 
stimulations done during slpha-1 blockade with prazosin; R: stimulations 
done during alpha-2 blockade with rauwolscine. A: Anterior ansa 
subclavia stimulation; P: posterior ansa subclavia stimulation; VL: 
ventrolateral cardiac nerve stimulation; VM: ventromedial cardiac nerve 
stimulation; I: innominate card[ac nerve stimulation. 
r 
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atropine (0.3 mg/kg, I.V.) with hemodynamic responses recorded before, 
during and after each nerve stimulation, at a paper speed of 100 mm/sec. 
1) nerve stimulations were carried out under control conditions in which 
there was no adrenergic blockade, 2) during &-blockade with timolol, 3) 
during alpha-1 blockade with prazosin, and 4) during alpha-2 blockade 
with rauwolscine. The sequence of adrenergic blockade was randomized. 
The adrenergic blocking agents used were not administered independently 
of one another but were added in combination to the previous drug. 
In Group 1 (n=7) the order of adrenergic blockade was 1) no 
blockade (Control); 2) Iimolol, 3) Prazosin, 4) Rauwolscine. In Group 2 
(n-7) the order of the blockade was 1) no blockade, 2) Timolol, 3) 
Rauwolscine, 4) Prazosin. Ihe purpose of the first two groups was to 
determine which of the five isolated cardiac nerves caused significant 
vasoconstriction in the presence of beta blockade, and to determine 
whether alpha-1 blockade or alpha-2 blockade would reverse the vasocon-
striction thus elicited. 
In Group 3 (n=S) the order of blockade was 1) Control, 2) Prazosin, 
3) Rauwolscine and 4) Timolol. In Group 4 (n=S) the order of the alpha 
blocking agents was reversed: l) Control, 2) Rauwolscine 3) Prazosin and 
4) Timolol. The reason for these last two protocols was to determine 
whether the order of alpha blockade resulted in any significant differ-
ences in blood flow and resistance, and whether either alpha-1 or alpha-2 
receptor blockade caused a lar~er restricting influence on &-receptor 
metabolically mediated increases in blood flow. 
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4. Data Analysis 
All measurements were read from a fast tracing (100 mm/sec). Flow 
was measured at end diastole which was taken at the point of the begin-
ning of the positive slope of the dP/dt signal (Figure 7-1). Resistance 
was calculated as the difference between end diastolic arterial pressure 
and end diastolic left ventricular pressure, divided by the end diastolic 
circumflex flow. The difference between prestimulation baseline flow 
values and the flow response to nerve stimulation in each dog was used in 
the analysis of data (delta). The percent change in flow during nerve 
stimulation for each dog was also used in the analysis of data, and was 
also based on prestimulation flow and flow during nerve stimulation. The 
delta and percent change for each nerve (AAS, PAS, VLCN, VMCN, ICN) were 
analyzed independently of one another. Analysis of variance was used to 
determine whether there vere significant differences between any of the 
treatment groups (Control, Timolol, Prazosin, Rauwolscine), and Tukey's 
test was used to isolate the differences at a p value of 0.05. This 
procedure was followed for Groups 1 through 4. 
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C. RESULTS 
1. Group One 
In each group of dogs, all five of the major left side cardiac 
nerves were stimulated and the responses to stimulation recorded and 
subjected to statistical analysis. The data for VMCN and ICN are not 
included, as these nerves had no major vasoconstrictor action following 
adminstration of timolol. 
The blood flow values during control and during stimulation of the 
AAS, PAS and VLCN are shovn in Table 7-2. The changes from resting 
levels are listed during each of the drug administrations. Stimulation 
of the AAS following timolol and prazosin resulted in a significantly 
smaller change in blood flov compared to control stimulation of the AAS 
(p<0.025). Stimulation of the PAS following timolol, prazosin and 
rauwolscine all resulted in significantly smaller changes in blood flow 
compared to control (p<0.01). There were no significant differences 
between different groups during stimulation of the VLCN in Group 1. 
Figure 7·3 illustrates the percent change in blood flow during 
stimulation of the AAS, FAS, and VLCN in each of the control conditions 
and following the adrninstration of the adrenergic blocking agents. In 
Group 1 during stimulation of the AAS (top left panel), the change in 
flow following timolol vas significantly lower than control (p<0.02). 
The change in flow following prazosin remained significantly lower than 
control (p<0.02). Following adrn.LnLstration of rauwolscine, the percent 
change in flow was no longer significantly different from control. 
During stimulation of the PAS (middle left panel), the change in flow 
following timolol and subsequent alpha blockade were significantly lower 
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TAl'>LE 7-2 
Blood flow data in ml/min for Group l (n-7). Data are listed as 
mean± SEM. Shown are the data for prestimulation baseline flow value, 
response to stimulation of each of the three major nerves studied, and 
the change in blood flow from prestimulation blood flow (delta). 
Results are shown for nerve stimulation during each of the stimulation 
protocols, 1) Control: during control (conditions of no adrenergic 
blockade), 2) Timolol: following beta-blockade, 3) Prazosin: following 
prazosin (alpha-1 blockade) and ~) Rauvolscine: following rauwolscine 
(alpha-2 blockade). All significant changes shown are differences from 
control response (no adrenergic blockade) to nerve stimulation. * 
indicates p<0.02, 'trindicates p<0.01. 
TABLE 7-2 
CIRCUMFLEX ARTERY £LOOD FLOW DURING STIMUI.ATION OF 
THE CARDIAC SYMPATHETIC NERVES IN GROUP 1 
--------------------------------------------------------
GROUP 1 llASELINE AAS DELTA 
CONTROL 46. 66 ± 2.75 57.04 ± 5.05 10.37 ± 5.89 
TIMOLOL 42. 69 ± 3.47 39.06 ± 3.94 -3.63 ± 0.61* 
PRAZOSIN 3/a.. la.O ± 5.88 30.63 ± 5.87 -3.78 ± 1.23* 
RAUWOLS_CINE 37. 86 ± 6.09 39.52 ± 5.66 1.67 ± 1. 51 
---------------------------------------------------------
llASELINE PAS DELTA 
CONTROL 45. 3J ± 3.28 53.95 ± 4.9 12.87 ± 4. 72 
TIMOLOL 41. 91 :!: 3.39 42. 90 ± 4.13 1.00 ± 1.84* 
PRAZOSIN 33. 01 :!: 5.41 31.65 ± 5.49 0.07 ± 1.31* 
RAUWOLSCINE 36.47 ± 5.62 36. 36 ± 5.56 -0.11 ± 0.58 * 
--------------------------------------------------------
BASELINE VLCN DELTA 
CONTROL 49. 91 ± 3 .62 54.87 ± 5.15 4.96 ± 4.82 
TIMOLOL 40 ' 76 ± 1 . 6 9 38.62 ± 2.67 -2.14 ± 2.03 
PRAZOSIN :n. s1 ± 5.45 29.81 ± 5.55 -2.58 ± 1.19 
RAUWOLSCINE 35. la.9 ± 5.80 35.53 ± 5.40 0. 04 ± 1.15 
182 
183 
FIGURE 7-3 
PERCENT CHANGE IN BLOOD FLOW DURING CARDIAC NERVE 
STIMULATION FOR GROUPS 1 AND 2 
Percent change in blood fLov (mean ± SEM) from prestimulation 
baseline flow for Groups 1 and l during stimulation of the AAS, PAS, 
and VLCN. All significant changes shown are significant differences 
from the percent change during control conditions of no adrenergic 
blockade. Group 1 (n-7) ( !locking order: Control, timolol, prazosin, 
rauwolscine) is depicted on the left. Group 2 (n=7) (Blocking order: 
Control, timolol, rauwolscine, prazosin) is depicted on the right.* 
indicates p<0.05, *indicates p<~.02. 
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than control (p<0.02). No significant changes were evident during VLCN 
stimulation in Group 1 (bottom left panel). 
Table 7-3 lists the values of resistance before and during stimula-
tion of the AAS, PAS, and VLCN and the change in resistance for Group 1. 
During stimulation of the AAS resistance did not change significantly 
following either 8- or alpha blockade. During stimulation of the PAS 
resistance was significantly lower following timolol and combined timolol 
and prazosin compared to control (p<0.005). There were no significant 
differences between treatments during VLCN stimulation in Group 1. 
Figure 7-4 illustrates the ~ change in resistance from resting 
levels. During AAS (top left panel), the change in resistance was 
significantly higher during timolol and timolol and prazosin (p<0.01). 
Following alpha-2 blockade with rauwolscine, the change in resis~ance was 
no longer statistically different from control. 
During stimulation of the PAS (middle left panel), the change in 
resistance was significantly higher during beta blockade and combined 
alpha-1 and beta blockade, from control (p<0.002). Administration of 
rauwolscine resulted in a change in resistance which was no longer 
significantly different from control. 
During VLCN stimulation (bottom left panel) with combined alpha and 
beta blockade, the resistance vas significantly higher than control 
(p<0.05). Note that tirnalol ad.ministration did result in significant 
increases in resistance during VLCN stimulation. Rauwolscine returned 
the response to VLCN toward control levels. 
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TABLE 7-3 
Calculated resistances (in llllD. Hg/ml/min) for Group 1 (n=7). 
Shown are the data (mean ± SEM) for the prestimulation baseline 
resistances, response to stimulation of each of the three major nerves, 
and the change in resistance from prestlmulation values (delta). 
Results are shown for response to nerve stimulation during each of the 
stimulation protocols used. All signiflcant changes shown are 
differences from control response (no adrenergic blockade) to nerve 
stimulation. *indicates p<0.005. 
TABLE 7-3 
CALCULATED RESISTANCE OF THE CIRCUMFLEX ARTERY 
DURING CARDIAC NERVE STIMULATION FOR GROUP 1 
GROUP 1 BASELINE AAS DELTA 
CONTROL 2.57 ± 0.21 2.20 ± 0.24 -0.37 ± 0.16 
TIMOLOL 2.78 ± 0.28 3.23 ± 0.42 0.44 ± 0.18 
PRAZOSIN 3.05 ± 0.84 3.92 ± 1.35 0.87 ± 0.53 
RAUWOLSCINE 2.06 ± 0.42 1.95 ± 0.27 -0.12 ± 0.17 
CONTROL 
TIMOLOL 
PRAZOSIN 
:BASELINE PAS DELTA 
2.55 ± 0.23 2.25 ± 0.18 -0.31 ± 0.17 
2.E6 ± 0.29 3.12 ± 0.32 0.26 ± 0.16* 
2.95 ± o.74 3.36 ± o.83 o.40 ± o.1s* 
RAUWOLSCINE 2.27 ± 0.44 2.27 ± 0.42 0.00 ± 0.03 
:BASELINE VLCN DELTA 
CONTROL 2 .39 ± 0.21 2. 20 ± 0. 20 -0.18 ± 0.12 
TIMOLOL 2. 96 ± 0. 22 3.19 ± 0.30 0.24 ± 0.18 
PRAZOSIN 2 .98 ± 0. 63 3.48 ± 0.80 0.50 ± 0.18 
RAUWOLSCINE 2. fi 5 ± 0. 82 2.33 ± 0.43 -0.32 ± 0.42 
------------·----------------------------------------
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FIGURE 7-4 
PERCENT CHANGE IN CALCUI.ATED RESISTANCE DURING CARDIAC 
NERVE STIMULA.IION FOR GROUPS 1 AND 2 
Depicted are the percent changes in resistance from prestimula-
tion baseline resistance (mean ± SEK) during stimulation of the AAS 
(top panel), PAS (Middle panel) and VLCN (bottom panel) for Group 1 
(n-7) (left side of graph) and Group 2 (n-7) (right side of graph). *P 
less than .05, *p less than .01. "ffp less than .002 and (jp less than 
.005. All changes shown are in comparison to percent change during 
control conditions of no adrenergic blockade. 
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2. Group Two 
The blood flow values for Group 2 during control and during 
stimulation of the AAS, PAS and VLCN are shown in Table 7-4. The changes 
from baseline levels are listed during each of the drug administrations. 
Stimulation of the AAS following timolol and combined timolol and 
rauwolscine resulted in a significantly smaller change in blood flow 
compared to control stimulation of the AAS (p<0.01). There were no 
changes between groups during stimulation of the PAS. During stimulation 
of the VLCN, flow changes were significantly reduced (p<0.005) following 
timolol and after rauwolscine. After prazosin, the changes during nerve 
stimulation were not significantly different from control. Figure 7-3 
illustrates the percent change in blood flow during stimulation of the 
AAS, PAS, and VLCN in each of the control conditions and following the 
adminstration of the adrenergic blocking agents. In Group 2 during 
stimulation of the AAS (top right panel, Fig. 7-3), the change in flow 
following timolol was significantly lower than control (p<0.05). The 
change in flow following rauwolscine was not significantly different from 
control. During PAS (middle right panel of Fig. 7-3), there were no 
changes in flow following timolol and subsequent alpha blockade. During 
stimulation of the VLCN {bottom right panel, Fig 7-3), after timolol the 
percent change in flow was significantly different from control (p<0.02). 
After rauwolscine the percent change was no longer different from 
control. Thus, Figure 7-3 illustrates that stimulation of each of the 
major cardiac nerves in the presence of &-blockade causes a significant 
vasoconstriction compared to the change in flow when no &-blocking agent 
was given. Administration of alpha·l blockade in addition to &-blockade 
f 
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TARLE 7-4 
Blood flows (m/min) for Group 2 (n-7) (Blocking order: control, 
timolol, rauwolscine, prazosin). Shown are the values of blood flow 
before and during stimulation of the AAS, PAS, and VLCN. Delta is the 
change from prestimulation flow during each of the interventions. 
Statistical comparisons were made between interventions. Data are 
shown as mean± SEM. *Pless ~ban .01, compared to control response. 
TABLE 7-4 
CIRCUMFLEX ARTERY BLOOD FLOW DURING STIMULATION OF 
THE CARDIAC SYMPATHETIC NERVES IN GROUP 2 
GROUP 2 
CONTROL 
TIMOLOL 
BASELINE AAS DELTA 
36.16 ± 5.14 47.28 ± 5.65 11.11 ± 5.57 
34.94 ± 4.01 29.85 ± 3.42 * -5.20 ± 1.29 
RAUWOLSCINE 39.57 ± 3.25 37.92 ± 2.61 -1.66 ± 1.29* 
PRAZOSIN 24.29 ± 2.90 25.89 ± 2.77 1.61 ± 2.33 
BASELINE PAS DELTA 
CONTROL 36.04 ± 6.23 38.82 ± 6.18 2.78 ± 1.66 
TIMOLOL 33.54 ± 3.48 32.05 ± 3.18 -1.49 ± 1.21 
RAUWOLSCINE 33.7S ± 2.51 38.24 ± 4.26 4.49 ± 3.09 
PRAZOSIN 
CONTROL 
TIMOLOL 
25.21 ± 4.53 25.18 ± 3.88 -0.03 ± 0.94 
.RA SELINE VLCN 
36.58 ± 4.77 40.83 ± 4.25 
34.04 ± 4.39 29.12 ± 3.93 
DELTA 
4.25 ± 2.12 
* -4. 92 ± 1.13 
RAUWOLSCINE l4.40 ± 2.29 32.42 ± 2.74 -1.97 ± 1.76* 
PRAZOSIN 22.05 ± 3.00 22.32 ± 2.86 0.27 ± 0.82 
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did not alter the vasoconstriction. However, alpha-2 blockade in 
addition to alpha-1 blockade or even prior to administration of alpha-1 
blockade returned blood flow values toward control. 
Table 7-5 lists the values of resistance before and during stimula-
tion of the AAS, PAS, and VLCN and the change in resistance (delta). 
During stimulation of the AAS resistance changed significantly following 
timolol and remained lower even after both alpha-1 and alpha-2 blockade 
(p<0.002). During stimulation of the PAS resistance did not change 
significantly. During VLCN stimulation, the change in resistance was 
significantly increased during timolol (p<0.01) but decreased after 
alpha-2 blockade so that resistance was no longer significantly different 
from control. 
The right hand side of Figure 7-4 illustrates the percent change in 
resistance for Group 2. During AAS stimulation (Top right panel), the 
change in resistance was significantly higher during tirnolol, rauwolscine 
and prazosin (p<0.002). There vere no changes in resistance during 
stimulation of the PAS (m.iddle right panel). Timolol produced increased 
resistance from control during stimulation of the VLCN, p<.005, (bottom 
right panel), but following rauvolscine, the resistance decreased back 
toward control. 
In summary, A-blockade during cardiac sympathetic stimulation 
resulted in increases in coronary resistance which were not affected by 
the addition of alpha-1 blockade. Alpha-2 blockade resulted in reduc-
tions in resistance to levels comparable to control conditions of no 
adrenergic blockade. Resistance did not return to control levels 
following alpha-1 blockade in combination with &-blockade. 
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TA:&LE 7-5 
Resistances (mm Hg/ml/min) for Group 2 (n-7) during stimulation 
of the AAS, PAS, and VLCN. Delta is the change from baseline resis-
tance during nerve stimulation. All statistical comparisons are based 
on the control response to nerve stimulation. Data are listed as mean 
± SEM. *indicates p<.002, 1indicates p<.01. 
TABLE 7-5 
CALCUI.ATED RESISTANCE OF THE CIRCUMFLEX ARTERY 
DURING CARDIAC NERVE STIMUI.ATION FOR GROUP 2 
-------------------------------------------------------
GROUP 2 :SASELINE AAS DELTA 
CONTROL 3.21 ± 0.31 2.35 ± 0.22 -0.87 ± 0.35 
TIMOLOL 3.30 ± 0.33 3.93 ± 0.34 0.63 ± 0.15 * 
RAUWOLSCINE 3.14 ± 0.27 3.42 ± 0.19 0.27 ± 0.16* 
PRAZOSIN z.ss ± 0.35 2.97 ± 0.53 0.12 ± 0.24* 
------------------------------------------------------
.BASELINE PAS DELTA 
CONTROL 3. 19 ± 0.33 2.97 ± 0.27 -0.22 ± 0.17 
TIMOLOL 3.LtB ± 0.29 3.58 ± 0.21 0.10 ± 0.20 
RAUWOLSCINE 3.78 ± 0.26 3.37 ± 0.19 -0.33 ± 0.20 
PRAZOSIN 2.96 ± 0.58 2.86 ± 0.49 -0.10 ± 0.13 
-----------------------------------------------------
BASELINE VLCN DELTA 
CONTROL 3.09 ± 0.28 2.82 ± 0.31 -0.27 ± 0.14 
TIMOLOL 3.4l ± 0.33 3.97 ± 0.38 o. 54 ± o. nt 
RAUWOLSCINE 3.56±0.17 3.74 ± 0.12 0.18 ± 0.15 
PRAZOSIN 3. ll ± 0.S6 3.14 ± 0.47 0.02 ± 0.16 
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In Groups 3 and 4, the sequence of adminstration of prazosin and 
rauwolscine did not result in differences in the change in flow with and 
of the major nerves. Combined alpha-1 and alpha-2 blockade did not alter 
the response to nerve stimulation significantly from the control re-
sponse, regardless of which agent was administered first. 
Comparison of the prestimulation flow values for Groups 1 through 4 
with analysis of variance, determined that there were no significant 
differences for prestimulation flow values between groups. 
In summary in Groups 1 and 2, the nerves which have a significant 
influence on circumflex blood flow are the AAS, PAS, and the VLCN. These 
nerves had not previously been shown to specifically cause vasoconstric-
tion of the circumflex artery. These nerves can cause significant 
reductions in blood flow and increases in resistance during beta block-
ade. The mechanism of this vasoconstrictor action appears to be alpha 
mediated. 
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D. DISCUSSION 
The aims in this study were to determine which of the major left 
side cardiac nerves influence circumflex blood flow, whether they can 
elicit significant vasoconstriction when stimulated separately in the 
presence of beta blockade, and whether the vasoconstriction is alpha-1 or 
alpha-2 mediated. 
Studies by Randall ~ al. addressed the question of specific neural 
innervation of the heart (22). They stimulated cardiac nerves and 
recorded the changes in contractile force measured by Walton-Brodie 
strain gauge arches. In this way the patterns of sympathetic distribu-
tion to the heart were determined. The ICN increased the contractile 
force of the right ventricle and left ventricular apex. The VMCN 
increased the contractility of the right ventricular conus. The VLCN 
increased contractility in the dorsal lateral aspect of the left ventri-
cle and slightly in the anterior wall. Geis and Kaye extended these 
findings by measuring the contractile changes of the posterior left 
ventricle (7). Both of these studies concurred that stimulation of the 
left stellate ganglion produced profound increases in the contractile 
function of all segments of the left ventricle. Randall and Armour also 
noted that stimulation of more distal branches caused more discrete areas 
to be affected by the nerves (23). 
Later studies investigated the influence of the sympathetics on 
myocardial blood flow. Rinkema et al. stimulated the left and right 
stellate ganglia and injected microspheres to determine the changes in 
regional blood flow. Stimulation of the left stellate ganglia produced 
pronounced changes in posterior wall blood flow as well as anterior wall 
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blood flow (24). Ross and Mulder placed electromagnetic flow probes on 
the LAD, right coronary artery and left coronary artery, and stimulated 
the ansae subclavia of the left stellate ganglion. Their results were 
similar to those of Rinkema et al., in that large increases in blood flow 
were produced in both areas, with the circumflex artery responding to 
stimulation of the left stellate with greater increases in flow than the 
left anterior descending artery (25). 
In the present study, there was an increase in blood flow during 
stimulation of the AAS, PAS, and VLCN. The response to stimulation of 
these three nerves during timolol was significantly different from the 
response to nerve stimulation under control conditions. Only these three 
major nerves actually had this effect. The VMCN and ICN did not actually 
increase flow during stimulation under control conditions. There are two 
plausible explanations for this. First the distribution of these nerves 
is not such as would cause major increases in left ventricular meta-
bolism. Second, both of these nerves contain proportionately more vagal 
fibers than the other three cardiac nerves. Hence it is not surprising 
that following B-blockade neither nerve would effect significant vasocon-
striction of the circumflex bed, since they usually have large parasympa-
thetic influences, which vere not elicited in this study due to prior 
muscarinic blockade with atropine. 
A problem with this method of analysis is that nerves which do not 
innervate a significant portion of the left ventricle and hence do not 
cause significant metabolic vasodilation are excluded from the study. It 
is possible that such nerves may in fact contribute to reduction in blood 
flow when stimulated, but the response would be significant only when 
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compared to resting blood flow during beta blockade. One possibility for 
assessing the influence of all of the cardiac nerves on blood flow would 
be to stimulate the nerves in an arrested or fibrillating heart prepara-
tion to avoid the confounding influence of neurally mediated metabolic 
changes. An additional disadvantage of this method is that it would 
appear that the nerves supplying the myocardium also .supply the arteries 
in the vicinity. While it is possible that a large nerve such as the 
VLCN has separate vasomotor and accelerator fibers, the separation of 
vasomotor and inotropic effects during stimulation of this nerve would be 
difficult. Without a separation of myocardial influences from purely 
vasomotor effects, the determination of a regional distribution and 
pattern of innervation on coronary blood flow is hindered. 
Only the AAS showed consistent vasoconstriction in Group 1 and 
Group 2. The reason for the non-uniformity of results between nerves is 
most likely due to the amount of myocardium innervated. Stimulation of 
the left stellate ganglion causes large increases in contractile force 
(7,22), and blood flow throughout the entire left ventricle (24). 
Stimulation of the cardiac nerves more distally produces more discrete 
changes in contraction and presumably blood flow. If a large amount of 
myocardium is innervated by one nerve, the response to nerve stimulation 
will be more consistent between animals. Smaller nerves which innervate 
less myocardium will probably result in more variability of response 
between animals, particularly if the site of stimulation is varied distal 
to the stellate ganglion. 
Following beta blockade with timolol the stimulation induced change 
in flow decreased compared to control. This indicates a vasoconstriction 
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which is most likely due to the unmasking of alpha receptors, and is in 
accord with previous studies which demonstrated a vasoconstriction 
following beta blockade (5). In a non-beating preparation, Gerova et al. 
demonstrated coronary vasoconstriction of the LAD during stimulation of 
the left stellate ganglia which was eliminated by adminstration of 
phentolamine (8). Many previous investigations have demonstrated 
vasoconstriction which limits metabolic vasodilation (9), or is unmasked 
by beta blockade (2), but most of those studies utilized phenoxybenzamine 
or phentolamine which block both alpha-1 and alpha-2 receptors. The 
results from such studies would not clarify the separate influences of 
both receptor subtypes. 
Although alpha-2 receptors have been demonstrated to modulate 
norepinephrine release (15,16,23), only recently have studies been done 
to determine whether alpha-2 receptors also control coronary blood flow. 
Investigations in recent years have proposed that it is actually alpha-2 
receptors which mediate coronary vasoconstriction (10,12). 
It is difficult to determine from the present studies whether 
alpha-1 or alpha-2 receptors predominate in mediating coronary vasocon-
striction. Although timolol in Group 1 reduced flow and increased 
resistance probably by unmasking alpha receptors, this reduction in flow 
was not blocked by prazosin. Subsequent adminstration of rauwolscine 
eliminated the vasoconstriction. 
In part, these effects of rauwolscine in Group 2 may be ascribed to 
its presynaptic action. ~y removing the negative feedback inhibition of 
norepinephrine (NE), more NE might be expected to have stimulated the 
unblocked alpha-1 receptors causing vasoconstriction following admini-
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stration of rauwolscine (See Figure 7-5). In addition the peripheral 
adminstration of rauwolscine may have resulted in a larger release of the 
NE due to the open chest anesthetized preparation. This higher back-
ground level of NE plus background levels of epinephrine which is taken 
up by nerve terminals and released, may have caused a higher preexisting 
level of vasoconstriction which would appear to cause of blunting of the 
effect of NE during stimulation. Thus changes in blood flow during 
stimulation would not be as apparent due to a high existing level of 
circulating catecholamines. Separation of the pre and post synaptic 
actions of alpha-2 receptors would clarify the results of this study and 
also elucidate the respective roles of alpha-1 and alpha-2 receptors. 
An unexpected result of this study was that blockade of alpha-1 
receptors in Group 1 resulted in significantly higher resistance and 
lower flows compared to control. There are several possibilities for 
this. First, it may be that alpha-2 receptors are responsible for the 
vasoconstriction. This eonclusion would be supported by the fact that 
subsequent alpha-2 blockade brought the change in resistance back toward 
control. Another possibility for this action of prazosin may be that 
alpha-1 receptors on the myocardium mediate some form of metabolic 
vasodilation and that olockade of these receptors unmasks alpha- 2 
receptors located on the vasculature. This conjecture has some basis in 
recent studies on the importance of myocardial alpha-1 receptors by Corr 
(3). Corr has proposed that alpha-1 receptors can influence electrical 
activity in the myocardium, and can also mediate the rise in blood 
pressure elicited with stellate stimulation in the presence of beta 
blockade. Corr has also shown that myocardial alpha-1 receptors increase 
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FIGURE 7-5 
SCHEMATIC OF PRESYNAPTIC ADRENERGIC RECEPTOR MODULATION 
OF NEURONALLY RELEASED NOREPINEPHRINE 
Schematic of the modulation of norepinephrine release from a 
sympathetic nerve terminal by adrenergic receptors and muscarinic 
receptors and the effects of adrenergic nerve stimulation on a blood 
vessel. (-) indicates a negative feedback effect on norepinephrine 
release and (+) indicates positive feedback on release of 
norepinephrine. (Modified from: Opie,L. The Heart. Ed. by L. Opie. New 
York: Grune and Stratton, 1982, pp.234.) 
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significantly in number during myocardial ischemia. 
The time course of stimulation of the nerves might be important in 
interpreting the results from this and previous studies. In our study 
the measurements were taken during a maximal response. Other studies 
which have demonstrated alpha-vasoconstriction have also measured either 
maximal response, or stimulated for less than 2 minutes. However, in the 
study by Ross and Mulder (25), a maximum response to stimulation fol-
lowing beta blockade was reached at 10-15 seconds and slowly subsided 
after 1-2 minutes of duration. Williams and Most demonstrated that bolus 
injections of phenylephrine caused vasoconstriction, but that with 
prolonged administration of the alpha-1 agonist, the vasoconstriction 
subsided (32). The possibility of an overriding metabolic influence on 
vasoconstriction during prolonged sympathetic stimulation cannot be ruled 
out. 
In conclusion, the major nerves which innervate the posterior wall 
also influence coronary blood flow. Furthermore, the traditional concept 
of alpha-1 receptors innervating the vasculature needs to be reexamined. 
It appears f.rom the results of this study that alpha-2 receptors play as 
important, it not more so, a role in constricting the coronary vascula-
ture. 
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CHAPTER VIII 
SUMMARY 
1. Stimulation of cardiac sympathetic nerves during beta blockade 
increased infarct size following coronary artery occlusion, 
compared to when the nerves were not stimulated, and compared to 
when the sympathetic nerves were stimulated without prior beta 
blockade. 
2. Blockade of alpha receptors in addition to beta receptor blockade 
with sympathetic stimulation resulted in a smaller infarct size 
compared to infarct size in the presence of sympathetic stimulation 
and beta blockade alone. 
3. Blockade of alpha receptors did not increase blood flow to the 
posterior wall following circumflex artery occlusion. 
4. Regional denervation of the posterior wall did not increase blood 
flow to the occluded region. 
5. The left anterior ansa subclavia, left posterior ansa subclavia, 
and ventrolateral cardiac nerve induce significant vasoconstriction 
of the circumflex artery. 
6. Alpha-2 adrenergic receptor blockade effectively blocked the 
vasoconstriction produced during stimulation of the left side 
cardiac nerves, in the presence of beta-blockade. Alpha-1 receptor 
blockade did not eliminate the vasoconstriction induced under 
similar conditions. 
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CHAPTER IX 
CONCLUSIONS 
This dissertation began as an attempt to define the role of alpha 
receptors in the evolution of a myocardial infarction and then broadened 
to encompass an investigation into how alpha receptors altered blood flow 
during coronary artery occlusion, how removal of the sympathetics 
affected blood flow during coronary artery occlusion, and how specific 
cardiac sympathetic nerves modulated blood flow to the posterior wall. 
It was initially hypothesized that stimulation of the left stellate 
ganglion in the presence of £-blockade would cause an increase in infarct 
size due to alpha receptor stimulation (Chapter IV). That study showed 
that administration of timolol prior to a coronary artery occlusion did 
not result in a smaller infarct size when compared to control. The fact 
that there was no difference in the mean size of the infarctions between 
the control dogs, and dogs given timolol, suggested that circulating 
catecholamines were not as important as neurally released catecholamines. 
However, when the left stellate ganglion was stimulated in the presence 
of beta blockade, the size of the infarcts were significantly larger than 
control. 'When alpha-blockade was given in addition to &-blockade prior 
to coronary artery occlusion, left stellate stimulation did not increase 
the size of the infarcts compared to control. Moreover, the size of the 
infarcts were significantly smaller than when the left stellate was 
stimulated in the presence of £-blockade alone. 
209 
210 
Thus, it was postulated that the deleterious effect on infarct size 
of stellate stimulation in the presence of &-blockade, was due to a 
reduction in blood flow to the ischemic zone via unopposed alpha receptor 
stimulation. 
In the next study (Chapter V), the possibility that alpha receptors 
reduced blood flow to the ischemic zone during stellate stimulation was 
tested as an explanation for the findings from the first study. In the 
second study, the administration of prazosin either before or after 
coronary occlusion did not result in increased blood flow to the ischemic 
region (Chapter V). However, prazosin did increase blood flow to the 
normal region when given prior to coronary artery occlusion. Further-
more, not only did prazosin cause a vasodilation in the normal zone, it 
actually increased blood flow above control levels, which was somewhat 
surprising since blockade of alpha receptors would have been expected to 
have merely removed the vasoconstrictor effects of left ansae subclavia 
stimulation in the presence of &-blockade. A possible explanation for 
the large vasodilation elicited following prazosin, is that removal of 
the influence of circulating catecholamines might account for the large 
increase in blood flow following alpha blockade (See Chapter V). In the 
study in which infarct sizes were measured (Chapter IV) circulating 
catecholamines may not have contributed as much to infarct size, due to 
the limitation in blood flow to the posterior wall. However, circulating 
catecholamines were not measured in either study. 
Even more surprising in the prazosin study than the increase in 
flow to the normal zone during alpha-1 blockade, was the fact that left 
ansae subclavia stimulation in the presence of g-blockade did not 
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decrease blood flow from control. Other investigators had reported a 
potent vasoconstriction via alpha receptors when unopposed by &-blockade. 
The posterior coronary artery occlusion in the prazosin study in all 
probability confounded the results of anterior wall blood flow measure-
ments. 
Whereas blockade of alpha receptors was involved in the evolution 
of a myocardial infarction in the infarct study, that effect did not 
appear to be mediated by a reduction in blood flow to the ischemic zone 
based on the results from the second study (Chapter V). In light of the 
fact that prazosin increased blood flow to the normal zone, the possi-
bility exists that prazosin also increased border zone flow, and thus 
retarded the extension of the infarction. Alpha-blockade might have 
accomplished this by blockade of peripheral alpha receptors resulting in 
a reduction of total peripheral resistance, with a consequent drop in 
afterload. With a drop in afterload, the reduction in myocardial oxygen 
conswnption would have allowed salvage of some marginally ischemic zones, 
by returning the balance between oxygen supply and demand toward normal 
levels. 
The possible contribution of myocardial alpha receptors to the 
development of ischemia should not be overlooked. It is conceivable that 
myocardial alpha-1 receptors alter cardiac metabolism and thus oxygen 
conswnption. Thus, in the infarct study, blockade of myocardial alpha-
receptors might have removed the detrimental influence of increased 
myocardial metabolism. During a coronary artery occlusion, the oxygen 
supply/demand balance is upset. Under such conditions alpha receptors 
may not be expected to cause noticeable changes in metabolism, due to the 
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overwhelming influence of &-receptors. However, if &-receptors are 
blocked, and the amount of coronary blood flow is decreased, a small 
increment in oxygen consumption (via alpha-1 receptor stimulation) may 
tip the balance on the side of increasing oxygen debt. A vicious cycle 
could result, with the increased demand outstripping the restricted blood 
supply. Blockade of alpha-1 receptors could then return the balance 
toward normal. It is likely that such a small change in blood flow could 
not be detected in these studies in which microspheres were utilized. 
Blood flows in the posterior wall following coronary occlusion dropped 
down to the limit of the blood flow necessary to deposit the requisite 
number of microspheres per tissue sample for accurate blood flow calcula-
tion. Thus, the limited resolution of the microsphere technique at low 
blood flows probably contributed to the lack of positive findings during 
the treatment with prazosin. 
Several possibilities exist for prazosin's beneficial effects on 
the extent of myocardial infarction. Prazosin may favorably alter 
hemodynamics by reducing afterload via peripheral alpha blockade and it 
may lower oxygen consumption by blocking myocardial alpha-1 receptors. 
Furthermore, as was suggested in the study investigating the effects of 
prazosin on blood flow, while it does not alter flow to the ischemic 
zone, it may increase border zone flow and salvage tissue in that manner. 
The results from the second study in which blood flow to the 
myocardium was assessed following prazosin (Chapter V) indicated that 
alpha receptors did not influence blood flow to the ischemic zone. The 
third study (Chapter VI) was included to determine whether regional de-
nervation of the posterior wall might influence blood flow to the 
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ischemic zone. It was originally hypothesized that removal of the 
sympathetic nerves to that region would entail removal of the 'tonic' 
level of vasoconstriction previously reported, and thus increase blood 
flow to the ischemic zone. This study demonstrated that posterior wall 
denervation did not result in increased blood flow to the ischemic zone 
by removing sympathetic vasoconstriction. However, posterior left 
ventricular denervation did drop blood flow to both the anterior and 
posterior wall and resulted in a reduction in mean arterial pressure. 
During LSS, in the presence of &-blockade, blood pressure and blood 
flow increased. The fact that resistance did not change during LSS 
suggests that the change in blood flow was not vasomotor in origin, but 
was passive and reflected the rise in arterial pressure. It was found 
that increasing the dose of timolol did not eliminate the rise in 
arterial pressure during stellate stimulation. These effects indicate 
the involvement of non-beta mediated effects, possibly via alpha-1 
receptors on the myocardium. However, alpha blockade was not admini-
stered in this study, to determine whether alpha-1 receptors would indeed 
have blocked the increase in blood pressure elicited by stellate stimula-
tion. 
One of the intriguing findings in the phenol study, was that 
regional denervation did not increase blood flow via removal of 'tonic' 
vasoconstriction. In fact, posterior wall denervation actually decreased 
blood flow to both the posterior and anterior left ventricle. In addi-
tion, regional denervation eliminated the response to left stellate 
stimulation in the innervated region. Prior to application of phenol to 
the posterior wall, LSS had increased blood pressure and blood flow even 
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in the presence of beta blockade. Following the regional denervation, 
both responses to LSS were eliminated. By removing the sympathetic 
influences to both the anterior and posterior wall, cardiac metabolism 
probably decreased as did cardiac function, with a consequent drop in 
blood pressure and a passive drop in blood flow. In addition, the 
possibility exists that denervation of the posterior wall interrupted the 
innervation of the anterior wall. Previously it had been thought that 
cardiac nerves travel in a base to apex fashion and follow the coronary 
arteries to innervate the adjacent myocardium. Finally, it cannot be 
ruled out that acute application of phenol caused a stunning of the 
myocardium, and decreased function possibly by a cardio-cardiac depressor 
effect due to stimulation of posterior wall receptors. 
In conclusion, the phenol study suggests that the previously 
reported tonic level of alpha-vasoconstriction does not appear to be of 
as much importance during coronary artery occlusion, as it might be 
during normal physiologic conditions. The results from the phenol study 
(Chapter VI) indicate that an important pathway for nervous innervation 
to the anterior wall is via fibers originating in the posterior region 
which cross over the posterior epicardium to innervate the anterior wall. 
Finally, there is possibility not tested in this study, that alpha 
receptors have inotropic influences which can be eliminated by posterior 
wall denervation. 
The actual cardiac nerves mediating coronary vasoconstriction have 
not been determined. It was found in the last study, that the VLCN, AAS, 
and PAS, all cause significant vasoconstriction of the circumflex artery 
but only with prior £-blockade. Many investigations have reported that 
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alpha receptors mediate potent coronary vasoconstriction, but these 
studies did not differentiate between alpha-1 and alpha-2 receptors. 
Only recently have alpha-2 receptors been found to mediate vasoconstric-
tion. The vasoconstriction elicited by stimulation of the AAS, PAS, and 
VLCN was eliminated more effectively by blockade of alpha-2 receptors 
with rauwolscine, than by alpha-1 blockade with prazosin. Thus, alpha-2 
receptors appeared to play a slightly greater role in vasoconstriction of 
the circumflex artery than did alpha-1 receptors. However, as was 
remarked upon, the pre- and post-junctional actions of alpha-2 receptors 
could not be separated in this study (See Discussion, Chapter VI). 
It would appear that alpha-mediated vasoconstriction does not play 
a major role in altering blood flow to ischemic regions. Alpha vasocon-
striction can be elicited by sympathetic stimulation, but only when the 
overriding influence of B-mediated vasodilation is eliminated. The time 
course of stimulation used may have led to some conflicting results when 
compared to earlier studies. In Chapter VII, vasoconstriction in the 
presence of B-blockade was readily elicited, but stimulations did not 
last for more than 90 seconds. This period of stimulation was comparable 
to that used in other studies demonstrating alpha-mediated vasoconstric-
tion. However, in the first three studies presented, stellate stimula-
tion was continued for much longer durations, 3-5 minutes before begin-
ning microsphere injections. It is possible that alpha-vasoconstriction 
is transient and of insignificant importance during longer periods of 
sympathetic input. If alpha receptors do mediate metabolic increases in 
flow, however slight, then these effects may not be of apparent immedi-
ately. This would be of particular importance during the course of 
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ischemia, when regardless of whether alpha receptors mediate noticeable 
vasomotor effects, the possibility of alpha-1 mediated increases in 
metabolism may be enough to initiate significant myocardial damage. 
It should not be disregarded that the open chest anesthetized prep-
aration utilized in this dissertation does not facilitate the responses 
of adrenergic receptors to stimulation. Therefore the activity of alpha 
receptors may be of more importance in studies done in conscious animals. 
In conclusion, I would like to put into writing a few closing 
comments on this area of research based on what I have found in my 
studies. I started this project with the concept that neural stimulation 
of alpha receptors would cause vasoconstriction, which would worsen the 
course of myocardial infarction. However, this rather simple assumption 
that alpha receptors vasoconstrict arteries during normal and abnormal 
conditions has evolved into an appreciation of the complex interactions 
between alpha-1 and alpha-2 receptors on blood flow and cardiac function. 
I assumed that alpha receptor stimulation would decrease blood flow 
to an ischemic bed and that this could be eliminated by alpha-1 blockade 
or regional denervation. Until recently alpha-1 receptors were thought 
to be the primary mediator of vasoconstriction. This was not seen in our 
study, contrary to other studies, in part because the duration of 
stimulation was longer than those used by other investigators. Thus it 
would appear that if alpha receptors induce coronary vasoconstriction it 
is probably transient in nature. 
However, if alpha receptors exert only transient influences on 
blood flow, this does not mean that they are a receptor of only inconse-
quential importance or interest. Our studies point toward the possible 
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role of alpha receptors in other aspects of neural regulation of the 
heart. It is possible that alpha receptors have influences on function 
and metabolism, but these effects have yet to be elucidated. Thus the 
concept of neural stimulation of alpha receptors causing coronary 
vasoconstriction does not appear to be as important as has been written 
in the literature. Instead, I have come around full circle, to stress 
the predominance of cardiac metabolism on blood flow. In this picture of 
blood flow regulation, the sympathetic nerves are even more important 
because of their complex influence on myocardial and vascular beta and 
alpha receptors. 
APPENDIX A 
RETROSPECTIVE ANALYSIS OF BLOOD FLOW 
In order to check the accuracy of flows in the ischemic region, 
endocardial and epicardial samples from the same slice were combined to 
estimate flow retrospectively thus achieving sample weights of close to 1 
gram. 
Initial blood flow analysis: 
Sample# 
Endo 
5 
7 
9 
CTRL 
2685 
4374 
3981 
Counts/min 
CAO 
1746 
969 
1328 
CAO-
LSS 
710 
500 
568 
Weight 
CAO- ' (gm) 
LSS-PRAZ 
451 
726 
764 
.495 
.540 
.587 
FLows (ml/min/gm) 
CTRL 
.549 
.819 
.686 
CAO 
.636 
.324 
.408 
CAO CAO 
LSS LSS-PRAZ 
.507 
.328 
.342 
.483 
. 712 
.690 
Blood Flow ........................................ 0.685 0.456 0.392 
0.628 
Epi 
6 5920 1818 779 846 .689 .869 .476 .400 .651 
8 3545 2075 1009 577 .555 .646 .674 .643 .551 
10 4621 2154 918 743 . 720 .649 .539 .451 .547 
--------------------------
Blood Flow ........................................ 0.721 0.546 0.498 
0.583 
* Blood flows were initially calculated per sample as shown above. The 
flows were separated into endocardial and epicardial flows, for each of 
the four experimental conditions. The final value of blood flow used in 
the analysis of data represents the average of all the samples in the 
left ventricular ischemic zone. 
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Flows estimated retrospectively: 
Sample# 
CTRL 
endo 
5 
7 
9 
Totals 
.674 
epi 
6 
8 
10 
2685 
4374 
3981 
5920 
3545 
4621 
Counts/min 
CAO 
1746 
969 
1328 
CAO-
LSS 
710 
500 
568 
11040 4043 
1818 779 
2075 1009 
2154 918 
CAO-
LSS-PRAZ 
451 
726 
764 
1778 
846 
577 
743 
'Weight 
(gm) 
0.50 
0.54 
0.59 
1941 
0.69 
0.56 
0. 72 
------------------------------------
Totals 
.621 
14086 6047 2706 2166 
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Blood Flow (ml/min/gm) 
CTRL CAO 
1.62 .732 
1. 96 . 771 
CAO-
LSS 
.478 
.590 
CAO-
LSSPRAZ 
.412 
.518 
**The samples of tissue in each slice of the left ventricular ischemic 
zone were first separated into endocardial and epicardial samples. The 
counts/min and weight of each sample were summed. Blood flow was 
calculated using the summed counts/min and weights for each slice. The 
final blood flow value for the left ventricular ischemic zone represented 
the average of the blood flow per slice of LV, not per sample of LV as 
described in the first section of the table. 
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